export const IPP_IMJUDO_PERU_FOOTER_HTML = `
<!DOCTYPE html><!--[if IE]>  <html class="pdf24_ie"> <![endif]-->
<html>
	<head>
		<meta charset="utf-8" />
		<title>
		</title>
		
	<STYLE> 
 .pdf24_ sup {
	vertical-align: baseline;
	position: relative;
	top: -0.4em;
}
.pdf24_ sub {
	vertical-align: baseline;
	position: relative;
	top: 0.4em;
}
.pdf24_ a:link {text-decoration:none;}
.pdf24_ a:visited {text-decoration:none;}
@media screen and (min-device-pixel-ratio:0), (-webkit-min-device-pixel-ratio:0), (min--moz-device-pixel-ratio: 0) {.pdf24_view{ font-size:10em; transform:scale(0.1); -moz-transform:scale(0.1); -webkit-transform:scale(0.1); -moz-transform-origin:top left; -webkit-transform-origin:top left; } }
.pdf24_layer { }.pdf24_ie { font-size: 1pt; }
.pdf24_ie body { font-size: 12em; }
@media print{.pdf24_view {font-size:1em; transform:scale(1);}}
.pdf24_grlink { position:relative;width:100%;height:100%;z-index:1000000; }
.pdf24_01 {
	position: absolute;
	white-space: nowrap;
}
.pdf24_02 {
	font-size: 1em;
	line-height: 0.0em;
	width: 51em;
	height: 66em;
	border-style: none;
	display: block;
	margin: 0em;
}

@supports(-ms-ime-align:auto) { .pdf24_02 {overflow: hidden;}}
.pdf24_03 {
	position: relative;
}
.pdf24_04 {
	position: absolute;
	pointer-events: none;
	clip: rect(38.48417em,44.05em,56.88em,6.040333em);
	width: 100%;
}
.pdf24_05 {
	position: relative;
	width: 51em;
}
.pdf24_06 {
	height: 6.6em;
}
.pdf24_ie .pdf24_06 {
	height: 66em;
}
@font-face {
	font-family:"VMRCFF+Times New Roman Bold";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_07 {
	font-size: 1em;
	font-family: "VMRCFF+Times New Roman Bold";
	color: #000000;
}
.pdf24_08 {
	line-height: 1.107422em;
}
.pdf24_09 {
	letter-spacing: -0.0001em;
}

.pdf24_ie .pdf24_09 {
	letter-spacing: -0.0015px;
}
.pdf24_10 {
	letter-spacing: 0.0007em;
}

.pdf24_ie .pdf24_10 {
	letter-spacing: 0.0116px;
}
.pdf24_11 {
	letter-spacing: -0.0003em;
}

.pdf24_ie .pdf24_11 {
	letter-spacing: -0.0052px;
}
.pdf24_12 {
	font-size: 0.92em;
	font-family: "VMRCFF+Times New Roman Bold";
	color: #000000;
}
.pdf24_13 {
	letter-spacing: -0.0019em;
}

.pdf24_ie .pdf24_13 {
	letter-spacing: -0.0286px;
}
.pdf24_14 {
	letter-spacing: 0em;
}

.pdf24_ie .pdf24_14 {
	letter-spacing: 0px;
}
.pdf24_15 {
	letter-spacing: -0.0027em;
}

.pdf24_ie .pdf24_15 {
	letter-spacing: -0.0392px;
}
.pdf24_16 {
	letter-spacing: -0.0008em;
}

.pdf24_ie .pdf24_16 {
	letter-spacing: -0.0118px;
}
@font-face {
	font-family:"KVCUDS+Times New Roman";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_17 {
	font-size: 0.92em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_18 {
	letter-spacing: -0.0014em;
}

.pdf24_ie .pdf24_18 {
	letter-spacing: -0.0203px;
}
.pdf24_19 {
	letter-spacing: -0.0022em;
}

.pdf24_ie .pdf24_19 {
	letter-spacing: -0.0318px;
}
.pdf24_20 {
	letter-spacing: -0.002em;
}

.pdf24_ie .pdf24_20 {
	letter-spacing: -0.0295px;
}
.pdf24_21 {
	letter-spacing: -0.0009em;
}

.pdf24_ie .pdf24_21 {
	letter-spacing: -0.013px;
}
.pdf24_22 {
	letter-spacing: 0.0001em;
}

.pdf24_ie .pdf24_22 {
	letter-spacing: 0.0018px;
}
.pdf24_23 {
	letter-spacing: -0.0018em;
}

.pdf24_ie .pdf24_23 {
	letter-spacing: -0.0263px;
}
.pdf24_24 {
	letter-spacing: -0.0017em;
}

.pdf24_ie .pdf24_24 {
	letter-spacing: -0.0244px;
}
.pdf24_25 {
	letter-spacing: -0.0015em;
}

.pdf24_ie .pdf24_25 {
	letter-spacing: -0.0228px;
}
@font-face {
	font-family:"ARLVGB+Times New Roman Italic";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_26 {
	font-size: 0.92em;
	font-family: "ARLVGB+Times New Roman Italic";
	color: #000000;
}
.pdf24_27 {
	letter-spacing: -0.0043em;
}

.pdf24_ie .pdf24_27 {
	letter-spacing: -0.064px;
}
.pdf24_28 {
	letter-spacing: -0.0016em;
}

.pdf24_ie .pdf24_28 {
	letter-spacing: -0.0232px;
}
.pdf24_29 {
	letter-spacing: 0.004em;
}

.pdf24_ie .pdf24_29 {
	letter-spacing: 0.0581px;
}
.pdf24_30 {
	letter-spacing: -0.0031em;
}

.pdf24_ie .pdf24_30 {
	letter-spacing: -0.0449px;
}
.pdf24_31 {
	letter-spacing: -0.0033em;
}

.pdf24_ie .pdf24_31 {
	letter-spacing: -0.0479px;
}
.pdf24_32 {
	letter-spacing: -0.0012em;
}

.pdf24_ie .pdf24_32 {
	letter-spacing: -0.0184px;
}
.pdf24_33 {
	letter-spacing: -0.0011em;
}

.pdf24_ie .pdf24_33 {
	letter-spacing: -0.0167px;
}
.pdf24_34 {
	letter-spacing: -0.0021em;
}

.pdf24_ie .pdf24_34 {
	letter-spacing: -0.0315px;
}
@font-face {
	font-family:"CTDADR+Symbol";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_35 {
	font-size: 0.92em;
	font-family: "CTDADR+Symbol", "Times New Roman";
	color: #000000;
}
.pdf24_36 {
	line-height: 1.225098em;
}
.pdf24_37 {
	font-size: 0.696em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_38 {
	letter-spacing: 0.0014em;
}

.pdf24_ie .pdf24_38 {
	letter-spacing: 0.0205px;
}
.pdf24_39 {
	letter-spacing: -0.001em;
}

.pdf24_ie .pdf24_39 {
	letter-spacing: -0.0146px;
}
.pdf24_40 {
	letter-spacing: -0.0028em;
}

.pdf24_ie .pdf24_40 {
	letter-spacing: -0.0405px;
}
.pdf24_41 {
	letter-spacing: -0.0013em;
}

.pdf24_ie .pdf24_41 {
	letter-spacing: -0.0195px;
}
.pdf24_42 {
	font-size: 0.648em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_43 {
	font-size: 0.83em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_44 {
	letter-spacing: 0.0013em;
}

.pdf24_ie .pdf24_44 {
	letter-spacing: 0.0167px;
}
.pdf24_45 {
	position: absolute;
	pointer-events: none;
	clip: rect(17.55em,43.87em,59.83966em,5.940333em);
	width: 100%;
}
.pdf24_46 {
	letter-spacing: -0.0023em;
}

.pdf24_ie .pdf24_46 {
	letter-spacing: -0.0335px;
}
.pdf24_47 {
	letter-spacing: 0.0002em;
}

.pdf24_ie .pdf24_47 {
	letter-spacing: 0.0031px;
}
.pdf24_48 {
	font-size: 0.75em;
	font-family: "VMRCFF+Times New Roman Bold";
	color: #000000;
}
.pdf24_49 {
	letter-spacing: 0.0022em;
}

.pdf24_ie .pdf24_49 {
	letter-spacing: 0.0261px;
}
.pdf24_50 {
	font-size: 0.6em;
	font-family: "VMRCFF+Times New Roman Bold";
	color: #000000;
}
.pdf24_51 {
	letter-spacing: 0.0045em;
}

.pdf24_ie .pdf24_51 {
	letter-spacing: 0.036px;
}
.pdf24_52 {
	font-size: 0.63em;
	font-family: "VMRCFF+Times New Roman Bold";
	color: #000000;
}
.pdf24_53 {
	letter-spacing: 0.0079em;
}

.pdf24_ie .pdf24_53 {
	letter-spacing: 0.08px;
}
.pdf24_54 {
	letter-spacing: 0.001em;
}

.pdf24_ie .pdf24_54 {
	letter-spacing: 0.012px;
}
.pdf24_55 {
	font-size: 0.75em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_56 {
	font-size: 0.6em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_57 {
	letter-spacing: -0.0055em;
}

.pdf24_ie .pdf24_57 {
	letter-spacing: -0.044px;
}
.pdf24_58 {
	letter-spacing: 0.0008em;
}

.pdf24_ie .pdf24_58 {
	letter-spacing: 0.01px;
}
.pdf24_59 {
	letter-spacing: 0.008em;
}

.pdf24_ie .pdf24_59 {
	letter-spacing: 0.0805px;
}
.pdf24_60 {
	font-size: 0.504em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_61 {
	letter-spacing: 0.012em;
}

.pdf24_ie .pdf24_61 {
	letter-spacing: 0.0805px;
}
.pdf24_62 {
	font-size: 0.54em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_63 {
	letter-spacing: 0.0018em;
}

.pdf24_ie .pdf24_63 {
	letter-spacing: 0.0234px;
}
.pdf24_64 {
	letter-spacing: 0.0016em;
}

.pdf24_ie .pdf24_64 {
	letter-spacing: 0.0214px;
}
.pdf24_65 {
	letter-spacing: 0.0019em;
}

.pdf24_ie .pdf24_65 {
	letter-spacing: 0.0246px;
}
.pdf24_66 {
	letter-spacing: -0.0005em;
}

.pdf24_ie .pdf24_66 {
	letter-spacing: -0.0081px;
}
.pdf24_67 {
	letter-spacing: -0.0002em;
}

.pdf24_ie .pdf24_67 {
	letter-spacing: -0.0022px;
}
.pdf24_68 {
	font-size: 0.696em;
	font-family: "VMRCFF+Times New Roman Bold";
	color: #000000;
}
@font-face {
	font-family:"TJSVIM+Times New Roman";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_69 {
	font-size: 0.92em;
	font-family: "TJSVIM+Times New Roman";
	color: #000000;
}
.pdf24_70 {
	letter-spacing: -0.0054em;
}

.pdf24_ie .pdf24_70 {
	letter-spacing: -0.08px;
}
.pdf24_71 {
	letter-spacing: 0.0024em;
}

.pdf24_ie .pdf24_71 {
	letter-spacing: 0.0352px;
}
.pdf24_72 {
	letter-spacing: -0.0007em;
}

.pdf24_ie .pdf24_72 {
	letter-spacing: -0.0098px;
}
.pdf24_73 {
	letter-spacing: 0.0011em;
}

.pdf24_ie .pdf24_73 {
	letter-spacing: 0.0144px;
}
.pdf24_74 {
	font-size: 0.92em;
	font-family: "KVCUDS+Times New Roman";
	color: #222222;
}
.pdf24_75 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.957998em,45.05em,59.34967em,5.960333em);
	width: 100%;
}
.pdf24_76 {
	letter-spacing: 0.0004em;
}

.pdf24_ie .pdf24_76 {
	letter-spacing: 0.0066px;
}
.pdf24_77 {
	letter-spacing: -0.0006em;
}

.pdf24_ie .pdf24_77 {
	letter-spacing: -0.009px;
}
.pdf24_78 {
	letter-spacing: -0.0025em;
}

.pdf24_ie .pdf24_78 {
	letter-spacing: -0.0363px;
}
.pdf24_79 {
	letter-spacing: -0.0029em;
}

.pdf24_ie .pdf24_79 {
	letter-spacing: -0.0431px;
}
.pdf24_80 {
	letter-spacing: -0.0034em;
}

.pdf24_ie .pdf24_80 {
	letter-spacing: -0.0313px;
}
.pdf24_81 {
	letter-spacing: -0.003em;
}

.pdf24_ie .pdf24_81 {
	letter-spacing: -0.0434px;
}
.pdf24_82 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.958333em,45.05em,50.87em,5.960333em);
	width: 100%;
}
.pdf24_83 {
	letter-spacing: 0.0023em;
}

.pdf24_ie .pdf24_83 {
	letter-spacing: 0.031px;
}
.pdf24_84 {
	letter-spacing: 0.0021em;
}

.pdf24_ie .pdf24_84 {
	letter-spacing: 0.0281px;
}
.pdf24_85 {
	letter-spacing: 0.002em;
}

.pdf24_ie .pdf24_85 {
	letter-spacing: 0.027px;
}
.pdf24_86 {
	letter-spacing: 0.0015em;
}

.pdf24_ie .pdf24_86 {
	letter-spacing: 0.0196px;
}
.pdf24_87 {
	letter-spacing: 0.0012em;
}

.pdf24_ie .pdf24_87 {
	letter-spacing: 0.0158px;
}
.pdf24_88 {
	letter-spacing: -0.0004em;
}

.pdf24_ie .pdf24_88 {
	letter-spacing: -0.0065px;
}
@font-face {
	font-family:"JRPTTM+Courier New";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_89 {
	font-size: 0.92em;
	font-family: "JRPTTM+Courier New", "Times New Roman";
	color: #000000;
}
.pdf24_90 {
	line-height: 1.132813em;
}
.pdf24_91 {
	position: absolute;
	pointer-events: none;
	clip: rect(12.31em,24.93533em,41.2275em,5.960333em);
	width: 100%;
}
.pdf24_92 {
	letter-spacing: -0.0024em;
}

.pdf24_ie .pdf24_92 {
	letter-spacing: -0.0358px;
}
.pdf24_93 {
	position: absolute;
	pointer-events: none;
	clip: rect(42.60417em,16.46533em,42.7275em,5.960333em);
	width: 100%;
}
.pdf24_94 {
	letter-spacing: -0.0038em;
}

.pdf24_ie .pdf24_94 {
	letter-spacing: -0.0566px;
}
.pdf24_95 {
	position: absolute;
	pointer-events: none;
	clip: rect(9.860001em,15.49367em,42.7875em,5.960333em);
	width: 100%;
}
.pdf24_96 {
	position: absolute;
	pointer-events: none;
	clip: rect(10.92em,18.49533em,11.04333em,5.960333em);
	width: 100%;
}
.pdf24_97 {
	position: absolute;
	pointer-events: none;
	clip: rect(29.6225em,22.70533em,49.51em,5.960333em);
	width: 100%;
}
.pdf24_98 {
	position: absolute;
	pointer-events: none;
	clip: rect(25.0125em,22.00533em,36.9075em,5.960333em);
	width: 100%;
}
@font-face {
	font-family:"LWOIEC+Times New Roman Bold Italic";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_99 {
	font-size: 0.92em;
	font-family: "LWOIEC+Times New Roman Bold Italic";
	color: #000000;
}
.pdf24_100 {
	letter-spacing: -0.0026em;
}

.pdf24_ie .pdf24_100 {
	letter-spacing: -0.0376px;
}
.pdf24_101 {
	letter-spacing: 0.0049em;
}

.pdf24_ie .pdf24_101 {
	letter-spacing: 0.0716px;
}
.pdf24_102 {
	position: absolute;
	pointer-events: none;
	clip: rect(27.1125em,15.23367em,27.23583em,5.960333em);
	width: 100%;
}
.pdf24_103 {
	position: absolute;
	pointer-events: none;
	clip: rect(10.18em,43.87em,58.97966em,5.960333em);
	width: 100%;
}
@font-face {
	font-family:"CUPOOA+Times New Roman Bold";
	src:url("data:application/octet-stream;base64,d09GRgABAAAAAEy0AA0AAAAAb4wAAQABAAAAAAAAAAAAAAAAAAAAAAAAAABPUy8yAAABMAAAAGIAAABkHDFVpWNtYXAAAAGUAAAA2wAABZat7r/hY3Z0IAAAAnAAAAZ9AAAILHTi+Z1mcGdtAAAI8AAAA6EAAAZAN554EGdseWYAAAyUAAAxCQAAQlNeblJZaGVhZAAAPaAAAAAvAAAANj4bCDloaGVhAAA90AAAAB4AAAAkDpYGW2htdHgAAD3wAAAAlgAAALi+vguHbG9jYQAAPogAAACmAAAAvAAGG/htYXhwAAA/MAAAACAAAAAgD9cktm5hbWUAAD9QAAABDgAAAnneKihucG9zdAAAQGAAAAAMAAAAIAADAABwcmVwAABAbAAADEUAABNoAl9gKHjaY2BmzmLaw8DKwME6i9WYgYFRFUIzL2BIYxJiZGVi4mBmZ2VlYmZ5wKD3/wBDRTQDAwMnEDOE+DorMADhbxZ2xX+ujMbsioy7HRgY////D9S9nNUHqESBQRSkEgAY2BE5AAB42u3RR05DMRCA4S95Cb33TggdCQRsQKxAsAFRJIqULSULJHpbcSwOwWHgDGGSO0Ri8Wx57JHlGev/kUMSa0YmosxPZHFKvmJvIv8pl/mOi5JteUMKZi1YtGLVmnUbNm3ZsWvPvgOHjhw7cerMuQuXrly7UXbrzr0Hj548e/HqzbsPv8VypRId6le5PqNUp5kNzgMGdYabRIMO8zUuY+GooGjclJFg1WXUnGlt2nVrDFs9mi3p1RKeJvRrNWxSn+Wa29Rj6jH1+I88xitRPVv9fJVLjU1kf/NVppsAeNpNVWtQldcVXXuf79yLNiWmlohvFFEitiSKinUcARERX6Sj0SgMRjANGp1EHd/ViJpGNA2phqiYViPaNGRKWxFfVYnamCYIEqpxhFFQYjFIZDoxaQnc0wV2Jr17vj/3+84+a++19tr21+hvp3Y+fcwu9AZcPZ8GPo2BFNdmFyM8sMjVme6ADHr4/O8XgS0YhEbk4yzS8akaTJSfYg48CUVPqIzBFOmGHrDSFZEIxxSkIgQp+EJ+iGI8hS8lCZskAjOwDwMxHY8jHm9iv0xyd7EJ1ZKNIp5+T+IwBFMl2d3E00h1x3gHMBZvY68Eoz/fdJVwd4MZluNXOImrcJiL3XY/s6Ti51jqjiENVTJX5rk+mIyl2IDdOIDTaJDXpMyzbj5GYgGWiV+6S6TJce8h1l7rctRdcJfRjd8fYNZ7GuUlua8Qh0ZP3Asw6I4RjKV4F6WolVAZaSYgGDG8Kx3rUWwiiTEZ21jbSVknxSbYFbKa0cjERtTJainTAfaabXFr8SPWF0OkuSjEhziPJmZLkplmSWC8mw5BEKIwkTdtwav4Izt3jnFBHpUBMpmZP5QbUm+WmjvM/Hs04xv8WyIlWzboeM2xw9s3uaMYzArjmGMyZuNFfCCDJU7m8ew+XaUbdKMpNbVepHffxbrz8CGa3+bgfdZVgWp8Tr6SZJpc1Q3miH3VrSPeaLzAKrbgEE7ggVjpIo/IjyVMRshoVrZOyqRe+2q4zjELTLHd4da41zGAWknHQp5chM3YimOoxC00oVl68WQ0T46XVHld3pALWmlmmzST78V5+V6Rd85rs4/Zc4GqQB273pHnSUxjpON5rGWvjzPO47oY6S39mGmcpDBThjwv6yVP3pKDclhK5aJclrtyX/6jobpDd+kp/ZtW6mXT1ww1ieZ3ptwb4F33vvM/1943cDZw3/3ARbkRLs/tczWuuZOFPlT8eEyguhbjFVafh7fwDntegku4Qt3d7IwGtJCD78RHNfUkooESLkNkGKubLXNkleTKTimUj6ReGqRNoY/oQMZQHaUpmqY5ek/bTFcTbuLNavO2+cy0emvscEaRPWpbfA3+iKDytoL2GwEEsgP5gQI3klr0UXndOXMxSKDmUshyFl5mLMNKrGKP1rLj+6icYvwFp/Axytn7StSgthNvR9wlE1+jHQFR8mkliPEQ+5NkZgLVMl8WktuHsU5yZJvsZhTIb+UA+1sln0m13JTb8oA1QX+i8TqJFaXqPE1nZGimbtLtWsKo0Ktao7e01XQzj5n+ZoiZaH5hXjO55k+mxPzDXPEGe/FesrfYu+hVsfJkO9lm2Ey73R6wB+05+4ltsM630/eu77iv0d/VP8qf6p/p3+b/g/+Uv9bvgoZQT9OI/gl8/9sp87xozROnx1n3GV1hPtVdUvR/X8DmEkEWMvS4Oa3vrM8zt8wHmgN4iZ2vx9HFyvFXlNtqL8Q24qL2wlf0w13mOT2jezRURpmx3lavnK6zhjgP6k31azG/aCIbGZglPfEv7xncZ/8rbS57mqQ3pEg/0hQq+RoK9RT2YD8Wymiiy8JRtOJNOWHCpJS624jLuIe679F60e0JOt4Xqit9PyNDJ+Rpd1GfcE2c+nrZihrTSu0/I9MlGodxm6xfkRjp7wW83qii8/VDAVX7TxzhDH7iDeIEPcAJE4O5Xh05j27/eyDRrjCb5RuNJ509Op17Rocb04N306s6fDQYxVQCXaRzoptwSQayi9W+69iLN3DShCDCHNJX1JmPvTD8BnVmKm/9Jf2pj8Qw0xJks44wdydQyAyLEItYWSBzkcg3yejnlhD5YXpRnEtze+yzNgoVMlVCcJbuFcou5tsugWZ+WcI5rEGybMeRQBbKuFdCJUKGU03NdqXNs+/bEnvGXvI9hdWc2gKyeAtfc2uESSZ78SW+pdYTOD3DOD/xRJHMHfaiPmtOY4L0wkv0wEj6dgJ7MJdMLmeWHOzgPB3iDqlAi3STNJzBNU5OD855Ju8PYp4pmEXWl+Mw3XGzHOE/WeiHoexTqwRLrK7gfR0+m0+fLSOmWtyhc7hOXMNkrCSSvUx82zHLvGEUUuXP3MmlGMNNmWjK8QUGcbsmcEYLeW4+tRGMvhhjb4tiWGC6i9Vsc1oe5zYMpqpmcrOPk5eJ4lHW0Y4QmYGRgUnMVkQvS7WHuH2juBlCNMSbbWcR93Vusgosc3Nkrz/RfG5avJf+CybcJAkAAAB42o1UTW/bRhDdpRRbluWYjmPLltJm2Y3k1JLqfgVVFdchRJFwIRSIbAUgjRxIfRRyTj4FSE+6BDHWLtB/0P6EodsDlVP+QP9DDz02QC85u7NLSZF6KCoQ5Jv33nBmd0c060/a5qODb/Yf1r6ufvXgyy8+/+zTvU8q5dLux/d3ioV7/COD3f3wgzv53PZWdnPj9vqtNX315kpmOb2UWly4kUxolJRt7vgMij4ki/zwsCJjHiARzBA+MKSceQ8wX9nYvNNE5/f/cpqx05w6qc72yX6lzGzO4PcGZxE9abmIf2xwj8Fbhb9T+CeFVxAbBiYwe2vQYEB9ZoPzfCBsv4GvC5fTFrf66UqZhOllhMuIIMvPQpo9oApoWbsWaiS1gk1Bjjds2OYN2QEkCnbQg8ct127kDcOrlIFaXd4BwuuwWlIWYqkysGDBoirDTuVqyAULy2/EZaSTjl/K9HgveOpCIvBkjbUS1m1A9oc/t96H+PJblvtqVs0nhL11ymQoxCsGv7TcWdWQd8/Dd2CuVnB84WDpS9zE5jHDatpLzwX6EksyuRK5qnh9fW5Lxn/GYInX+UA88/FocgLI0QvjKpczR9d/kJzNRNvlBjzKcy9o3AlvE3H04tdtk23PK5VyqK/FGxveXB2DzMos6E81hZRdoubRdGep7Ih/iwMBrMuwE5fjmqry1q8S0a2iDX8exSzo4YmcwpLlC70meZkPNwo6Z+IdwQngb/+aZ4Ixs1DQ3xEJ5ZxMRw31CYZSCXZ35YgsWnim2OOBih9Uys8j7Wd+pjN84PaRx7i3gVfbw+03DHnAF5FJOhjAsOXGMSOd/BUx90oeaL5U3kyUjSdSGU6UabrPcZJ/I5QQsgGp4vRa1TfX7UEN6OZ/yP1Ybx7zZuvEZbbwx3vbbM9FsV6damME65abyGtjpOUTSsWhfDo1y8DNQLKA14Ia6l60mMKpVAxlDuj+YXz30obxP5Oi679llnq8Txu3CbXSfPxwLp5rLyMS2HCyqDXbJ0Kk5zQHv0BCOJw5whdBdD3scKZzMUrsJHbEme1PTjS6fn2RB+fSw0UMaA2nVSP1kNPzVmjS8+MTd6QTws7b7pVGNcuve+E91NwRI8RUrCZZScqAyYA0KQ76lZZS/vzIJGSo1KQiVNyNKFFcasJR0o20mNPjQkVVyCQaKslYMSfuJHKpmBvG7vtjdwoVXSqvCX7UiRLjn/xqWG13dh7Un8yrkH8AVmG4KAAAAHjajXwLfBvFue/MrHb11q5Wj9V7pV2tZGktS7Yl24oVe0Peb/MKJCASkhICAWK7JSFJUwcIBPoggUJCCJRAedM2IU8F2oML4dXSg/s60HNom9PmnlJaU3oxaU+J5TuzK4dw6O/ea8fzze6OVrsz33zf///NNwEI4B90qQUACpgBgI0f4ywA499Fi3B5EADcAvwdABoA82lyEbgmZpuW0BAwwAa+paXm0JCh6QMQeCFtgsCE64jyIppBlIkCFGO1HdAs5heQDX8RgMOH0ffg9+gaHNY8ccrSDM3NJgpfYAQhZIeoNjGs2a18EQlC0DGyK6Au4mZeNeO0WiFirMLh34WnuFMgHwyNj46OBrjTldB4BfJCebulRTVt4U5gGdArrQVY9UAfLEFIJXwJ1jTrk+epgTM7oGnOJzUa1ovfqBefgWvgmk++8SCAYDvuiFX0GiCAW78PXPC7sAQs8PGj0nLzOjOC05z6GTP8byADP3wcsPBvAN8b+BHSXKwF0BazA58UIYI1yqpxLlcfu47dz1IcC9lgwPUvuL8t6FUQQAL8LQio3OlTi7ixarWykBuvVkBvpZcvfzx6Bn6swqqKH93t9fvb232JUntbR0fJXUylZMmcVtBe/6yF4nhH8pJ5Ib413j6Xhx/Raz55dsvMZkVpmrUVvXhFPhFPnsLDNG/iFHUEv5AfqHCeFrSGGZFRrBnBHAj74j4lkLGaLXCDJVqDtoM8ncbiEOPkhRpl0xSgJVNFoKktuGjvwEX31KIG+sA+PIahHM9KooQk0tK1wwmdmsdXdAabP/4rGa7T6uDC0er0SzVB0pLpokRuIpGbSOQm6yQ4oOKfpbihXlk4Ov3S40CYGD6EGwt4+A/h9rrEHyHyCP7UCqHxKdA72jvaWpi+UVsJs/GEmEAM6+JciEnKiowYu8PmsDosDhPj83v9iAkGQoFwgGIQpKAJUkxWzaiIibmllSBlxkXEI6yETTQuEq7oSig70itBwI9rKsQ18o2QFNnGz81gAA5Ar9mFZCmVxr+lYmdHR3ubX/DTHDnGQ8Qwbk7AQ9fW2dFJHSlLX7xnycpvTW1OqD3tI19a/5PC9PqbJlsq2KUGlZCX7WppC2YZ9MSPD1z31fO/UJ0xsOfbvz6+59uP3PHCu/AL3V9rjQfk58b/Uj+5cnYh3nUjnoN3TbxmHqTX4mFgQQq0gbmw78jL4GUKqbWJvx8KRYuWhsxjqblwxWUJRYqtAd5LTr13CEvc9D3NhSsZctZFCkvjkoNcsuIKQ87OJ7ORxRVsHfaTOY0oot3uo7l0pb8dttdQUWN7Ks0tOSegTLbKUBiGyTmOq9CsiZ6Pp/RI9mQWZWvoJ8dmvD3SdbILdeH6YW24AAs1OOtoHOwfpiCFP3TYDPdrSD83Yj5pRmbymcTbI76TPuTDdc067BxxImdw3vzvw7dBAmyCATyN1EVj1YXjg6fHB0PjocAod7oaGA+NV0MB/dwibDT+C8+tysLx09VRrlLBVb02VtlOt6iGkVD1gZ78gVUIZZho8/u8DB7lUrFDIIPq8wp4lPVR7SgVyVjD/3cTRjkz9XbqpTPaXS+fuHvHD166y+8KBt22AOv1OwW7m7MHHabs3S+/+vWvvfwvd3tdgRBrDzl9HkfQ4eYcAQe99h+X04+98fC3f3xi3+M/KTmFgee+sbDZ73T48gvufGp+MWAfv+a1R7795pv7HvlR0eG//oHH5rQLDrtQnHvvg3OKPjs2am3YqD2IbUAEvKcl70DfQ9+hqLTjPgrZ7DY7BHSY3+c/7Ef+CMJmyWa3RGpwxVE+LxwQkFCD0kHIW8hUtDuxhlDJwy4aOqgaHNPCgOZoRL/L/5yNwBcjMBKKsRC+iP1HMPo8vBTuBMQUnKoO4AEZWDg2Xj0FentH1emXX6p5LJrf2WvRBBcugiwunGV9bmM7iK8btgC30G0AbqTLMKfLgxF3r972lLtcdvNliP+q7jJfxofcG8Tgg2oiUQJ8qaibS31y4mEyM3hEOzo626m+M7+D6x665YoHLlY63t159TMr5l1V/w5UrpuWlZJ+eAS27Lzmaw84h2srnpx7253H60d4dSY2pYsnTplm0gtADOTgJk2+3/mU87jzmN/E850WEONiSBBzVkvgUTH2isyaRaK98IPD8FFGxJXLjlnUbQ6HxS7W4HItKGxMpLxmfCvsDzgLsmRBgAugQBaSyeZqC/aycDFEB3BXhvLkleeXiDiErSCRmtfhKvblR/KoP78vj/JiCqY0jlzwkY9ysMBpXB83wpm4YEvXzWQUxqoD2MpWF3HVQdx1p42jUcPnjI6N9la4UU73PFWVcuE5UqnAqm5im6Ss05NUZAUxfKopnUkjxqVInlQaZJ24UNyJNEyzahoAw05m1ezNN2PDn+939nv6pf7sgfxwnul3DfHrhSG5P7M5d7vw1dz9zt3+vc1P+J9tfr7ZtZW9043AQBVWl+pjn8dvGkz06m8ciOvyoCD2Qt32V7FTxKZV8NElBk88Yn4N6+vGsy0llzyG/fV5jWlI/Yyx5LrqN85eN+vQmovWHFkzfU231VE4b/u8tUpAyRdzQtOli+gFn7x5vTcRNyUW3rukZ98tP9j9l03FaTC01h+NZMdvv8srPvjIc8+kPF81tICqUi8DH4jDknYpw8/3Vr3rvGt8VwU2es2K7Un0KnrD/VP0U+od5zu+j6i/O21DPigR77iEWk2tkzZQQ9Kt1O2u953v+axZy4QfWqxWlahB3EJZqnTcD+Asfw02HQ6nPGaMkWKHHHarX8dEeHT9WlAq+q8B+PgoGWw8v/XJ6SoSqQXcJRDKS73ScukvkkmKZww00ka04xBur8sYb8hUoahrjQOr0wgHuWCi6y5DWXSnjCcs1pfTqkqURVUrut8dGyf4a6x6CnJvDOgaEnPHokpACAqIifBiDIS8/hiMucMxKPhwYehFVr0ZQxoyyAMwoQ9NR6cwOYA8Hj9zseE6fT6qOj5hXTbzysrKLmlBbePI2iXjz9z10w9kxScXE93w4+evu3D6Jf69N++7+cX3oe+Pjz5yk8i3L90r465QMTRN4jnKgWEtwm91C70reHiAhyyNgSon0hzDcYw9KTJkakowKdKkIjuSIocrml/Gn2RoWwPDZR12Dd/CThRwSomIQ7liUZdxWZea7BGKB+xwB7ajds6O7JtFfh9/gKfyfC+/gx/mT/I0T9q3FotEHs21FN2LhjHyU9XqwOlqVUc0aqWB/iq67yEmbEAl4E/A0I84Eoz80iV4qGV63dwT87achxV2/apOUzKJJGEV9frKTpPSwHrHsGo6QQJepAVeC8G0A/KXWFwpJwRmIWW2WuxRzTRpYkxaSi2yJmgKyYaJ0cVsQ/Tq4lB5apFILdmkFoflERkBWZNXyKRKa/LDMpJZXuQRr43Yob2hYrrEtybyKNYse1DC99h6OF3qGiC+mhvDb1k1jNHAoP7+BAUuHCU+epT86Wo1AyY4BSliLB5DjNfj8yCGSYUjoUgwQjGsk0/jt4zGoN/Kx0DAHE1Dt8OVhjHKFYMemxADEVpIn4PeMH5TVWKYWptgGc6Fc7mNDrqfGXIMcf3BrcwOxw5ua/B19KpoGzJj08UOBXaYtzq3sjsCFuJQBpZCrLsNPyJLCCutIBnuvuHtyRilYH3Tz66/atPbPz/1x7fa5wou+5yWXCzt9KaUEPXyV9776mu3PwqbXn4DqrMX/v5Ha6uz5wWlqcth4pmhqA9r7/kTp9Av8AC2oWe0y+0FH9dr4pwZLxfNmBiv3/uq8mrqV9z73H9z5gynZLu4jux2+33yfcmn7d+Wa/bDsp120E5LxueYbZ/vYDS75kB8mwj2IhFC7DN6oWbnex/GTqUGZ2oesJfP4xPF/EdqQAzuDYuhEBkx3GRnCIZqcK0WC+71f8TzdEo187EUb+eNaaHxviK8jE/UJk4etnqZi0lFs1m96GKQ4BIooZsqO1s0jiQXOZ6CFUN0QVeILcJ8cXFxeXFdcai4v8gUeUuc3ISU6GLWImJvqOEPGzUplGmatHRNkFQ1K1appmA70SWiStg2nRqtYkFwxRFLHIMEglY0AX/EonkTvZaKT8aFX8GH+N0MgLeU6N7pQeIEJz+aiOMe0l/Fiu+RuAJ/nrzJIXwLXeK76BLfiMiDZ++FgYg6QEBNEGpNAdzJGJ9AjQvjwiXgwuk3GhLeQr4oFouxvbHaxO8OObyGxC2IPIib6w31dscBPXFE43FbOoYb0jHcivZONuH+PIYfHXLYdwPuzzqmYvOazd2b16wsLvC7kGakkdGKfLOSw4+Gp+XIIUPiV8XYS8lhgIWPfq5ZcUXJYdil1Cb+egi7XCxPHcMu2BHB/vhThLwUYMuvO+wqppUemdBSfSqYCBrWjTq25DLVTuYGhsENmoTdtGH40b2sNPXWaZkp3jhMVRfdtWR6f8ye8Cc4KffQrMLUypo9ufPu+8aC2WE37w9QP6z/8K41nclwMPPa15Ys2tWXtbfBvm3burOFWbOv7bpg1XX7FZaVsf27fOIj6jd4+rSCCrpc82FTXzbFuXKbVplR/Frpm+a9JaqHqMaV80tHy/Ar5idy36kcy72aeyfxdu6d0n/lrCXzTPM8zzxhbulSYbXlPrC39Dg8Co9aHO1muLVnj+mB3IOtJtDT17PKv6JnUNjl2w8fn/IiPNljs/j7er7UTc2xIB/vQ93kW7qE8l+6YVu7xWoxq81NarOiNmcq7c+2v9BOmdqnti9s39L+jfaH27/b/oP2f23/dftou53QqW6svW9qu61WdLHXkrBcZbnRYkKWbssCyybLnZaHLU9YXrf8ymK1W8KWfgvl5S1UwJkSVXzvzOp89xzUthtU83kU0DLYuAfEwPLAusDDgf2BFwPm3wb+HDgToAIBzcUVAwgjVDvbLDbnm3ubTc0zMtNZRcQG930ArAHy9Xlrr3XI+qLVFMcCAStnRdYafEHjtJ6tPUjrWdGDep7yQV+YvG1TX1PvBGZ+KujkOlFnG/YOSnEd/SGNCrRG99EraBMdnNp1caAGW287i0cHxgbUH1bxVByrYlxaweD/9KkqJgl8Wc3jBgRojGJgOj52iht1C2XiLnhSYqRPUD+G+xau4qpUAJ4Kg88xaPpFlx52BKIBBKpLdSfS1jUlIts4ysQq0VRCsafKKRfGK8ARt8agJE+hOmOAizhj0CbhosvUHSM4FrsMrtLQ9ZvxDxwcqIJBgl0wgsHnlAbjU0pGREbX/bM80IgF+PTYTZsBclJpN2O0am9Dc5+9o+/aGiwJWtO0bCiSmtvde/Hgmzfctldw2bzOUDjWtnZG3zLbxu50Iphr++ruaxavffauK67tzET5gE9Um1pnLmifc+usgfOyu+v3adhJBuZNn38fLM8+v6OzRQ7jiaBiphLGKEgAaXg+5u6zLEDgBAQDQXdSFAjQCcupbZQ5lrLbXYMsy9kFADgJo1RziM8YYCCj6zAmHH2ZkQwqZLRMX6Y/sy9zIDOcMWdcLsAGxSAKZt28Nsk3hjHjoLlg06IBEtmqDuhGjDPAPNcA81wDzBMrQlBPOa8zEr1pxmiaaTTNnNP09GhVx0fcKYJBDYrSIChtIcXkpJVkKhyKhBBjTcUVxSSlYdQRjAGnS7Thusyk0jDkjMVAwhJLf2aICSogsEDeQvdb++NDyV2WJ+knLMdMllsst1nRkGnINiQOKbvo3UkGA4GB6lLobhBKY2TNss48MD5zG2CgQyf+sgT3r//6imdWbHrz1gXry3sls01th9sY24Lu9rmtHenzltALxsc3DYzcsecftxY6rjI9fr4nEkbK+GP1FUNy99wp3zn5dt8UDApmYlT3Fh5MG9il2YE1SCPGYrbabDX4LQ2jfy8A0AYBZTVDi5mwcgcfRy8iBBCHEML0/ajVajEBB1NDP8ZOOuTYaYbm0/aPj8O7SQDyvzAKO72QEHMy+wj31ryIeDCkYS+ICEFHhKobfk4n20J5ux41gXgWEqhKwwSeAmbZk4BwLRyo/+HxC6ekUiuppno5Ylquxi6Ej//jfvwiyyb+AJ+ERWAH0mEwl7FTNejR7HFrAduVoGPdncSfn6kSGIgB4LmBFQhmXbly5swrr4RFXcycuRIreQoA+le4X2RMx2/Sei8ODYbu91EWOSDPD82OzJaujKySzDzAwB8rJWMq5K8ObwhvkO6Q3wz/WB7JW/b4fxH678AnwU9CdN7iqKFfHo6aJQnqFUaSnbiilaO8JEfCIMyFUTgnS15Zlobkr2HYC7KRRHirdEoakyhO6pNGJGoETyAhG5HklNISrsHfaYIMAJPMtXg8PIr/LJGQMGA0W+KJGqQxigFZLouyvxFqFO5gR1JRQIN15ByOPid0bmmZehwG9SBxlYyNHvbmxker3DjhCvoR4e3jFb6cr4yOVxqhkIHBatlN4iLV7a4WterCI4VRt6rPlXi62RvyKcFUk9LszeZhOoQL1Z/Lw0wglQehMJkTsGH3APHv+sRsmvi7ZneUVYujHAl4fD16tGwpgcVGhBqzlLPx6VKiAZLNEFtBTGAg5TbmREpG8fCM6vi8K6aHsUTrT5/aed3ML8NZWjjTUb+4Pn9p+WtfXXz3I+ja+rYbypKiyF03UP2kNuPY5l0re8R6aalfpBR0Ldoz/r3229buvRdr1SI8PZZjpy+Dv2rXf8zApBUutT4RewW9Ir8D34e/Q2abBTajrPcScbX1anG9db1tMLbb8x3Pd7w19Lz3aOx5+ZXYW4obQJ8HUK7ICDiJlWsEnoTIBL14OBIeXyAY+NAN3X8KpOzmxByTncVAVoUNuqOHbMJWd5GFcB88gD8R2q/8BTtSNiJGUKTN3GhH5FFMo0bw/JvEseZgssG41araiM+Q2AzGtIM62x4d4CokyoWdXnlAn3uNCBd2RoMDiu5cEAlAt0/Ol8kIdCMA0kFp4nmvrHvh5OrN79z97Myu7oVWRhDEglS8aG7n/NZL/xr48kYYevXFu/ffs6w8Y9EXeoPB9oUPb/trt9qCuyGL6bRMX4enbAT8h+aPEULNugEPIqKb47kIIyRFXqfSzqTo1ql0IClGXoAf4PFg8Eu6ix3F/QxkNAAdEYZ326zk1SP4rIEnNCrjcLBO0Ymc2YBAyLZgkG2hQbJ1iTk2kVo+VygeEOAOAer+TNisxfpiSIytiO2LHYiZ8rHe2A5cGY6djDFRnWVjrPAZks0RQKx7kt7RqjrJttVzrY3nc7w7NW3ZZZq2bNmbn/Lv6/QTmnZZvXs8fJaJI2kVYeLYXgFg6sRKqSLTcdwP7x2xl60MzOkudX6pLwdpmmYUhvoV+jfqlyHKx5ToWYj6N/jbMOJZF0gAVXRxCU7dz77IWmA44k2KbA39h+aWUkkxIUu2pOiS5UhSjNfQv2s+OZ0UVVlOxOMs67IFV9OUyYwt0PJDI4TrYRaxJFCCG7HbY2yiFVqzPp9XS0zr9WpTS6wXxr1veZFXmzm76NWml7xaeQqulDpwUWjFhZrDRboJF1ISFzERF5y7yHmhl6BBVswdyKF8rj+HclpPKadHDaYUdYlvokt8H102txgS302X+F56n7AeXzEXYYFIVC6dTukRCvyAH6ZgPjWcGklR5NShzilFXeZbdalZo8liKti8yAhwkqDCgGqspHGTTIUgy0/D+kQRKo2VNkIdR42AAzGl+nWKcxFYodu8OP4i3t4b178IsymWUCr9yIPdIUscI0si1yzxkyxR2oS39yxBwvRokIS6MLbBiBH6zgGF5+gWmaif07aX52xbcNlNXi7dU0+XBI5XQ0vmpUv1dHfQne6hnty4aPZV88uP1u+9rmROJs1KcBXc98VKYnPdfk0XPsHE/dch7tqihaihB9vGD6gnQQRu00I8hgSQBzw0FWJLhaWBvtgxx8nYhzEzpp5bDzpLMfJuqYhY7PUv9i9hKLPLIppNAhTCAVHATpRBDKRFxs/5RH9t4k7tWhZE4uFIZBbLeTGEhABcwbpwzRVxQWBiuDjuJo5wagIOERcW2DCHDScdwSDJbGaYCLCH/8ZtLLAa28dSbNX1PiRAQw9UxLElRcQbvgUp2Eee7FBlcVF/wrCcLsY0J1vk9Gl/MmbiYvAAfg8UjdUgdSjxw4sDZKRJYGlsAA/+eHCsOhYYNeAj/sU2VOcO+JIBZYiH3E63BPSKGgDcKOSGjbL6WUFMhWqAJF+MPGyMPCzi3JFeSAoXptQHvWVd+Ij4+0E72wsnlYKGxDqXEj6DMXg8OjXGxxgWQPin+ivluJCDf827A80PbC7lyrCtuaur/noE/fJWOWRVFLc/pqyuPwLzt3SIaaQoTMe2cQkP83wAqBuwtcnAtGazp+xlu9fBGWE4PGWx/MOhsEgW/PQwpEqGWyzph9GYcZrldKmlvf4ip8Jd9p0qsged2KdFQQxkxCgX4zIM9PkFAUiPijHd5AuvilHd5MtJMUNIRVS2tbFarILnRKSzl72amCGQYWJRG1sFtufhcmCCy4/tNJOlPQpj1ecxns2wgogteVaWDNoh6faiWNRlOK5Lzcv7i8MS7JcgkDgJSf+eXXSxjosMy44N+9hYdXSUO2VYdjypVRX/U836SgYx8UCFDS+gEuzSmJCTHpP4SxJ4FoyVBTwbyWQ0QP0b1a9P65o+raW0yGxzRkMZXxyaHfmuunmqarGlCtSTv7h7+cze6fNmmBi/1HvljW93lblwkEom6fImRPf5IyGaTMUL6qvRPfRa7Dr7tKbtrmMs6jTdj+61PoUet9LwJUA5XnJ6nA4HRvMFL1k9ypMuQvdpVkyvuCWedbv0F8bo77SuxY01cILRoI8hj48dMsFbKeDmALpnTeuMVOGS+cXqX+vPwUX02pYZ05Z9Y3/91fo79dpVs0pt58OP4AyowVH8bEH8bEv1Z7tAkzpM2+k72Bpr2oX2WJ9AT1tN+Ok8+OkoYObM8cZTuReTp/ICCB0OZ8FzAQbvnJGYoT/kOU/nIaats8PNIaL7fvJ0wTWt09PGw8HF9efqq1tmTlv29QNwCmyCs/WHqzvr36//sO7B/iBdn2cKYeWWQB5+SQvyeQvLADNwiwxn5tyMJy9jaJEkS2wfaHYS0WdekRtgBNuK3DbB7OYx8GCUlGhnsEJkYEYLh/hWQ91aG6tqRGoF7Ib6WkdaUaFVa+1r7W81tTYinlknrzlgwaE5+hzDjhEH7QgWPsNyHQZ1dTSoq+N/sNzGspvetNVo2tpo2nouy11o0NxRA6AQj/SZtbh4qjkQCypqKppKK82BTBqmYrjIhnJp2BRRzq7BqQ1O253UemcXZVIMBYZiQ6mhZtOXvEPB/uiX5f70kHqb9+vyLu/uwJ7YHmlv8gnv09IzyaPe7yf5GT6oh/cIzFcmIf5ZF5XwdXSeQ4HxuOohcIP1muF+oTBr/E86ToJ3tLbPXXL105de9t1rF05v61yyskMullPaVdOW1x+bUwwoCkoIK6j/ILBp85x4/pb/te2uP22WQo9tKl/05/+9tPserJ2piY/QLtM4CIL7NdcO+w4H0gu7AwRr8KgWhCavl/LdiiATtxfsmp2yD1qvctkRppcuLUrbjzpCYWgyAZYWaURnPX7fRq/Xozm8vR4y6FxUKuY9w54RD+UJhohdMda/MJAY07EC1mlCkUm6AOgdP1XtrYxX9CWwCtSx+ADAwLzdJ5+N9+gmpeSWsRXphLXf/IZNcdOmxM4/unSz27bpK8+dZxqvP7Nq/MXz89FV/uFVU6Vd8L/lpSc24leNTvwnvRtT2gQcOMiT+PrfDzrLRGgbHGUuEmG5SDTKOqdELZIUjkcFSUJTMGmV3fGof4FshNuj8WiCiwiQjUZ7jOhANCwBN/a8MCokLBazGSDBb2GtEDW5WCdcTqhmnwxlzt0UAWHYF4YgvA7T3S3S1PV6ZwxUBysLx3F/YGqi10iwoOFLjTgcT+gmYZvbTVtOAHwyYPhLoojbucqWE9u5E1CnoFj/wcQBTfWUAMuxnWAw3p/YGt+auBvsZHfGdyYOg8MJpyluSmRNabvkyYYYrjZx2UFPCYsnNA9fMkGAkSfH7YT7Ige4AxELIAFu7OfJ0vERzuINkxDTSc3KB3qBxeXpBbWJDxtHrJcAtT8cwm2w/HcSboeTHmEphMTim7Fyu5DPLRNiq2deEVdgeII6ekguDMDhJd0J6czatTPjdbH/0qh6Xg+94MwxNHuTOgX7ZLu8eMUnu03XnHn0xgsUBS67jvpBskNCxAVcO3HSlMBmtgxzWjlQuCSzIUExLmhlzSpTCLCCmmNVLuPOS3E12dyR7VCvztyZuTP7dLGWfb7oKUfBMhQlSzdzNR9YxnaIHajj6dZoNLYsHhXjIhRr8CZtVmwZCHEhFHral1FZS4q1s2zEHmFN69n1mb3s4/Yj9hMso2ZYu0mmS62UXPJZF8PlcB0cgjsgDS8BKS6FUjXIaS4+1K3ZncVuYyUGnzostrYEp9Rg+blLdcUgCy+LOJVYrVOGyddjtDq6KgPuz1VMtiZXKHBdrxpBWi1O2SkWKZmUeq39GnaTfSN7e+Y29T72O/YX7D+y/4h1khU34kAwhD53gcH49XlNDb/NmGX32VWGVLoFNVYZ9GUG6iV7Jvr7bas3+KJa/pkPLryg/rc3tcElBTE0hVeU5k/u7r+tfc22449e8sGR83ry28OhmJNeW68889b1s3NyviVx0Y1r1tz+zMehpLcpg8A7v990fmHZ+dMu2/qt5Y+e4hzT4lP1Jbv/pC/Bg5qE0ePAP7H1kNVWjNQMyTSkE0ttKa44QtZwh2dh6Hb/10I7wndGLGvda/mN7o38ne4nmaecjwuvCT8O2xg/SE33T4ts9d8m3B7eFjlmeiFmy6fWiBuY9c714ds9z7PmTpebT57VCK+Gq4mn3byLvjZKua71WeHyvBu6Q/0pmOKVG47DNj0VB7sEK2sTbci2MBgcW/jHaviQURtdqgceSByQjGK5/OfGcAFi4uZfuPG5Ngv2P0l/hHE6UoJisZqtiAmnnH6bApgILuwBlwKsGOvAyTQQ7IIw5iIjqPNstzGIBPny+uj4iO9IkoXU5OS6EH1JuvnD+4d+0dp7+YkHt/5y/eDfHv9Vff+xH8OlL+14+PJgPG/G45Otnbhn/e7jR+u/3NN/540b1n4Pzqq9BC8f7knm24m7AIB2YhuqgB1ax0q4AW7Grs60U96ZfCJJ2eJRJEmheJRfINnjUbckJ2WJCstJABRO6Ve2KvsUWqnB4xoXTzQh3o0gVn3lZ+AhWEP7NX+IDYvYNPbYbcFUIa2l96WpqWQuVLE3WIh9xdjYODaOelBurFohxlEo67E3HadRJI+z8yz3k7GtaSBPtx6sIWGyTtrZ/smCXHcy5LL7p5dz6OfduM7aA3JwxcB1O6/Jw3frScXnkgKrqS+vKaYVo35m35qyy7rgsX0YMS3CiGkeRkxR0AKvwdiZn2VhBYBJHBcwxUCUbywBpOToq2LgFSmZcpibt5nsAcHFDnKc28yyblEEUS6Kolk3fzYhiV/MowM85EMFAzoVGtCpcDYhqTBSQP2FfQVUEJtgk6Yvw9rIRy1wxAItk0EvSzDfyElSP5eUpPcith95oMf6K3q0/7Ph/rhKu1KKLZWIS3HEZFMMNrpNaSA7xRh0sSqN62lrMg3jrmQMZszN/zzcn+2n++39Sr96oDBcYPqZIdtQqj+7ueXOlvvhHvrBlqfo/S01+sWWN1pc4GxiUsGAboUGdCucm5ikMObPpCN1tpPlAGEyNOqeTG9x64tAHej41NKsBQdWn7/57Zv6tuQekrjQ4vFTPV0+OR9QFmTPK6d7kpet1ELJh7Z87+6J7R2d138y83JBgYoSaZkNfwBvfmRNyjP96vp7b1/S3YbVvnfilKkVU30J3nMcJHFPPzG/1JccSSKrI+zIOuY6TGXHA5GnI7WI6S/mDyxIIqY9QQqWBh6R5jym35rhBOahSZGWZTYpemQ5lhQlWaYZ2ha8ymq32YEkYejEACbbgMUxhoSNGG1qidGm47/yFHxQaMVFugkXmH0yJH7EkKgRQ6JGbzGQZWCceYtBRkiBhJBsSRKNSmo9pWQjepRsRI2SjagRkQezxmV852QjeESkFsSofTgJxeSBJMon+5Mo6RV90JdlSd7BIXxjVyN25GrEjlzGzfS0BE80WfzQBfOuYdeIi3IF5UVns+V0ZknU8WyWCvkZq557RKjn6GQ0Xg8m6VpGvJYeK9BB9ODZVB59wSjVANENvNjRqR9SbzZNrd86/fYLF2/OpnvgFk8mnIw2dZGIz3hybcmc3NI398pbHoVfJKGd8Zu/MCXmCS2GY41ATwYA9AE2eiL4qpZLaJ2R3k8tnQ4VoSQb9g6bNGzTPrVjes7YLLn3pA0WbJqt3zZsMy3HBbIF43oiRzgcLZ5MwP7EcAIVElpieWJr4gA+YHR0SDqD9Nag0VWTOUwkd11VfP83e+dvRx+Md59j6F7J6YZOmF5WlH9i4LbhuvGm5jX4TTvgYm0wxtn5XnsMWmObY6jQNbOjr+tJ8DqglUgH3AA2RDZEbwfbI9uje6JPRd+P/iPq6CfJxyIvekQvl+QUmuVZD+sFSaBYO5hzu6xlSjQlNVyEOCWqSHI+Hi2RPKY7tOkgGolDAJoiYW8kEgYdHQDkojEvhmIAdkQjlAhDoKOEIEop0QjvtgDQ2RXmQjDUY3vL/ls7soe6dFsYiRX7jWxojA+sPn+xKyY25VvINTe51nKyBQ23jLSglmBnVw1edCiB+7wGm2/TE571LsfURB3EllPv/SAxnAGSRVXRk5wrOjYXypbtLSq9hTuBZUCvqAFDe8lKQnWQOGkSpISfHZ72c4YPyo3FTXLO33HukFIjsB81NVeSQdbun1FuHq8Y9fG/B8Y/pJ2XVOsFV25Rkx3hiyrKwn+lvoJHNBG46swtn44uNfqJanrzzMwvCG29GDWLxbz9MmrZ1e1potz+if+kxvCQZ8Elms0YpBTW6Br6hRaQfT4Wd3SixFpTxIUjpcf2MElFgysPNUejuLdWH+IXqzuOw5P6StpoOU+W03RVxSwb95feC+dqJtNYB9DjQ42M7k+3X0AZ/dR4wUWvff3Zny/pmXqh2dQZSk1VuwSsuvTkG42vefm5DYevn3XJonLEZzvfHfJEmqu/QL80tLgwcZJ+DL9SC6S0RwJsUEIBW1rKypvlb7jukvfLP5EnZCtuhwDFQQ5xVD/u5CH/kHDc9XrTO03vNblo2efipHgiJbcmlknmlxIfy+gJ11EXareYyXSXxHg0IEnZeEsUSEk3IYtyQBAgvqfj2qQVk734kAiXixMiErcUClqhr0BcN12wGKnLPZlMXxZmt+QbJLCxRUUngQMGCTwncq57ZinRhNFlKqW4FLtiyYN0k1Pm8lBKWNOOPGAlXJBcpErDE5MFxoFBDBEHPaT3mYbaNXo6nTLMxadjkjYsZ8pcQN+XF3cHO7+y4oa9C1PR3AXwl5HyArezd+znB1bcel1IW0IvUBJTvjS+5uj6Rau+9w7KXLaIFRSlpSV+4fj4X35xMK+9/jS6/8ayRDo4jPHiAB6KMFChXbs8tBXjdJkUHClUUlztWRO4WnkgU2uir3Zfgw92u+/3P+ZhVrlwV2OfaIlHXZIcaWFdSCqFw8DC5yJsVMT4qcdSMMM+MzRvaZ56pOFY9Km6kGBxziBbC4GX8xa8lLcDI3CMyY+mFha8UD8aXUp8C+7oUdLHBIdfQXD4PFnlQrzH7UEMycjOpinm0yPE+H2CL+AL+kxMUlG5lAKzpJBDuEh7IqRQ8TlsnyUFqGdXfI3NLfqqLzlsJ3uOzpnnGKLzPq8LYZRDuRvJ1R1ufcNLONfdy1p1I778o3uPvHD5PS9+deqtyzhPuP3JS2+6YNrqOYoS911jmPPzzq/X3trx14eWhxymiU9+c1HKxg4+AGdA+sFNzWT9pw8Tqg8xoXKCGHxWa1/DrfHcb3ubfzv4TuidyNvRP/BWc8AcE1DAIYSESJpLe9LeppAtRgZKIIWvwbrYc9gXkRZiZb9AaBlpBUnB74a70B5mj2WXY7fzCfSE4zX6Neur0bfh204nMpktjJWxCVBAgkNw+qPW1cHVkZvoDY71wfXR3ezRwNHo2+EPLfYlLlcJUP6S2crbg+INDW6Mxzdo5A0s1ChIhfLx3jiKG9myeJQJ3xogo62xn2nALxw1Lo1ObnMio34+GfUKjHFKNOVNWRU6FQwFQoikwSq4n8IK9FlwTWBwze1wKdAZQbiEHptfASETLjBUwb+NVFh9+umLyBjWHrYwfJmuTYxpdr6MAnzZgf9QbeK9g+6yozbxZyxocuQsW/HRc87y2TzApfDsfhmMc5LAzZlRIp5OuTlAE6TLGUrClziUogQ8xvftfr3+zfo9r38L7oVdz1+5eNPFe66eeenKL+yllzvqN9R/Vq+fqJ/5+wnohC3wmwv+5cH6u/XHn/hSmwaDv8Pn7DdgizgPT1cHnq5x8J3jQCI4PGSsEXRzfDEuaVKfNCyZCriC4K/N5jOYIAfiUU6SrPEoi335r0OhM7GoaA41gTjiWAvo19Nhs5pkYa2iFVl7glwAxgN9gZ0BKhDnRBgX+8QhcadoEp+HWRBA3zuUIGPMnSZzGWND4kzGGtBnvIJZ858BN64nXZIKCRBWG/QX2zT5c65V9zuym3Yk44tmpJZfJUyfkhufYmChlXf2XCKk6AX1u4fWJfhP3v/UYZr8U87fBdcBCsyZOEXV6FVAwCimDYOiJsph8rgdXs9Mx5rUxpRZgZ3CkrYNplvRtuADzr3JZ5zPJGuWo15HIxIjWCkfm22Vwg4lABzFdiJMYotobAhsweI5xmmEBYyVM6Ec1koq6AVFB3Who09Z5fii41aMuRxOZ1sgmQQONqC0SsAXdmgshy5WAg5gYvg2mEySLZE+Z5sXN4RJSmpztrLOJGwzMed82UHGGW5sNgrXKKBFfYXWdzWqj9pHUVSoaOw5fJctZDWrs5glLVw7rNBKtldYg+1k8yHZeziqjpGVkoHRsXFVf/bJRT/ypwcqXVtOAPIuKjlNzvJlslq03cWdOKETvgZn93+aGNCZOgsLGPNkkhfJs6AYY8OJEYZCz+9Y97dfvPHu0L2PXPaHN1766cDLSrIrO2/6FdfkRKc3Xlian/sFVL/myI2P/f7VHdc/NmPzg1ff8daxrSu+aWn78rxbZpaunDP3ofrrEUG+fe4VQ11rqy9ho7h/4g/wDPUSsONhbjsOgoT28J4iMxeYHXN5O0vNtTa/iElPMPDOW4abWTg2PrlG9D/SG85NrFqiZ1NdeeWMRoIV9dKVRoLVleOD56RacXjSHaDXgARIwoL2TYnA7tXcem6DvJ27XX7GeYwz73IeciKYlBHAjDFhc9mjNiERiAp2PDjIErX63b6oHyZtQPJ/UWa5eCNaLaNEzs153W5ORnKCRKS9LheL1rugy7bJDRNujjX55YTbhUxQkFkp2aRvUj7FaRxLYUBqs1ktrB/6n4e3ABm2aHLcFiyk+lNbU/tSI6mTKUbhUvGUlurDZ3amDqTMO67H/TPAVceCoYXjo1UQmORuIQJvxiskc6qh5lW+XNWVxUIWiF0YO+NK9YSq5+OU/9k6sVGauUrFXKk0FEiFCSPz01hX7ITtjbyo0uSaSTqNVfuieqIcaQlfW58694qZ8H954B9n5aSe8f7w4rifQZFrfzQCb9l2nloOcxZFsa/aa5ryyVPfyoi0ovi5GO+xnvcR/Hk9hw3kAgCYG6mXwSy0SBNnI8jzomaLdVpYD6iAWaIHv+0sBnZ0BpOit4bePizlkmITrmheaVpSrMiSQf21NJSSYrqG3jkma92wMyl247qWlc9LirNk2SzlOhJmaIpV2labYqttNpMZzGIq3U1pr8c2R2sL9s4hRvnimFQEc/bNOTBneI5pjiCEXCwrsojNhoLa1FKQxAYeDr4YfCtIacEdQRT8Y0LKtuTwpZx+Kfdi7q0cpeV25FDuj4DtFDtRZ/a8aeTOoahUXDHt5DS0b9qBacPTqDwuRqZR04Kz59TQhYcShMcTljTJTPWsKjy+DVmt6LtCcf0sXerFoGyUm7RyZZIapBpQqJEWooPcZL41HLU7aaaQiqRa6ZYYZMxReygGHc4804ZdsSNmbHmaxLkkfxjMvWijxotxizVuiaVp0ZpIg3jCYoY6fgZGRCq5Ys7JOYhxJB1Fhzbn3+z0YnqxZZF1sX14Dt2FFjOLHf9gTESlBgaNaNQcshkhqnf0Ic7Xy5A9v16HIXk7WYP88KzE6Fg/j6V+zNqNY7ZxnWt8Dkty/Jy9fM5+WGjsu2sksTS2U34uk4UxTwa8etBkcgvz+fSWNxbeumjZpkTfN/uu/GIu3VOPlsO8V42ql+bcwrR6JJ1jvflwUyJfwtdijZyXzRdNv2jJsr6ld+6q33xd0ZJM0unwlfCeLTMSvb1121UhheRfya0XwHuGtKRPnF+3repl/kcujJ7KRj2Jbdkezfvb/+8dYREZcMy5O8JW2PvtyNjxZWwEk4yNYHaPv9jYAqbHTLE/KIr8ik/3glHuRkYaput6gsrnN319fsvXwbMpZ9ST/yzR7JRJRLfRmzAOmKI5AGbCkDLSqGpw1uEh8j851OCMw9RNKGiqwYnnVhnYdGwc5Kt6aKuify2UPei2+pElX6I31R+Hl01M6L3Vh+/7KNlRp5H/DgKX2MY2//jsEfBpVuh1bJujQsgfRw+ADGZQaun/AKgfby0AAAB42mNgZACDk+kmHvH8Nl85JDnA/Keb7m2F0b87/yYKMHAUMTAysAExUAcAZGUNPwB42mNgZGBgV/znysDAwcDA8P8FexEDOtADAF2tBAMAAHjaFY49CsJAFISHzW8VBEEQSbshsRG7VKkiEkNiLETE0srWQ1jFg6TxGF7Eg/htMcx7387srrlI/l2JES69UBNLb3zrP9V7o3pTau24l2rAb3C313SuwVeWTEemgO/gc/aDmXRCS1iGW3Ip8wMfgrMsc4cq7syjUTm9BWcbtApLHck0sD3dD2wWTmrdG+w/958/KrQc9AAAeNotzkFKggEUxPGfiEiFIYQfYUgYRvSJJImRVKhdITyD0N5btPAIKrRu06ZNCCEtgohwGbho0zF8hAN/Bh4zj+Ffl2R2N6zIPpP7JZ+y1WT7k50PCg8Uw/eWlKYk98EL+3PKFQ4GVH44fKM65CgbTKhF9ji6J5E/7ZJ+Uf+m8c7ZguYT5zNaI9ox52Ick+LWib9Xj1zXuIlO74/+K7dJcLcGFjAe/AAAAAEAAAAuEAAEAAD/AP8AAgAQAC8A/wAACJsTaAD/AB542p2QzU7CQBSFv4FClKhLY+LCxi1C2mT4iTuoW2gDhY2rEroooW1CFzyCz+BL+CoufR1vywRdGBKZycz97jn3zGKAGz5QlEtxX93lqmFJd+C60IPhUn023OCKheEmt0SGWzyyl5SyLkXp8264xgWfhuuifxm26Ktrww3ulGe4yZN6NdziRb15i8D3R+0wSePCnsZ7e5anUWaP8+26PCfsE9Yy3hVJntmDruNWvtiVG8w7pT8J/1Zdx+0Ndb7auFrjyUcE+LJHtAlJSIkpsJlK3UudkYsWkQmPhbesj/W89HmppXg7mUqkL/UBXRzcX/lD+icbMKdzzE9k8j+zbvV6jyFa1BUb6TT6Gz0eb1YAAHjaY2BmwAsAAH0ABHjaxVd7cFTVGT+Pyz6yudlNAiEawl2yy7rsEhJvgGCUzd088BE3BEhtghQCysprIJjAVGtJsONYxyqZ2qmCrUSxlWqV3XMdXYzoznRqtR2HjNMO+ChJq47VKqG26vhMf+fcCDrDX/2nG37f7zvn+53vfOfcc3cPyULSqc1gB0glMbQZ+JuulZLL4JfarkojmNMK7cIiU7IonWnmNJ8dDRr+ZEArIYMAI37YRmAdwJWlxNJKxPfrrBzoRoe2O7TFoc4661kIryJ1k3mtxJ5Zbspuu6DQHJTs8cp2sVhdZyW9WjG5RumKySqHRUedCqdklmJyudNrt7Q6o5qc7sSUuKHOSIbRDgIW0AscAc4ALlRfTGqAIWAS0FRL6gaAfcAwMC61Kpunzp+s0AKIBNTaA9ipAMYEsPYezYu1Z5T1ax7siocsBw5qbqJpBYJsM44iCbdbVaXcji9QLKLzTBUQF84yj2mc7ScXEQMdVJRVqAgRTU1TzuIljmPHqs2xZIFGyATANKJREnVG2dEF5pnn0ab8K+KnVPbyL+zAdMzGv7T9paaVDPBPSQfASIZnSR5gZAf/iAwADPIjovpiORE/YhcUmQHoJ0gQGAQ4GYalqm0BUj9hl5bJ9O8If7EaNyZqFzqOHSg3O5LT+Ruo5yX+CgkRg/8dPBv8BzAOHn+Bv0h0VefDtj9gDmK+Q5Af4jeReQj/it9MTPBhvodUKNmrosiZ51URjZnJAv4Iv0VJ+vhOshC8jW8VphEc4Q/L88jft70+Wd/7IjDDPMbf5VvJdKjegmqm4T/Gt5MaQK4kZ3t1cyhZyHNYZg7bYqBGSg4qa/FXBBJhvt/wQVKG2HG+l8wAP8pvFTOM/Aj/RMk+llkw30M4MZJsvcjMJ738IXlC+IfY8Q/VbP+xI0tMkozwn5BagGFT34T3JrwAPw3vNB7TaTya03g0p1HFaRxawj9A5ANoavgp0stfJ0PAQfgaUt4ksINHlROOmkf5D/kt2InACPaOoneP7S2Sld0iSkqV7Bb5gjce4yfIcoCh+JPyjdwxwu9WSxmyyyvkgD8LbyG27gfOs8DAm+UzOMYH+a1qJ/aqHcg8hybOP/+RGjxpFxabA3j6nWjugN0HjAITgAZZJ9bQSdYBHPIOu8hv+kf4ajX4SlFUZxzjV2DpV6jdukLMqFI1Xz7laH5RMdt8TjqkmhJiakWaS9QYK0Z4G87Pct4urjdQ+wqBvHJgu72kwawd4e1qL9qFEXK6RekFylkmvM65arYLimUlLUoYF54i1R2feiV5zJ4+0zRwThvUautgCa/H46vHo6nHe1KnHoZpB0pw+q/nplqRSXqAYSADaHjGJuQmnrFJxlWPny/GcheTSYDj2S4mZwB81fCLSSOwD3geGAemqd4egKG/FjP0wA4BDBlr0A7AWkAPMAgMA3ngDOAmx3k15qmGuhZ2EMgAY4CGZzUfdcxHrIQHyZceQgwywPZbDXSADNABNsAHtIFpA4GBYo+1aO5809oizQJpojD1Pd5e76CX13otb4eXB7xBL8tN5oW7oQ5klbga6l5LvZf6LMVL6odcQ252PFlIi8kYMAFwcpwG0AqgFbBu58cTY4mJBD+eGktNpPjxU2OnJk7x49Vj1RPV3EpVNJj16+gOOkD3Uc2gNbSRLqfaOr6DD/B9XDN4DW/EWdB6fL2+QR+v9Vm+Dh8P+II+NuQb9mV8ed+ob1rGlXeNusZdZ1zTOlw9rl7XoGvINexyGe4ad6Pbcmlnks3sdWzqMGwGYGQQdkh5ARXJw46q9pBq98D2qrYF26G8EGyt9IAQcr0G3SDsECB1sh2CrZVtIIRv91fR1ws7BDD2qjWrqjZshVkgHAwzEqZnwnQ0PB5mmXA+zPLJBnZSVXkSVZ5UVZ7EyJNq7pPICw8IodoTSncCuhNKdwI66Z2vrwe2V3kWbIfyQrC10mMnRKjen5zJ7kfGdbAHgTGAkxrYRmCHahlSwe6HtdgB+6L5+MFnB0QE35GgKodmOzRLkX3Bhea6pB8XlIPAGMCJbBlAo2xN5tl+0SK1+8VShxrqxpKX4FdUlrKfHAEYWQ57UHk1sI3KO6I0/rPtDOy48nphh8+OW6c8qTOAr8dr7AD+9sPzs5vRe7PlY6SsjBBSUuwpybFnxOYSI8eeFNEAyHZISEqWMo791+lpZZ9Q9qCyP1P2u8r6LV9I/zSk/z6kPxLSkwXsKhJG9xll31V2i1UU1v8R1l8I64fC+kNhfYS+SaoQmGNdWKW/XaX/tUp/ukp/tEq/p0pfU6WvqNKvrpKpoiRIdFYpLV2r7CxrZlD/Iqj/Laj/Kai/GNQfDOrdQb0hCDn9EL+pOv2Fsvcqu+jphbqxUK9cqD/DsDf0WuEn3hHG6LVE5wUiljBy3KuIzRGpuaBZIpUEVYjUStCFInUjqFSk7jGSXuanWVxYDFZEsx7JhSK2F2GfQx4RWwuaJmKXGDn6lYiFQJ+LdCXoM5GeDfpYpBeCPpL0LP03STOkof8S6QeQnr5HojItfYdE2GPgnEg1Qv20Mzt9kiToXHQL3Pyk7LcihuLoYRGLgh4RsTDo1w4dEjED9KBILwA9INL3gH4p0m+BDojoNplvP4mqPPeRiOI+kapAeKdIyQy9IlUD2iFSi0BbReJl0GaReEsOvYFmKU43TZOYqnS9SMcQXje1kO+RqAqvIYtU5stFSm7JMpkkqdPWqYW00GZ576NNNKuyWCJWC1lCxCKgpc7OXSbScdASEcUe03oRfQA7t3hqgnny+TxLwyhDJgqJ2GMQGSI9DzRbpFtBFXIkiiqdmrWEJFRRxSImVQERCxrPUR9Jq4wFJEIPPGV8ibyfJ3L0GmF8ZuU8VBifREFPGe+nNhj/TOVw6zXew2v82FPGGKSnEnAtn/FG7C3j9XSV8ccYFFaF8VJsgfG7yE1GLjpi2KnZRhaFZdIbjCNpleGJCIYJ43A0xyhGD6evNu6LxY17IzlZw08hvl3OgUS3xW4ybo3sNXbhKPSn7jD6YpVGb3StsSUqJ5ppbI6tNDZhITdgzMb0Dcb62D1GzyJV8drYy8aqRWoNbWm1oisTKnBFeqWxDBUg0CgDqOBSnEsTQxcsGpF7hNtKs/2y8Z36Zxl+iekgcKO1wH3Mvce9wd3pbsJvzkXuue457tnu6Z4ST8BT5Cn0FHg8HpdH8zAP8RA2PTc5bsUJvsGmuwKSXJq0mvIDTFoYeS9h1MPwn61MKW9jbauaMvXxtpx7cmVmSbwt4+m4titL6d3dtC2Tv460bQhmPl4VytGCFasz00JNNFPSRto6m8ohzrAf5yjp7MrRSTnitopMSXPXUULp/NvuqpC87La7urtJ2e7G8saSRPEly1rOY3qmbGtL/NynPB7/Vqsy8/O2VV2ZRyu7M6Z0Jiu72zLzVgXXdB1l29iW1pajbKuk7q6jdBPb1rpS9tNNLd2QXapkJMG2QkZSkiBja0hCytC/5hsymkV3SzaRcETLaVaK8NIsV6LVjqj5myJ+J21WomZ+pxI94EwYQx2Y0JIE2bRtJKYmjE3bpmTlUpaNRJApHZGSrBmBIBsxVXjFuXDUCT/uhB+X4Ryl5+KLIk61URJRM0RYFJr4//Gzsel/GETtpbu3d7VuDLX2hFo3Aj2ZO3dvKs8MbggGs9t3y0AwwyM9G67bJHn9xszu0MaWzPZQSzC7tOs84S4ZXhpqyZKu1s6ubJe1sUUstZa2hta3dNvte5fs/NZcd5yda8ne8yTbK5MtkXO17zxPeKcMt8u5dsq5dsq52q12NVfbyiba1tGV9ZCm7uY1DtvMV4C3padiTndTWaA3oV6dS+eU76l4RiP0MPHFuzOFoaaMDshQdbI6KUN4pWWoCN3+qVD5nkvnVDxDD0+FAuguDjWR/vLWzS3414dPf/8ufLDHfX1Tr5QT6I+3qjgE/fD61QdK+BJ9qncq3k92nfvE446W9MWbu7KpVGv55pYKXORtefeOd/eReNyZMB4nmBOrVpf9MnXZ97nK6v6Sejv1UYrn1S1/FBhXt/w8bvijwDhu+bN5PjGaGE/wfGo0NQ7tqdFT46d4vnq0erya109VIKfqpqjw3N+ueN8u2R2narVq3bIQFA1HrvrrbehTgX61Mfg4/WpoHIniZ4fHzzl9TnCXGuL09p07wwjI9P27znO+nV4kx97H4/8FXC0pXwAAAA==") format("woff");
}
.pdf24_104 {
	font-size: 0.92em;
	font-family: "CUPOOA+Times New Roman Bold";
	color: #000000;
}
.pdf24_105 {
	letter-spacing: 0.0003em;
}

.pdf24_ie .pdf24_105 {
	letter-spacing: 0.0044px;
}
.pdf24_106 {
	letter-spacing: 0.0005em;
}

.pdf24_ie .pdf24_106 {
	letter-spacing: 0.0044px;
}
.pdf24_107 {
	letter-spacing: 0.0006em;
}

.pdf24_ie .pdf24_107 {
	letter-spacing: 0.0086px;
}
.pdf24_108 {
	letter-spacing: 0.0009em;
}

.pdf24_ie .pdf24_108 {
	letter-spacing: 0.0086px;
}
.pdf24_109 {
	letter-spacing: 0.0026em;
}

.pdf24_ie .pdf24_109 {
	letter-spacing: 0.0388px;
}
.pdf24_110 {
	letter-spacing: 0.0042em;
}

.pdf24_ie .pdf24_110 {
	letter-spacing: 0.0388px;
}
.pdf24_111 {
	letter-spacing: 0.0032em;
}

.pdf24_ie .pdf24_111 {
	letter-spacing: 0.0476px;
}
.pdf24_112 {
	letter-spacing: 0.0051em;
}

.pdf24_ie .pdf24_112 {
	letter-spacing: 0.0476px;
}
.pdf24_113 {
	position: absolute;
	pointer-events: none;
	clip: rect(5.958333em,43.44em,22.98583em,5.960333em);
	width: 100%;
}
.pdf24_114 {
	letter-spacing: 0.0029em;
}

.pdf24_ie .pdf24_114 {
	letter-spacing: 0.038px;
}
@font-face {
	font-family:"HRGLQU+Times New Roman Italic";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_115 {
	font-size: 0.92em;
	font-family: "HRGLQU+Times New Roman Italic", "Times New Roman";
	color: #000000;
}
.pdf24_116 {
	letter-spacing: -0.0037em;
}

.pdf24_ie .pdf24_116 {
	letter-spacing: -0.0551px;
}
.pdf24_117 {
	position: absolute;
	pointer-events: none;
	clip: rect(20.05em,43.65001em,56.18em,5.940333em);
	width: 100%;
}
.pdf24_118 {
	letter-spacing: -0.0039em;
}

.pdf24_ie .pdf24_118 {
	letter-spacing: -0.0581px;
}
.pdf24_119 {
	letter-spacing: -0.0098em;
}

.pdf24_ie .pdf24_119 {
	letter-spacing: -0.145px;
}
.pdf24_120 {
	letter-spacing: -0.0044em;
}

.pdf24_ie .pdf24_120 {
	letter-spacing: -0.0651px;
}
.pdf24_121 {
	letter-spacing: 0.0017em;
}

.pdf24_ie .pdf24_121 {
	letter-spacing: 0.0221px;
}
.pdf24_122 {
	position: absolute;
	pointer-events: none;
	clip: rect(17.46em,45.1695em,56.53em,5.840333em);
	width: 100%;
}
.pdf24_123 {
	letter-spacing: -0.0132em;
}

.pdf24_ie .pdf24_123 {
	letter-spacing: -0.1936px;
}
.pdf24_124 {
	letter-spacing: -0.0058em;
}

.pdf24_ie .pdf24_124 {
	letter-spacing: -0.0858px;
}
.pdf24_125 {
	position: absolute;
	pointer-events: none;
	clip: rect(7.88em,45.1695em,57.64em,5.840333em);
	width: 100%;
}
.pdf24_126 {
	letter-spacing: 0.0027em;
}

.pdf24_ie .pdf24_126 {
	letter-spacing: 0.0354px;
}
.pdf24_127 {
	letter-spacing: -0.0069em;
}

.pdf24_ie .pdf24_127 {
	letter-spacing: -0.1018px;
}
.pdf24_128 {
	position: absolute;
	pointer-events: none;
	clip: rect(9.050003em,45.1695em,58.68967em,5.840333em);
	width: 100%;
}
.pdf24_129 {
	font-size: 1em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_130 {
	position: absolute;
	pointer-events: none;
	clip: rect(55.08667em,10.62367em,55.21em,5.960333em);
	width: 100%;
}
.pdf24_131 {
	position: absolute;
	pointer-events: none;
	clip: rect(6.910004em,14.87367em,14.41333em,5.960333em);
	width: 100%;
}
.pdf24_132 {
	position: absolute;
	pointer-events: none;
	clip: rect(13.18em,28.75783em,13.30333em,5.960333em);
	width: 100%;
}
.pdf24_133 {
	position: absolute;
	pointer-events: none;
	clip: rect(7.01em,44.92em,58.77375em,5.988333em);
	width: 100%;
}
.pdf24_134 {
	letter-spacing: 0.0048em;
}

.pdf24_ie .pdf24_134 {
	letter-spacing: 0.0703px;
}
.pdf24_135 {
	font-size: 0.67em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_136 {
	font-size: 0.5em;
	font-family: "KVCUDS+Times New Roman";
	color: #000000;
}
.pdf24_137 {
	position: absolute;
	pointer-events: none;
	clip: rect(10.07em,45.1695em,54.1em,5.960333em);
	width: 100%;
}
.pdf24_138 {
	font-size: 0.83em;
	font-family: "CTDADR+Symbol", "Times New Roman";
	color: #000000;
}
.pdf24_139 {
	font-size: 0.83em;
	font-family: "CTDADR+Symbol", "Times New Roman";
	color: #242424;
}
.pdf24_140 {
	font-size: 0.92em;
	font-family: "KVCUDS+Times New Roman";
	color: #242424;
}
.pdf24_141 {
	font-size: 0.696em;
	font-family: "KVCUDS+Times New Roman";
	color: #242424;
}
.pdf24_142 {
	position: absolute;
	pointer-events: none;
	clip: rect(29.1525em,44.12em,49.29em,5.960333em);
	width: 100%;
}
.pdf24_143 {
	letter-spacing: -0.0032em;
}

.pdf24_ie .pdf24_143 {
	letter-spacing: -0.0299px;
}
.pdf24_144 {
	position: absolute;
	pointer-events: none;
	clip: rect(8.133331em,45.05em,28.75583em,5.848333em);
	width: 100%;
}
.pdf24_145 {
	letter-spacing: 0.006em;
}

.pdf24_ie .pdf24_145 {
	letter-spacing: 0.08px;
}
.pdf24_146 {
	position: absolute;
	pointer-events: none;
	clip: rect(19.5em,21.42533em,53.96em,5.960333em);
	width: 100%;
}
.pdf24_147 {
	letter-spacing: -0.006em;
}

.pdf24_ie .pdf24_147 {
	letter-spacing: -0.0876px;
}
.pdf24_148 {
	position: absolute;
	pointer-events: none;
	clip: rect(11.19em,45.0495em,38.165em,5.958333em);
	width: 100%;
}
@font-face {
	font-family:"STBCNA+TimesNewRomanPSMT";
	src:url("data:application/octet-stream;base64,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") format("woff");
}
.pdf24_149 {
	font-size: 0.92em;
	font-family: "STBCNA+TimesNewRomanPSMT";
	color: #000000;
}

 body > div {
	box-shadow: 0 0 5px rgba(0,0,0,0.3) !important;
	margin: 20px auto !important;
}

</STYLE> 
</head>
	<body>
		<div id="page_0" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAYj0lEQVR4nO3asaqsBxmF4QFbQbAxIMjBRluvwNh6A6YLpLBSO8EupNPGStRCElCx8iKdg3YSF3JWXHM+nwdWtZtvptnz8v+PBwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAb/3tuS/MBvvNv7a+w8w6+/Vzn7/AHWavvL8/9/0H8E7+sj6A/1s/fu6j9RFAzdsfZ19bHwEv7rPnvrs+At53AoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBb99/POfjtn/er9/7o8vcIeZdfbX5z5/gTvMXnl/eu7NA3gnnsCw4gkM3PL2x5knMPCfeQIDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVlLAfPDcGzP7yvbtR5eAgeyzh4CBdyZgWEkB88lzn5rZV7afPbq+eAgYSAQMFAgYVrxCBrcIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGElBczbv398fN/8L78zeGUCBjIBAwUChpUUMD947sPj+/q/fWp4fwkYyAQMFAgYVrxCBrcIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWEkB88Fzb8zspfaNx5cTMJB99hAw8M4EDCspYD557lMze6n98PHlvngIGEgEDBQIGFa8Qga3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhJQXMB8+9ObjvfMnnhfedgIFMwECBgGElBcwnz316cL/6778qeC8IGMgEDBQIGFa8Qga3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQIGAYUXAwC0CBjIBAwUChhUBA7cIGMgEDBQIGFYEDNwiYCATMFAgYFgRMHCLgIFMwECBgGFFwMAtAgYyAQMFAoYVAQO3CBjIBAwUCBhWBAzcImAgEzBQIGBYETBwi4CBTMBAgYBhRcDALQIGMgEDBQKGFQEDtwgYyAQMFAgYVgQM3CJgIBMwUCBgWBEwcIuAgUzAQMGfn/vQbLCfPveLF7jDzDr7w3M/eoE7zF55v3vuew/gnfz8uY/NBnv79OUnL3CHmXX20QvcYPbq++Vz33oAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADwFfoH1gKo/nwnCqQAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_04" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:20.7942em;top:6.0406em;"><span class="pdf24_07 pdf24_08 pdf24_09" style="word-spacing:0.0022em;">IMJUDO 20 mg/mL &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.0042em;top:8.1106em;"><span class="pdf24_07 pdf24_08 pdf24_10">(tremelimumab) &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.4442em;top:10.1706em;"><span class="pdf24_07 pdf24_08 pdf24_11" style="word-spacing:0.0019em;">Concentrado para solucin para perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.2918em;"><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.6343em;">1. INDICACIONES</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0018em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_15" style="word-spacing:-0.0008em;">Y USO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.3418em;"><span class="pdf24_12 pdf24_08 pdf24_16" style="word-spacing:0.8165em;">1.1. Carcinoma</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0008em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_13">hepatocelular &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.3918em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0003em;">IMJUDO, en combinacin con durvalumab, est indicado para el tratamiento de pacientes adultos con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.4518em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0048em;">carcinoma hepatocelular no resecable (uHCC). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.5606em;"><span class="pdf24_07 pdf24_08 pdf24_14" style="word-spacing:0.6097em;">1.2. </span><span class="pdf24_12 pdf24_08 pdf24_19" style="word-spacing:0.0033em;">Cncer de pulmn de clulas no pequeas (NSCLC) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.6943em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.1554em;">IMJUDO, en combinacin con durvalumab y quimioterapia basada en platino, est indicado para el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7443em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0684em;">tratamiento de pacientes adultos con NSCLC metastsico sin mutaciones sensibilizantes del receptor del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.7943em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0373em;">factor de crecimiento epidrmico (EGFR) ni aberraciones tumorales genmicas de la quinasa del linfoma &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.8543em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:-0.0072em;">anaplsico (ALK). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.9743em;"><span class="pdf24_12 pdf24_08 pdf24_11" style="word-spacing:0.631em;">2. DOSIS</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0001em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_15" style="word-spacing:-0.0007em;">Y ADMINISTRACIN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.0143em;"><span class="pdf24_12 pdf24_08 pdf24_22" style="word-spacing:0.8146em;">2.1. Dosis</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0093em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_23">recomendada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.1243em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0017em;">Las dosis recomendadas de IMJUDO se presentan en las Tablas 1, 2 y 3. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.2343em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0027em;">Administre IMJUDO como una perfusin intravenosa despus de la dilucin recomendada [</span><span class="pdf24_26 pdf24_08 pdf24_27">ver &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.2843em;"><span class="pdf24_26 pdf24_08 pdf24_28" style="word-spacing:0.0032em;">Preparacin y administracin (2.3)</span><span class="pdf24_17 pdf24_08 pdf24_29">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.396em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.0007em;">IMJUDO, en combinacin con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.506em;"><span class="pdf24_12 pdf24_08 pdf24_20" style="word-spacing:0.0032em;">Tabla 1: Dosis recomendada de IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:38.596em;"><span class="pdf24_12 pdf24_08 pdf24_09">Indicacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.552em;top:39.696em;"><span class="pdf24_17 pdf24_08 pdf24_30">uHCC &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:38.596em;"><span class="pdf24_12 pdf24_08 pdf24_20" style="word-spacing:0.0021em;">Dosis recomendada de IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:39.696em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0038em;">Pacientes con un peso corporal de 30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:40.746em;"><span class="pdf24_17 pdf24_08 pdf24_31" style="word-spacing:0.0065em;">kg y ms: &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8058em;top:38.596em;"><span class="pdf24_12 pdf24_08 pdf24_25" style="word-spacing:0em;">Duracin del tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8058em;top:39.696em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.1189em;">Despus del Ciclo 1 de terapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8058em;top:40.746em;"><span class="pdf24_17 pdf24_08 pdf24_33">combinada, &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8058em;top:41.806em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0677em;">durvalumab como agente nico &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8058em;top:42.856em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:2.3954em;">cada semanas</span><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:0.829em;">&nbsp;</span><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.82em;">hasta la &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6737em;top:40.746em;"><span class="pdf24_17 pdf24_08 pdf24_20">administre &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:41.7709em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:18.0142em;top:41.876em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0284em;">Una dosis nica de Imjudo</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_14" style="word-spacing:-0.0431em;">1 </span></sup><span class="pdf24_17 pdf24_08 pdf24_38" style="word-spacing:-0.0358em;">300 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:42.926em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0652em;">seguido por durvalumab</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_14" style="word-spacing:0.25em;">2 </span></sup><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0564em;">1500 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:43.976em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0028em;">en el da 1 del ciclo 1; &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.4738em;top:42.856em;"><span class="pdf24_17 pdf24_08 pdf24_14">4</span></div>
					<div class="pdf24_01" style="left:31.8058em;top:43.916em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1582em;">progresin de la enfermedad o &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.8058em;top:44.966em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.003em;">toxicidad inaceptable. &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:44.9909em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:18.0142em;top:45.096em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0256em;">Contine con durvalumab 1500 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:46.146em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0433em;">como agente nico cada 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:48.2585em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.1023em;">Pacientes con un peso corporal menor &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:49.3185em;"><span class="pdf24_17 pdf24_08 pdf24_40" style="word-spacing:0.0064em;">de 30 kg: &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:50.3334em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:18.0142em;top:50.4385em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.4825em;">Una dosis nica de Imjudo</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_14" style="word-spacing:0.6983em;">1 </span></sup><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:0.4402em;">4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:51.4885em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0061em;">mg/kg seguido por durvalumab</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_14" style="word-spacing:0.1293em;">2 </span></sup><span class="pdf24_17 pdf24_08 pdf24_14">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:52.5485em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0008em;">mg/kg en el da 1 del ciclo 1; &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:53.6685em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.8067em;">Continue con durvalumab 20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:54.7185em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1727em;">mg/kg como agente nico cada 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0142em;top:55.7685em;"><span class="pdf24_17 pdf24_08 pdf24_39">semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:16.5142em;top:53.5634em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.8787em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">1 </span></sup><span class="pdf24_43 pdf24_08 pdf24_38" style="word-spacing:0.0004em;">Administrar IMJUDO antes de durvalumab el mismo da. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.8384em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">2 </span></sup><span class="pdf24_43 pdf24_08 pdf24_44" style="word-spacing:0.0041em;">Consulte la informacin sobre la dosificacin de durvalumab en la Informacin de Prescripcin. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_1" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_45" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_12 pdf24_08 pdf24_20" style="word-spacing:0.0019em;">IMJUDO en combinacin con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.0015em;">En las Tablas 2 y 3 se indican el programa de dosificacin y los regmenes recomendados para IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.002em;">en el tratamiento del cncer de pulmn de clulas no pequeas (NSCLC) metastsico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.003em;">Pesar a los pacientes antes de cada perfusin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.042em;">Calcule la dosis adecuada utilizando la Tabla 3 a continuacin, segn el peso del paciente y la histologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_17 pdf24_08 pdf24_47" style="word-spacing:-0.0063em;">del tumor. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_12 pdf24_08 pdf24_25" style="word-spacing:-0.0006em;">Tabla 2: Programa de dosificacin recomendado &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.5142em;top:17.6733em;"><span class="pdf24_48 pdf24_08 pdf24_49">Semana</span><sup style="top: -0.25em;"><span class="pdf24_50 pdf24_08 pdf24_51">1,2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:11.2217em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:12.2717em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">1</span></div>
					<div class="pdf24_01" style="left:13.2517em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">2</span></div>
					<div class="pdf24_01" style="left:14.3017em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">3</span></div>
					<div class="pdf24_01" style="left:15.3517em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">4</span></div>
					<div class="pdf24_01" style="left:16.3342em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">5</span></div>
					<div class="pdf24_01" style="left:17.3842em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:18.4342em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">7</span></div>
					<div class="pdf24_01" style="left:19.4142em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:20.4642em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_14">9</span></div>
					<div class="pdf24_01" style="left:21.6742em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_53" style="word-spacing:1.0595em;">10 11</span><span class="pdf24_52 pdf24_08 pdf24_14" style="word-spacing:0.7341em;">&nbsp;</span><span class="pdf24_52 pdf24_08 pdf24_53" style="word-spacing:0.6911em;">12 13 14 15 16</span><span class="pdf24_52 pdf24_08 pdf24_14" style="word-spacing:1.0833em;">&nbsp;</span><span class="pdf24_52 pdf24_08 pdf24_53" style="word-spacing:1.2976em;">17 18 19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8058em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_53">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.9658em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">7</span></div>
					<div class="pdf24_01" style="left:37.5283em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_53">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.3683em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_53">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.0683em;top:18.7803em;"><span class="pdf24_52 pdf24_08 pdf24_53" style="word-spacing:0.8849em;">23 24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:42.5883em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:11.2217em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">1</span></div>
					<div class="pdf24_01" style="left:14.3017em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">2</span></div>
					<div class="pdf24_01" style="left:17.3842em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">3</span></div>
					<div class="pdf24_01" style="left:20.4642em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">4</span></div>
					<div class="pdf24_01" style="left:24.5642em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">5</span></div>
					<div class="pdf24_01" style="left:29.5158em;top:19.9103em;"><span class="pdf24_52 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:21.0328em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:5.992em;top:20.0958em;"><span class="pdf24_48 pdf24_08 pdf24_54">Ciclo: &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.1517em;top:21.0328em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:11.1517em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:11.1517em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:14.2317em;top:21.0328em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:14.2317em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:14.2317em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:17.3142em;top:21.0328em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:17.3142em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:17.3142em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:20.3942em;top:21.0328em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:20.3942em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:20.3942em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:5.992em;top:21.2158em;"><span class="pdf24_55 pdf24_08 pdf24_16">IMJUDO</span><sup style="top: -0.25em;"><span class="pdf24_56 pdf24_08 pdf24_51">3,4 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:5.992em;top:22.3458em;"><span class="pdf24_55 pdf24_08 pdf24_38">Durvalumab</span><sup style="top: -0.25em;"><span class="pdf24_56 pdf24_08 pdf24_57">1,3 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:5.992em;top:23.4658em;"><span class="pdf24_55 pdf24_08 pdf24_58">Quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.4942em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:29.4458em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:35.8958em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:42.5183em;top:22.1628em;"><span class="pdf24_52 pdf24_08 pdf24_14">X</span></div>
					<div class="pdf24_01" style="left:24.3942em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_59">X</span><sup style="top: -0.21em;"><span class="pdf24_60 pdf24_08 pdf24_61">5 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:29.3458em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_59">X</span><sup style="top: -0.21em;"><span class="pdf24_60 pdf24_08 pdf24_61">5 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:35.7858em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_59">X</span><sup style="top: -0.21em;"><span class="pdf24_60 pdf24_08 pdf24_61">5 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:42.4183em;top:23.2828em;"><span class="pdf24_52 pdf24_08 pdf24_59">X</span><sup style="top: -0.21em;"><span class="pdf24_60 pdf24_08 pdf24_61">5 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.002em;top:24.4245em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">1 </span></sup><span class="pdf24_43 pdf24_08 pdf24_44" style="word-spacing:-0.0003em;">continuar con durvalumab hasta la progresin de la enfermedad o toxicidad intolerable. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.3845em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">2 </span></sup><span class="pdf24_43 pdf24_08 pdf24_38" style="word-spacing:-0.0003em;">el intervalo de dosificacin cambia de cada 3 semanas a cada 4 semanas a partir del ciclo 5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.3445em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">3 </span></sup><span class="pdf24_43 pdf24_08 pdf24_10" style="word-spacing:0.0079em;">perfusin intravenosa durante 60 minutos [vase preparacin y administracin (2.3)]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.273em;"><span class="pdf24_62 pdf24_08 pdf24_14">4</span></div>
					<div class="pdf24_01" style="left:6.552em;top:27.3045em;"><span class="pdf24_43 pdf24_08 pdf24_63" style="word-spacing:0.0788em;">si los pacientes reciben menos de 4 ciclos de quimioterapia basada en platino, los ciclos restantes de IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.2645em;"><span class="pdf24_43 pdf24_08 pdf24_54" style="word-spacing:0.0252em;">(hasta un total de 5) deben administrarse despus de la fase de quimioterapia basada en platino, en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2245em;"><span class="pdf24_43 pdf24_08 pdf24_64" style="word-spacing:0.0018em;">durvalumab, cada 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.1745em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.0648em;">5 </span></sup><span class="pdf24_43 pdf24_08 pdf24_10" style="word-spacing:0.0492em;">Terapia opcional con pemetrexed desde la semana 12 hasta la progresin de la enfermedad o toxicidad intolerable &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.1345em;"><span class="pdf24_43 pdf24_08 pdf24_65" style="word-spacing:-0.0009em;">para pacientes con enfermedad no escamosa que recibieron tratamiento con pemetrexed y carboplatino/cisplatino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.1443em;"><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:-0.0022em;">Tabla 3: Rgimen y dosis recomendados &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:34.236em;"><span class="pdf24_12 pdf24_08 pdf24_32">Histologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:35.296em;"><span class="pdf24_12 pdf24_08 pdf24_25">tumor &nbsp;</span></div>
					<div class="pdf24_01" style="left:11.7381em;top:34.236em;"><span class="pdf24_12 pdf24_08 pdf24_19" style="word-spacing:0.7305em;">del Peso &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.8017em;top:35.296em;"><span class="pdf24_12 pdf24_08 pdf24_66">paciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.191em;top:34.236em;"><span class="pdf24_12 pdf24_08 pdf24_24" style="word-spacing:0.74em;">del Dosis</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.5355em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_22" style="word-spacing:0.7086em;">de Dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.2625em;top:34.236em;"><span class="pdf24_12 pdf24_08 pdf24_40" style="word-spacing:0.7399em;">de Rgimen &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7237em;top:34.236em;"><span class="pdf24_12 pdf24_08 pdf24_67">de &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.8231em;top:34.236em;"><span class="pdf24_12 pdf24_08 pdf24_34">quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2642em;top:35.296em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:0.726em;">IMJUDO Durvalumab</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14" style="word-spacing:1.3017em;">1 </span></sup><span class="pdf24_12 pdf24_08 pdf24_16" style="word-spacing:0.0015em;">basado en platino</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_41" style="word-spacing:0.0024em;">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:36.386em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:0.002em;">No escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.8017em;top:36.386em;"><span class="pdf24_69 pdf24_08 pdf24_14" style="word-spacing:0.0055em;"> </span><span class="pdf24_17 pdf24_08 pdf24_70" style="word-spacing:0.0109em;">30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2642em;top:36.386em;"><span class="pdf24_17 pdf24_08 pdf24_71" style="word-spacing:-0.0048em;">75 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.8842em;top:36.386em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0049em;">1500 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:36.3509em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:32.5758em;top:36.456em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0465em;">carboplatino y nab- paclitaxel &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5758em;top:38.566em;"><span class="pdf24_17 pdf24_08 pdf24_14">O</span></div>
					<div class="pdf24_01" style="left:13.8017em;top:40.116em;"><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:0.0006em;">&lt; 30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2642em;top:40.116em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:0.0013em;">1 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2642em;top:42.886em;"><span class="pdf24_17 pdf24_08 pdf24_71" style="word-spacing:-0.0048em;">75 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.8842em;top:40.116em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:0.0011em;">20 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.8842em;top:42.886em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0049em;">1500 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:40.6309em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:31.0758em;top:42.8509em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:32.5758em;top:40.736em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.375em;">carboplatino o cisplatino y &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5758em;top:41.786em;"><span class="pdf24_17 pdf24_08 pdf24_66">pemetrexed &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5758em;top:42.956em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.003em;">carboplatino y nab-paclitaxel &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:42.886em;"><span class="pdf24_12 pdf24_08 pdf24_41">Escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:13.8017em;top:42.886em;"><span class="pdf24_69 pdf24_08 pdf24_14" style="word-spacing:0.0055em;"> </span><span class="pdf24_17 pdf24_08 pdf24_70" style="word-spacing:0.0109em;">30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5758em;top:45.056em;"><span class="pdf24_17 pdf24_08 pdf24_14">O</span></div>
					<div class="pdf24_01" style="left:13.8017em;top:46.166em;"><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:0.0006em;">&lt; 30 kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.2642em;top:46.166em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:0.0013em;">1 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.8842em;top:46.166em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:0.0011em;">20 mg/kg &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.0758em;top:47.1309em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:32.5758em;top:47.236em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.375em;">carboplatino o cisplatino y &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5758em;top:48.2885em;"><span class="pdf24_17 pdf24_08 pdf24_39">gemcitabina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.3987em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.0093em;">1 </span></sup><span class="pdf24_43 pdf24_08 pdf24_73" style="word-spacing:0.0001em;">Consulte el prospecto para obtener informacin sobre la dosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3985em;"><span class="pdf24_12 pdf24_08 pdf24_16" style="word-spacing:0.8164em;">2.2. Modificaciones</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0006em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_18" style="word-spacing:-0.0031em;">de la dosis por reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.5085em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0636em;">No se recomienda reducir la dosis de tratamiento. En general, suspender el rgimen de tratamiento en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5585em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0095em;">caso de presentar reacciones adversas severas (Grado 3) inmunomediadas. Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.6185em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.027em;">el rgimen de tratamiento en el caso de reacciones adversas inmunomediadas que pongan en peligro la vida &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.6685em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.4199em;">(Grado 4), reacciones recurrentes severas (Grado 3) inmunomediadas que requieran tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.7182em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0027em;">inmunosupresor sistmico, o imposibilidad de reducir la dosis del corticosteroide a 10 mg de prednisona o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.7782em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0021em;">su equivalente por da dentro de 12 semanas del inicio de los corticosteroides</span><span class="pdf24_74 pdf24_08 pdf24_25" style="word-spacing:0.0021em;">. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_2" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAs9klEQVR4nO3aMarv+Vrl4T0FI9NTJkZFh6ZmQg1AEBEnYFTQgeC1KIoGLxeqwBaq7q1DV2tDgxMwFXoUgoHD6HD722PwvJy113oeWPmb7P3nw/f38gIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABw7PX19f+/AsCGf//cv7sA/Be9ChgAdggYgPfuVcAAsEPAALx3rwIGgB0CBuC9exUwAOwQMADv3auAAWCHgAF4714FDAA7BAzAe/cqYADYIWAA3rtXAQPADgED8N69ChgAdggYgPfuVcAAsEPAALx3rwIGgB0CBuC9exUwAOwQMADv3auAAWCHgAF4714FDAA7BAzAe/cqYADYIWAA3rvnn/m/PfsPMzOzgf3r5/7dBQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgHq/evaXZgX702d/EXCHWeve/sb+LOAOs/X992e//wLD/vnZH5sV7IdnfxJwh1nr/vrZnwfcYba+f3j2hy8w7P987gPgE/n7Z7/3uY+AYn/17I8+9xHAy7fP/uBzHwGfk4ChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOb987N/NSvYPz37l4A7zFr3jy9+M8wS9n+fffECw7zAAAC8H15gmCdgAADeDwHDPAEDAPB+CBjmCRgAgPdDwDBPwAAAvB8ChnkCBgDg/RAwzBMwAADvh4BhnoABAHg/BAzzBAwAwPshYJgnYAAA3g8BwzwBAwDwfggY5gkYAID3Q8AwT8AAALwfAoZ5AgYA4P0QMMwTMAAA74eAYZ6AAQB4PwQM83777C/NCvanz/4i4A6z1r39jf1ZwB1m6/vNsw8vMOwtYP7YrGA/PPuTgDvMWvfXz/484A6z9f2PFwHDOJ+Q0eLvn/3e5z4Civ3Vsz/63EcAPiEDAUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzPv15z4APpG/efbx2S9mdrLfPvsx4A6z9f387MMLDPMCQwsvMHDLCwxk8ALDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMz7+OyDWcF+ePZlwB1mrfv62VcBd5it79tnX7zAsLeA+casYD8F3GDWvO+ffRdwh9n63r44EDBM8wkZLXxCBrd8QgYZ3l5gfELGNAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDM++lzHwCfyK+fffnsg5md7OtnXwXcYba+b5998QLD/u5zHwCfyK+efWNmZ/v+2XcBd5it7+2LAwHDNJ+Q0cInZHDLJ2SQ4e0FxidkTBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDM+/jsg1nBfnj2ZcAdZq37+tlXAXeYre/bZ1+8wLC3gPnGrGA/Bdxg1rzvn30XcIfZ+t6+OBAwTPMJGS18Qga3fEIGGd5eYHxCxjQBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDMEzC0EDBwS8BABgHDPAFDCwEDtwQMZBAwzBMwtBAwcEvAQAYBwzwBQwsBA7cEDGQQMMwTMLQQMHBLwEAGAcM8AUMLAQO3BAxkEDDM+8dnv5gV7H89+xhwh1nrfvvsx4A7zNb387MPLzDMCwwtvMDALS8wkMELDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAMO83n/sA+ET+9tnHZ7+Y2cl+9+zHgDvM1vf2W/fhBYZ5gaGFFxi45QUGMniBYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5gkYWggYuCVgIIOAYZ6AoYWAgVsCBjIIGOYJGFoIGLglYCCDgGGegKGFgIFbAgYyCBjmCRhaCBi4JWAgg4BhnoChhYCBWwIGMggY5r0FzC9mBfvfzz4G3GHWut89+zHgDrP1vf3WfXiBYV5gaOEFBm55gYEMXmCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCY99PnPgA+kV8/+/LZBzM72dfPvgq4w2x93z774gWG/d3nPgA+kV89+8bMzvb9s+8C7jBb39sXBwKGaT4ho4VPyOCWT8ggw9sLjE/ImCZgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCY9/HZB7OC/fDsy4A7zFr39bOvAu4wW9+3z754gWFvAfONWcF+CrjBrHnfP/su4A6z9b19cSBgmOYTMlr4hAxu+YQMMry9wPiEjGkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnn/9OwXs5L9HHCDWet+9+zHgDvM1vfx2YcXGOYFhhZeYOCWFxjI4AWGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnkChhYCBm4JGMggYJgnYGghYOCWgIEMAoZ5AoYWAgZuCRjIIGCYJ2BoIWDgloCBDAKGeQKGFgIGbgkYyCBgmCdgaCFg4JaAgQwChnm/+dwHwCfyt88+PvvFzE72u2c/Btxhtr6337oPLzDMCwwtvMDALS8wkMELDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzPj77YFawH559GXCHWeu+fvZVwB1m6/v22RcvMOwtYL4xK9hPATeYNe/7Z98F3GG2vrcvDgQM03xCRgufkMEtn5BBhrcXGJ+QMU3A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzfv25D4BP5G+efXz2i5md7LfPfgy4w2x9Pz/78ALDvMDQwgsM3PICAxm8wDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8z4++2BWsB+efRlwh1nrvn72VcAdZuv79tkXLzDsLWC+MSvYTwE3mDXv+2ffBdxhtr63Lw4EDNN8QkYLn5DBLZ+QQYa3FxifkDFNwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8wQMLQQM3BIwkEHAME/A0ELAwC0BAxkEDPMEDC0EDNwSMJBBwDBPwNBCwMAtAQMZBAzzBAwtBAzcEjCQQcAwT8DQQsDALQEDGQQM8/7fs1/MCvbjs58D7jBr3f989g8Bd5it71+e/bcXAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgzX8CPBl+HZ0uKtwAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_75" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_74 pdf24_08 pdf24_18" style="word-spacing:0.0015em;">Las modificaciones de tratamiento recomendadas se presentan en la Tabla 4</span><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0015em;">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:-0.0028em;">Tabla 4. Modificaciones recomendadas de la dosis por reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.3617em;top:9.2318em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:0.002em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.0642em;top:9.2318em;"><span class="pdf24_12 pdf24_08 pdf24_72">Severidad</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_33">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:33.1958em;top:9.2318em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:-0.001em;">Modificacin de la dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:10.3318em;"><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:-0.0007em;">Reacciones adversas inmunomediadas </span><span class="pdf24_26 pdf24_08 pdf24_20" style="word-spacing:0.0068em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0007em;">Advertencias y precauciones (5.1)</span><span class="pdf24_26 pdf24_08 pdf24_28" style="word-spacing:0.0007em;">] &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:11.4318em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:0.004em;">Grado 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:12.5218em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0017em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:11.4318em;"><span class="pdf24_17 pdf24_08 pdf24_11">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.2558em;top:12.5218em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.532em;top:11.9718em;"><span class="pdf24_17 pdf24_08 pdf24_21">Neumonitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:14.0718em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:0.001em;">Grado 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:14.0718em;"><span class="pdf24_17 pdf24_08 pdf24_11">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.422em;top:16.7318em;"><span class="pdf24_17 pdf24_08 pdf24_76">Colitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:17.7318em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.002em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:17.7318em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:20.9343em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:24.1343em;"><span class="pdf24_17 pdf24_08 pdf24_11">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.532em;top:20.9343em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.003em;">Perforacin Intestinal &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:20.9343em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0038em;">Cualquier Grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:22.0343em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0011em;">La ALT o AST aumentan hasta &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:23.0843em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0002em;">ms de 3 y hasta 8 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:24.1343em;"><span class="pdf24_17 pdf24_08 pdf24_14">o</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:25.1943em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0007em;">la bilirrubina total aumenta a ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:26.2443em;"><span class="pdf24_17 pdf24_08 pdf24_30" style="word-spacing:0.0079em;">de 1.5 y hasta 3 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:27.3443em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0009em;">La ALT o AST aumentan hasta &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:28.3943em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.0038em;">ms de 8 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:29.4543em;"><span class="pdf24_17 pdf24_08 pdf24_14">o</span></div>
					<div class="pdf24_01" style="left:6.532em;top:26.2643em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0007em;">Hepatitis sin compromiso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.532em;top:27.3243em;"><span class="pdf24_17 pdf24_08 pdf24_78" style="word-spacing:0.0091em;">tumoral del hgado &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:29.4543em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:30.5043em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0007em;">la bilirrubina total aumenta a ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:31.5543em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.003em;">de 3 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:32.6543em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0016em;">La ALT o AST son mayores de 1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:33.706em;"><span class="pdf24_17 pdf24_08 pdf24_79" style="word-spacing:0.0072em;">y hasta 3 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:34.766em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0036em;">inicialmente y aumentan a ms de &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:35.816em;"><span class="pdf24_17 pdf24_08 pdf24_79" style="word-spacing:0.0078em;">5 y hasta 10 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:36.876em;"><span class="pdf24_17 pdf24_08 pdf24_14">o</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:36.876em;"><span class="pdf24_17 pdf24_08 pdf24_11">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:17.6742em;top:37.926em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0016em;">La ALT o AST son mayores de 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:38.976em;"><span class="pdf24_17 pdf24_08 pdf24_79" style="word-spacing:0.0072em;">y hasta 5 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:40.036em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0036em;">inicialmente y aumentan a ms de &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:41.086em;"><span class="pdf24_17 pdf24_08 pdf24_40" style="word-spacing:0.0067em;">8 y hasta 10 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:42.186em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0006em;">La ALT o AST aumentan a ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:43.236em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0027em;">de 10 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.532em;top:38.996em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0061em;">Hepatitis con compromiso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.532em;top:40.056em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0084em;">tumoral del hgado</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_80" style="word-spacing:0.0134em;">3 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:17.6742em;top:44.296em;"><span class="pdf24_17 pdf24_08 pdf24_14">o</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:44.296em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:45.346em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0007em;">la bilirrubina total aumenta a ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:46.396em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.003em;">de 3 veces el ULN &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:47.496em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0062em;">Suspender hasta que est &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:48.5485em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0024em;">clnicamente estable o descontinuar &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:49.6085em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0043em;">en forma permanente dependiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:50.6585em;"><span class="pdf24_17 pdf24_08 pdf24_67" style="word-spacing:-0.0035em;">de la severidad. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.532em;top:49.0785em;"><span class="pdf24_17 pdf24_08 pdf24_39">Endocrinopatas &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:49.0785em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0016em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:51.7585em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0011em;">Grado 2 o 3 creatinina en sangre &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:52.8085em;"><span class="pdf24_17 pdf24_08 pdf24_39">aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:53.9085em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0021em;">Grado 4 creatinina en sangre &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:54.9585em;"><span class="pdf24_17 pdf24_08 pdf24_39">aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:56.0585em;"><span class="pdf24_17 pdf24_08 pdf24_81" style="word-spacing:0.0073em;">Sospecha de SJS, TEN, o DRESS &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:57.1482em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.004em;">SJS, TEN, o DRESS confirmado &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:58.2482em;"><span class="pdf24_17 pdf24_08 pdf24_19" style="word-spacing:0.0051em;">Grado 2, 3, o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:52.2785em;"><span class="pdf24_17 pdf24_08 pdf24_11">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:52.8285em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.003em;">Nefritis con disfuncin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:53.8885em;"><span class="pdf24_17 pdf24_08 pdf24_32">renal &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:54.4285em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:56.0585em;"><span class="pdf24_17 pdf24_08 pdf24_11">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.2558em;top:57.1482em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:58.2482em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:56.0785em;"><span class="pdf24_17 pdf24_08 pdf24_41">Condiciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:57.1282em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0055em;">dermatolgicas exfoliativas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:58.2482em;"><span class="pdf24_17 pdf24_08 pdf24_66">Miocarditis &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_3" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_82" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:8.3617em;top:6.0718em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:0.002em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.0642em;top:6.0718em;"><span class="pdf24_12 pdf24_08 pdf24_72">Severidad</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_33">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:33.1958em;top:6.0718em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:-0.001em;">Modificacin de la dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:7.1718em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:0.004em;">Grado 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:8.2618em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0016em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:7.1718em;"><span class="pdf24_17 pdf24_08 pdf24_11">Suspender</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:7.7218em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0062em;">Toxicidades neurolgicas &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:8.2618em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:9.3618em;"><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.0037em;">Otras reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:10.4518em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0034em;">Reacciones relacionadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:11.5118em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0002em;">con la perfusin </span><span class="pdf24_26 pdf24_08 pdf24_20">[ver &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:12.5618em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0065em;">Advertencias y &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:10.4518em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0014em;">Interrumpir o reducir la velocidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:11.5118em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:0.0029em;">de perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:10.9818em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0017em;">Grado 1 o 2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.6742em;top:13.1118em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0017em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.2558em;top:13.1118em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.008em;">Descontinuar permanentemente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:13.6218em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0018em;">precauciones (5.2)</span><span class="pdf24_26 pdf24_08 pdf24_39" style="word-spacing:0.0018em;">] &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.722em;"><span class="pdf24_43 pdf24_08 pdf24_63" style="word-spacing:-0.0102em;">ALT = alanina aminotransferasa, AST = aspartato aminotransferasa, DRESS = Erupcin cutnea medicamentosa con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.682em;"><span class="pdf24_43 pdf24_08 pdf24_83" style="word-spacing:0.0254em;">eosinofilia y sntomas sistmicos, SJS = Sndrome de Stevens Johnson, TEN = necrlisis epidrmica txica, ULN = &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.642em;"><span class="pdf24_43 pdf24_08 pdf24_84" style="word-spacing:-0.0007em;">lmite superior normal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.602em;"><span class="pdf24_43 pdf24_08 pdf24_73" style="word-spacing:-0.0384em;">1 Basado en los Criterios de terminologa comn del Instituto Nacional de Cncer para eventos adversos, versin 4.03. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.552em;"><span class="pdf24_43 pdf24_08 pdf24_85" style="word-spacing:0.1702em;">2 Reanudar en pacientes con resolucin completa o parcial (Grado 0 a 1) despus de reduccin progresiva del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.512em;"><span class="pdf24_43 pdf24_08 pdf24_54" style="word-spacing:-0.0352em;">corticosteroide. Descontinuar permanentemente si no hay resolucin completa o parcial dentro de 12 semanas despus &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.4745em;"><span class="pdf24_43 pdf24_08 pdf24_86" style="word-spacing:-0.0166em;">de iniciar los esteroides o incapacidad para reducir la dosis del corticosteroide a 10 mg de prednisona o menos por da &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.4346em;"><span class="pdf24_43 pdf24_08 pdf24_87" style="word-spacing:0.001em;">(o su equivalente) dentro de 12 semanas despus de iniciar los corticosteroides. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.3945em;"><span class="pdf24_43 pdf24_08 pdf24_10" style="word-spacing:0.0347em;">3 Si la AST y ALT son menores o iguales al ULN inicialmente en pacientes con compromiso heptico, suspender o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.3545em;"><span class="pdf24_43 pdf24_08 pdf24_64" style="word-spacing:0.0288em;">descontinuar en forma permanente la administracin de durvalumab segn las recomendaciones para la hepatitis sin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.3045em;"><span class="pdf24_43 pdf24_08 pdf24_85" style="word-spacing:0.0031em;">compromiso heptico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.3143em;"><span class="pdf24_12 pdf24_08 pdf24_28" style="word-spacing:0.0031em;">2.3 Preparacin y administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.4243em;"><span class="pdf24_17 pdf24_08 pdf24_88">Preparacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.4392em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:29.5443em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2314em;">Inspeccionar visualmente el medicamento en busca de partculas y decoloracin. Desechar si la &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:30.5943em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0027em;">solucin est turbia, decolorada o se observan partculas visibles. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:31.7143em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0018em;">No agitar el vial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:32.8343em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.0057em;">Extraer el volumen necesario del vial(es) de IMJUDO y deseche el vial con cualquier porcin no &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:33.886em;"><span class="pdf24_17 pdf24_08 pdf24_09">utilizada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.6092em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.7292em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.9109em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:35.016em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0569em;">Transferir a una bolsa intravenosa que contenga cloruro de sodio inyectable al 0.9% USP o dextrosa &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:36.066em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.008em;">inyectable al 5% USP y diluya a una concentracin entre 0.1 mg/mL y 10 mg/mL. Mezclar la solucin &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:37.116em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0049em;">diluida por inversin suave. No agitar la solucin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.126em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0023em;">Almacenamiento de la solucin de perfusin diluida de IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.1509em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:40.256em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0055em;">IMJUDO no contiene preservantes. Administrar la solucin de la perfusin inmediatamente despus &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:41.306em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.3096em;">de preparada. Si la solucin de la perfusin no se administra inmediatamente y es necesario &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:42.356em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1557em;">almacenarla, el tiempo total desde la preparacin hasta el inicio de la administracin no debe ser &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:43.416em;"><span class="pdf24_17 pdf24_08 pdf24_19" style="word-spacing:0.0074em;">superior a: &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:44.5199em;"><span class="pdf24_89 pdf24_90 pdf24_14">o</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:45.5699em;"><span class="pdf24_89 pdf24_90 pdf24_14">o</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:44.466em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0003em;">24 horas en un refrigerador a una temperatura de 2C a 8C &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:45.516em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0029em;">24 horas a temperatura ambiente a una temperatura hasta 30C &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.5409em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.6634em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:46.646em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0028em;">No congelar. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:47.7685em;"><span class="pdf24_17 pdf24_08 pdf24_47" style="word-spacing:-0.0003em;">No agitar. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.8685em;"><span class="pdf24_17 pdf24_08 pdf24_32">Administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.8934em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:50.9985em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0949em;">Administrar IMJUDO concentrado para solucin para perfusin intravenosa durante 60 minutos a &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:52.0485em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:0.0325em;">travs de una lnea intravenosa que contenga un filtro estril, de unin baja a protenas, de 0.2 o 0.22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:53.0985em;"><span class="pdf24_17 pdf24_08 pdf24_66">micras. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.1134em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:54.2185em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0013em;">Utilice bolsas de infusin y filtros distintos para cada medicamento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.3285em;"><span class="pdf24_26 pdf24_08 pdf24_41" style="word-spacing:-0.0031em;">IMJUDO en combinacin con otros productos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.3431em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.4631em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:57.4482em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0022em;">Administrar todos los medicamentos en infusiones intravenosas separadas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:58.5682em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:-0.0016em;">No coadministre otros medicamentos a travs de la misma lnea de perfusin. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_4" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANa0lEQVR4nO3RsQ2DQBBFwU1ogRR34JAMUQOhZcmFENAHCa2yOQFOjO7wjPQK2L8RAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABQkHf2kaQCmgIA4MSQjZJUQH0AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPyDNdskqaKeAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA99dlj0prv7oQAAC4jTlbKu31gz0AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAoHhrtqnamuNLAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAALjEDmjJ1Nis1rR3AAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_91" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:5.9967em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1667em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:6.1018em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0359em;">Para la quimioterapia basada en platino, consulte la informacin de administracin en la Informacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:7.1518em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0033em;">de prescripcin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:8.2718em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.065em;">Para el tratamiento con pemetrexed, consulte la informacin de administracin en la Informacin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:9.3218em;"><span class="pdf24_17 pdf24_08 pdf24_16">prescripcin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.4318em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0036em;">Regmenes combinados: Orden de las perfusiones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.5418em;"><span class="pdf24_26 pdf24_08 pdf24_41" style="word-spacing:-0.0026em;">IMJUDO en combinacin con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.5567em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:14.6619em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0023em;">Infundir IMJUDO, seguido de durvalumab el mismo da de la dosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.7718em;"><span class="pdf24_26 pdf24_08 pdf24_25" style="word-spacing:-0.0004em;">IMJUDO en combinacin con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.7867em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:17.8918em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0442em;">Infundir primero IMJUDO, seguido de durvalumab y luego quimioterapia basada en platino el mismo &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:18.9418em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0018em;">da de la dosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.0543em;"><span class="pdf24_26 pdf24_08 pdf24_28" style="word-spacing:0.0007em;">IMJUDO en combinacin con terapia con Durvalumab y Pemetrexed &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.0692em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:22.1743em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0234em;">Infundir primero IMJUDO, seguido de durvalumab y luego tratamiento con pemetrexed el da de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:23.2243em;"><span class="pdf24_17 pdf24_08 pdf24_16">dosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.3343em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0092em;">Regmenes combinados: Instrucciones de perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.4443em;"><span class="pdf24_26 pdf24_08 pdf24_33" style="word-spacing:-0.003em;">IMJUDO en combinacin con Durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.4592em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:28.5643em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.003em;">Observe al paciente durante 60 minutos despus de completar la perfusin de IMJUDO [</span><span class="pdf24_26 pdf24_08 pdf24_63">ver &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:29.6143em;"><span class="pdf24_26 pdf24_08 pdf24_33" style="word-spacing:-0.0008em;">Advertencias y precauciones (5.2)</span><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0011em;">]. Luego administre durvalumab como una perfusin intravenosa &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:30.6743em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0036em;">separada durante 60 minutos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.7843em;"><span class="pdf24_26 pdf24_08 pdf24_18" style="word-spacing:-0.0019em;">IMJUDO en combinacin con Durvalumab y quimioterapia basada en platino/terapia con pemetrexed &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.886em;"><span class="pdf24_26 pdf24_08 pdf24_73" style="word-spacing:-0.0132em;">Ciclo 1: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.9109em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:36.016em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0324em;">Infundir IMJUDO durante una hora. Una o dos horas despus de finalizar la perfusin de IMJUDO, &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:37.066em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.3099em;">infundir durvalumab durante una hora. Una o dos horas despus de finalizar la perfusin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:38.116em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0003em;">durvalumab, administrar quimioterapia basada en platino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.226em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0033em;">Ciclos posteriores: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.286em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0097em;">Si no se producen reacciones a la perfusin durante el ciclo 1, los ciclos posteriores de durvalumab pueden &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.336em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0121em;">administrarse inmediatamente despus de IMJUDO. El tiempo transcurrido entre el final de la perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.386em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0016em;">de durvalumab y el inicio de la quimioterapia puede reducirse a 30 minutos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.566em;"><span class="pdf24_12 pdf24_08 pdf24_16" style="word-spacing:0.6321em;">3. FORMAS</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0007em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_78" style="word-spacing:0.0001em;">DE DOSIFICACIN Y PRESENTACIONES &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.6085em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0024em;">Forma farmacutica: Concentrado para solucin para perfusin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.7185em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0465em;">Inyeccin: solucin transparente a ligeramente opalescente, incolora a ligeramente amarilla en un vial de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.7685em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0019em;">dosis nica de 25 mg/1.25mL (20 mg/mL) o 300 mg/15 mL (20 mg/mL). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.8885em;"><span class="pdf24_12 pdf24_08 pdf24_92" style="word-spacing:0.6353em;">4. CONTRAINDICACIONES &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.9285em;"><span class="pdf24_17 pdf24_08 pdf24_47">Ninguna. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_5" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANL0lEQVR4nO3DQQ0AIAwEsBM+JXywyjzwWbI2aQIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADw4/Srw1YAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAC2eDv0Z5KV7fP9AAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_93" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0418em;"><span class="pdf24_12 pdf24_08 pdf24_40" style="word-spacing:0.636em;">5. ADVERTENCIAS</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0014em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_46" style="word-spacing:-0.0007em;">Y PRECAUCIONES &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.0818em;"><span class="pdf24_12 pdf24_08 pdf24_77" style="word-spacing:0.8161em;">5.1. Reacciones</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0005em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_18" style="word-spacing:-0.0018em;">adversas inmunomediadas severas y fatales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.1418em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0178em;">IMJUDO es un anticuerpo monoclonal que bloquea las seales inhibitorias de las clulas T inducidas por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.1918em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.2932em;">la va de CTLA-4, eliminando as la inhibicin de la respuesta inmunitaria. En combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.2518em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.1292em;">durvalumab, un inhibidor de PD-L1, estos frmacos tienen el potencial de inducir reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.3018em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0492em;">inmunomediadas. Las reacciones adversas inmunomediadas enumeradas aqu pueden no incluir todas las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.3618em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0045em;">posibles reacciones graves y mortales inmunomediadas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.2418em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0647em;">En cualquier sistema orgnico o tejido pueden ocurrir reacciones adversas inmunomediadas, que pueden &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.3018em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:-0.0286em;">ser graves o mortales. Las reacciones adversas inmunomediadas se pueden presentar en cualquier momento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.3518em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.3721em;">despus de iniciar IMJUDO en combinacin con durvalumab. Aunque las reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.4018em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2629em;">inmunomediadas se manifiestan generalmente durante el tratamiento, tambin se pueden manifestar &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.4743em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0028em;">despus de descontinuar IMJUDO y/o durvalumab. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.3544em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0147em;">La identificacin y el tratamiento precoces de las reacciones adversas inmunomediadas son esenciales para &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.4043em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0063em;">garantizar el uso seguro de IMJUDO en combinacin con durvalumab. Vigilar los signos y sntomas que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.4543em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.2153em;">puedan ser manifestaciones clnicas de reacciones adversas subyacentes inmunomediadas. Evaluar la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.5143em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.2519em;">qumica clnica, incluyendo enzimas hepticas, creatinina, nivel de la hormona adrenocorticotrpica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.5643em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0062em;">(ACTH) y funcin tiroidea al inicio y antes de cada dosis. Establecer un tratamiento mdico con prontitud, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.6343em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0017em;">incluyendo la consulta con especialista si es necesario. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.5043em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0382em;">Suspender o descontinuar en forma permanente IMJUDO y durvalumab dependiendo de la severidad [</span><span class="pdf24_26 pdf24_08 pdf24_94">ver &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.5643em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:0.2377em;">Dosis y administracin (2.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.2419em;">. En general, si la combinacin de IMJUDO y durvalumab requiere &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.6143em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0309em;">interrupcin o descontinuacin, administrar tratamiento con corticosteroide sistmico (1 a 2 mg/kg/da de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.6743em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0837em;">prednisona o su equivalente) hasta obtener mejora a Grado 1 o menos. Al mejorar a Grado 1 o menos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.726em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0082em;">iniciar reduccin gradual del corticosteroide y continuar reduciendo durante al menos 1 mes. Considerar la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.776em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.2076em;">posibilidad de administrar otros inmunosupresores sistmicos en pacientes cuyas reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.846em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0007em;">inmunomediadas no se controlen con el tratamiento corticosteroide. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.726em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1392em;">A continuacin, se comentan las guas de manejo de la toxicidad para las reacciones adversas que no &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.776em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.78em;">requieren necesariamente esteroides sistmicos (por ejemplo, endocrinopatas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.836em;"><span class="pdf24_17 pdf24_08 pdf24_18">dermatolgicas). &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.7237em;top:38.776em;"><span class="pdf24_17 pdf24_08 pdf24_14">y</span></div>
					<div class="pdf24_01" style="left:41.1331em;top:38.776em;"><span class="pdf24_17 pdf24_08 pdf24_30">reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.726em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0034em;">Neumonitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.616em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:-0.0302em;">IMJUDO en combinacin con durvalumab puede causar neumonitis inmunomediada, que puede ser fatal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.506em;"><span class="pdf24_26 pdf24_08 pdf24_20" style="word-spacing:-0.0009em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.376em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.2366em;">Se produjo neumonitis inmunomediada en el 1.3% (5/388) de los pacientes que estaban recibiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.4385em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2004em;">IMJUDO en combinacin con durvalumab, incluyendo reacciones adversas fatales (0.3%) y Grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.4885em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0612em;">3(0.2%). Los eventos se resolvieron en 3 de los 5 pacientes y dieron lugar a una descontinuacin permanente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.5485em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1379em;">en 1 paciente; de estos, 5 requirieron tratamiento con corticosteroide a dosis alta (al menos 40 mg de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.6085em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0019em;">prednisona o su equivalente por da). Un paciente (1/5) requiri otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4985em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0007em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.3685em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.0105em;">Se produjo neumonitis inmunomediada en el 3.5 % (21/596) de los pacientes que recibieron IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.4285em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0874em;">combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones adversas mortales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.4782em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1312em;">(0.5 %) y de grado 3 (1 %). Los eventos se resolvieron en 11 de los 21 pacientes y dieron lugar a la &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_6" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANQElEQVR4nO3DsQ2AMBAEsKuzBBSZgHHTZFV+gu8QSNiSEwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAv1t1a/MKAAB8xFFPbY4AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA0Fl16wNnAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAXnQDQ5vEVsTlOiUAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_95" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.3715em;">descontinuacin permanente en 7 pacientes. Todos los pacientes con neumonitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0918em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0015em;">necesitaron corticosteroides sistmicos, mientras que 1 paciente (1/21) necesit otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.9818em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0052em;">Colitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.8618em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.2351em;">IMJUDO en combinacin con durvalumab y quimioterapia basada en platino puede causar colitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.9218em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0051em;">inmunomediada, que puede ser mortal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.8018em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.3945em;">IMJUDO en combinacin con durvalumab puede causar colitis inmunomediada que se asocia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.8518em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:-0.0126em;">frecuentemente a diarrea. Se ha descrito la infeccin/reactivacin por citomegalovirus (CMV) en pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.9119em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2028em;">con colitis inmunomediada refractaria a los corticosteroides. En los casos de colitis refractaria a los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.9618em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1344em;">corticosteroides, se debe considerar la posibilidad de repetir los estudios infecciosos para excluir otras &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0318em;"><span class="pdf24_17 pdf24_08 pdf24_32">etiologas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.9143em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7943em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.2026em;">Ocurri colitis inmunomediada o diarrea en el 6% (23/388) de los pacientes que estaban recibiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8543em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0295em;">IMJUDO en combinacin con durvalumab, incluyendo reacciones adversas Grado 3 (3.6%). En 22 de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9043em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0338em;">23 pacientes se resolvieron los eventos y en 5 dieron como resultado descontinuacin permanente. Todos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9543em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.1127em;">los pacientes recibieron corticosteroides sistmicos y 20 de los 23 pacientes recibieron tratamiento con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0143em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0396em;">corticosteroide a dosis alta (al menos 40 mg de prednisona o su equivalente por da). Tres pacientes tambin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0743em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:-0.0083em;">recibieron otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9643em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0043em;">Se ha observado perforacin intestinal en otros estudios de IMJUDO en combinacin con durvalumab. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.8543em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.7243em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0111em;">Se produjeron colitis inmunomediadas en el 6.5 % (39/596) de los pacientes que recibieron IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.786em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0874em;">combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones adversas mortales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.836em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0971em;">(0.2 %) y de grado 3 (2.5 %). Los eventos se resolvieron en 33 de los 39 pacientes y dieron lugar a la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.896em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0729em;">descontinuacin permanente en 11 pacientes. Todos los pacientes con colitis inmunomediada precisaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.956em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0031em;">corticosteroides sistmicos, mientras que 4 pacientes (4/39) necesitaron otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.836em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1668em;">Se notific perforacin intestinal y perforacin del intestino grueso en el 0.1 % de los pacientes que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.896em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0012em;">recibieron IMJUDO en combinacin con durvalumab. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.786em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0048em;">Hepatitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.676em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0028em;">IMJUDO en combinacin con durvalumab puede causar hepatitis inmunomediada, que puede ser fatal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.556em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.436em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.2855em;">Se produjo hepatitis inmunomediada en el 7.5% (29/388) de los pacientes que estaban recibiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.4985em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.1759em;">IMJUDO en combinacin con durvalumab, incluyendo reacciones adversas fatales (0.8%), Grado 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.5485em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0639em;">(0.3%) y Grado 3 (4.1%). Los eventos se resolvieron en 12 de los 29 pacientes y dieron como resultado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.5985em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1464em;">descontinuacin permanente en 9 pacientes. Se requirieron corticosteroides sistmicos en todos los 29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.6585em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0175em;">pacientes; y todos los 29 pacientes requirieron tratamiento con corticosteroide a dosis alta (al menos 40 mg &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.7185em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0032em;">de prednisona o su equivalente por da). Ocho pacientes (8/29) necesitaron otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6085em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.4885em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0248em;">Se produjeron hepatitis inmunomediadas en el 3.9 % (23/596) de los pacientes que recibieron IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5382em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0213em;">en combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones adversas mortales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.5882em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0706em;">(0.3 %), de grado 4 (0.5 %) y de grado 3 (2 %). Los eventos se resolvieron en 12 de los 23 pacientes y &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_7" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANL0lEQVR4nO3DoREAMAgEsF+HlWu6avEVSExylwQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYHT6Vb8VAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAIBlD53Pe75o5BETAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_96" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.3233em;">dieron lugar a la descontinuacin permanente en 27 pacientes. Todos los pacientes con hepatitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.018em;">inmunomediada precisaron corticosteroides sistmicos, mientras que 2 pacientes (2/23) necesitaron el uso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1518em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0023em;">de otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.0418em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0025em;">Endocrinopatas inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.9119em;"><span class="pdf24_26 pdf24_08 pdf24_41" style="word-spacing:0.1316em;">Insuficiencia adrenal</span><span class="pdf24_17 pdf24_08 pdf24_30" style="word-spacing:0.5002em;">: IMJUDO</span><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:0.1393em;">&nbsp;</span><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.1272em;">en combinacin con durvalumab puede causar insuficiencia adrenal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.9718em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.2514em;">primaria o secundaria. En caso de insuficiencia suprarrenal Grado 2 o superior, iniciar tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.0218em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0775em;">sintomtico, incluyendo reemplazo hormonal segn est clnicamente indicado. Suspender o interrumpir &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.0818em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1218em;">permanentemente IMJUDO en combinacin con durvalumab en funcin de la gravedad </span><span class="pdf24_26 pdf24_08 pdf24_46" style="word-spacing:0.128em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_78" style="word-spacing:0.1149em;">Dosis y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.1418em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0097em;">administracin (2.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0318em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.9043em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0522em;">Se produjo insuficiencia adrenal inmunomediada en el 1.5% (6/388) de los pacientes que estaban recibiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.9643em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.019em;">IMJUDO en combinacin con durvalumab, incluyendo reacciones adversas Grado 3 (0.3%). Los eventos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.0143em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0145em;">se resolvieron en 2 de los 6 pacientes. Se requirieron corticosteroides sistmicos en todos los 6 pacientes, y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0743em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0231em;">de estos, 1 paciente requiri tratamiento con corticosteroide a dosis alta (al menos 40 mg de prednisona o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.1343em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.005em;">su equivalente por da). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0243em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0007em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.9043em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0247em;">Se produjo insuficiencia suprarrenal inmunomediada en el 2.2 % (13/596) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9543em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.2144em;">IMJUDO en combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.0043em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.1426em;">adversas de grado 3 (0.8 %). Los eventos se resolvieron en 2 de los 13 pacientes y dieron lugar a la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.0643em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0894em;">descontinuacin permanente en 1 paciente. Todos los pacientes con insuficiencia suprarrenal precisaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.1243em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0005em;">corticosteroides sistmicos. Un paciente tambin requiri terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.006em;"><span class="pdf24_26 pdf24_08 pdf24_88" style="word-spacing:0.2005em;">Hipofisitis: </span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.199em;">IMJUDO en combinacin con durvalumab puede causar hipofisitis inmunomediada. La &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.056em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1528em;">hipofisitis se puede presentar con sntomas agudos asociados a con un efecto de masa, como cefalea, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.116em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.002em;">fotofobia o reducciones del campo visual. La hipofisitis puede causar hipopituitarismo. Iniciar tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.166em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0096em;">sintomtico que incluya reemplazo hormonal segn lo clnicamente indicado. Suspender o descontinuar en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.226em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0088em;">forma permanente IMJUDO en combinacin con durvalumab, dependiendo de la severidad </span><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:0.0077em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_78" style="word-spacing:0.0059em;">Dosis y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.286em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0097em;">administracin (2.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.176em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.046em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0314em;">Ocurri hipofisitis inmunomediada en el 1 (4/388) de los pacientes que estaban recibiendo IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.106em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.2906em;">combinacin con durvalumab. Los eventos se resolvieron en 2 de los 4 pacientes. Se requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.156em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0343em;">corticosteroides sistmicos en 3 pacientes, y de estos, 1 paciente recibi tratamiento con corticosteroide a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.216em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0286em;">dosis alta (como mnimo 40 mg de prednisona o su equivalente por da). Dos pacientes tambin necesitaron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.276em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:0.0016em;">terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.1685em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0007em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.0485em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0508em;">Se produjo hipofisitis inmunomediada en el 1.3 % (8/596) de los pacientes que recibieron IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.0985em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0142em;">combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones adversas de grado 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.1485em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.3349em;">(0.5%). Los eventos dieron lugar a la descontinuacin permanente en 1 paciente. Se requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.2085em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0951em;">corticosteroides sistmicos en 6 pacientes con hipofisitis inmunomediada; de ellos, 2 de los 8 pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.2585em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0637em;">recibieron tratamiento con corticosteroides a dosis altas (al menos 40 mg de prednisona o equivalente al &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.3285em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0021em;">da). Cuatro pacientes necesitaron tambin tratamiento endocrino. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_8" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_26 pdf24_08 pdf24_21" style="word-spacing:0.2446em;">Trastornos tiroideos</span><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.262em;">: IMJUDO en combinacin con durvalumab puede causar trastornos tiroideos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0134em;">inmunomediados. La tiroiditis puede presentarse con o sin endocrinopata. El hipotiroidismo puede seguir &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0927em;">al hipertiroidismo. Iniciar la terapia de reemplazo hormonal para el hipotiroidismo o instituir el manejo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.191em;">mdico del hipertiroidismo segn est clnicamente indicado. Suspender o interrumpir IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2618em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0047em;">combinacin con durvalumab segn la severidad </span><span class="pdf24_26 pdf24_08 pdf24_20" style="word-spacing:-0.0041em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0005em;">Dosis y administracin (2.2)</span><span class="pdf24_26 pdf24_08 pdf24_67">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.1418em;"><span class="pdf24_26 pdf24_08 pdf24_72">Tiroiditis: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.0318em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.9119em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0441em;">Se produjo tiroiditis inmunomediada en el 1.5% (6/388) de los pacientes que estaban recibiendo IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.9618em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.2019em;">en combinacin con durvalumab. Los eventos se resolvieron in 2 de los 6 pacientes. Se requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0218em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.009em;">corticosteroides sistmicos en 2 pacientes (2/6) con tiroiditis inmunomediada, de estos, 1 paciente necesit &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.0718em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0124em;">tratamiento con corticosteroide a dosis alta (como mnimo 40 mg de prednisona o su equivalente por da). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.1243em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.3038em;">Todos los pacientes requirieron otra terapia, incluyendo terapia de reemplazo hormonal, tiamazol, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.1943em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0006em;">carbimazol, propiltiouracilo, perclorato, bloqueador de canales de calcio, o betabloqueador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0843em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9543em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0898em;">Se produjo tiroiditis inmunomediada en el 1.2 % (7/596) de los pacientes que recibieron IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0143em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0304em;">combinacin con durvalumab y quimioterapia basada en platino. Los eventos se resolvieron en 2 de los 7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0643em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.1778em;">pacientes y uno de ellos dio lugar a una descontinuacin permanente. Se requirieron corticosteroides &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1243em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0073em;">sistmicos en 2 pacientes (2/7) con tiroiditis inmunomediada, mientras que todos los pacientes requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.1843em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0021em;">terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.0743em;"><span class="pdf24_26 pdf24_08 pdf24_18">Hipertiroidismo: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.9543em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.836em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0633em;">Se produjo hipertiroidismo inmunomediado en el 4.6% (18/388) de los pacientes que estaban recibiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.896em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.019em;">IMJUDO en combinacin con durvalumab, incluyendo reacciones adversas Grado 3 (0.3%). Los eventos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.946em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0em;">se resolvieron en 15 de los 18 pacientes.</span><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:0.2515em;">&nbsp;</span><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0024em;">Dos pacientes (2/18|) necesitaron tratamiento con corticosteroide &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.996em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0023em;">a dosis alta (como mnimo 40 mg de prednisona o su equivalente por da). Diecisiete pacientes requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.056em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2983em;">otra terapia, (tiamazol, carbimazol, propiltiouracilo, perclorato, bloqueador de canales de calcio, o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.116em;"><span class="pdf24_17 pdf24_08 pdf24_21">betabloqueador). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.006em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.886em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0006em;">Se produjo hipertiroidismo inmunomediado en el 5 % (30/596) de los pacientes que recibieron IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.936em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0192em;">en combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones adversas de grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.996em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0104em;">3 (0.2 %). Los eventos se resolvieron en 21 de los 30 pacientes. Se requirieron corticosteroides sistmicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.046em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0464em;">en 5 pacientes (5/30) con hipertiroidismo inmunomediado, mientras que 28 pacientes (28/30) requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1085em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0023em;">tratamiento endocrino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.9985em;"><span class="pdf24_26 pdf24_08 pdf24_39">Hipotiroidismo: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.8885em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.7685em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.2174em;">Ocurri hipotiroidismo inmunomediado en el 11% (42/388) de los pacientes que estaban recibiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.8185em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1352em;">IMJUDO en combinacin con durvalumab. Los eventos se resolvieron en 5 de los 42 pacientes. Un &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.8685em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1406em;">paciente recibi tratamiento con corticosteroide a dosis alta (como mnimo 40 mg de prednisona o su &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.9282em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0665em;">equivalente por da). Todos los pacientes requirieron otra terapia (tiamazol, carbimazol, propiltiouracilo, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.9882em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0047em;">perclorato, bloqueador de canales de calcio, o betabloqueador). &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_9" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANS0lEQVR4nO3DsQmAMBAAwMfGMWLnEII4SMBBLFzdHyCksArkDi4CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACYW823aucRAACDOPOl2rkHAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD8UvKm2rgEAMBgnvyqNq4BAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABM7QMnm0mfJtfyLwAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_97" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0418em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0018em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.9218em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.033em;">Se produjo hipotiroidismo inmunomediado en el 8.6 % (51/596) de los pacientes que recibieron IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.9718em;"><span class="pdf24_17 pdf24_08 pdf24_78" style="word-spacing:-0.0307em;">en combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones adversas de Grado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.0318em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0189em;">3 (0.5 %). Se requirieron corticosteroides sistmicos en 2 pacientes (2/51) y todos los pacientes requirieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.0918em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0021em;">terapia endocrina. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.9718em;"><span class="pdf24_26 pdf24_08 pdf24_25" style="word-spacing:-0.0162em;">Diabetes mellitus tipo 1, que puede presentarse con cetoacidosis diabtica: </span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0144em;">Supervisar a los pacientes para &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.0218em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1381em;">detectar hiperglicemia u otros signos y sntomas de diabetes. Iniciar tratamiento con insulina segn lo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.0818em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1026em;">clnicamente indicado. Suspender o descontinuar en forma permanente IMJUDO en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.1418em;"><span class="pdf24_17 pdf24_08 pdf24_11" style="word-spacing:-0.0055em;">durvalumab segn la severidad </span><span class="pdf24_26 pdf24_08 pdf24_19" style="word-spacing:0.0079em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0041em;">Dosis y administracin (2.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0318em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.9043em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0261em;">Dos pacientes (0.5%; 2/388) tuvieron eventos de hiperglicemia que requiri tratamiento con insulina, que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.9743em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0036em;">no se haba resuelto en el ltimo seguimiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8643em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.7343em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.091em;">Se produjo diabetes mellitus tipo 1 inmunomediada en el 0.5 % (3/596) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.7943em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.2144em;">IMJUDO en combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.8543em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0029em;">adversas de grado 3 (0.3 %). Todos los pacientes requirieron tratamiento endocrino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.7443em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.007em;">Nefritis con disfuncin renal inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.6343em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.005em;">IMJUDO en combinacin con durvalumab puede causar nefritis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5143em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.396em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:-0.0005em;">Se produjo nefritis inmunomediada en el 0.1% (4/388) de los pacientes que estaban recibiendo IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.446em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.2937em;">en combinacin con durvalumab, incluyendo reacciones adversas Grado 3 (0.5%). Los eventos se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.506em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0136em;">resolvieron en 3 de los 4 pacientes y dieron como resultado descontinuacin permanente en 2 pacientes. Se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.556em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1602em;">requirieron corticosteroides sistmicos en todos los pacientes con nefritis inmunomediada; de estos, 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.616em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0049em;">pacientes necesitaron tratamiento con corticosteroide a dosis alta (como mnimo 40 mg de prednisona o su &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.676em;"><span class="pdf24_17 pdf24_08 pdf24_88" style="word-spacing:-0.0076em;">equivalente por da). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.566em;"><span class="pdf24_26 pdf24_08 pdf24_23" style="word-spacing:0.0021em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.446em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1276em;">Se produjo nefritis inmunomediada en el 0.7 % (4/596) de los pacientes que recibieron IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0142em;">combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones adversas de grado 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.546em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0027em;">(0.2 %). Los eventos se resolvieron en 1 de los 4 pacientes y dieron lugar a la descontinuacin permanente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.616em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0016em;">en 3 pacientes. Todos los pacientes con nefritis inmunomediada precisaron corticosteroides sistmicos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.5085em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0033em;">Reacciones dermatolgicas inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.3785em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:-0.0085em;">IMJUDO en combinacin con durvalumab puede causar erupcin cutnea o dermatitis inmunomediadas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.4385em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.309em;">Se ha presentado dermatitis exfoliativa, incluyendo Sndrome de Stevens Johnson (SJS), erupcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4885em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0124em;">medicamentosa con eosinofilia y sntomas sistmicos (DRESS), y necrlisis epidrmica txica (NET) con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.5485em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.1278em;">anticuerpos bloqueadores del CTLA-4 y PD-1/L-1. Los emolientes tpicos y/o corticosteroides tpicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5985em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0237em;">pueden ser adecuados para tratar las erupciones cutneas leves a moderadas. Suspender o descontinuar en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.6485em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0088em;">forma permanente IMJUDO en combinacin con durvalumab, dependiendo de la severidad </span><span class="pdf24_26 pdf24_08 pdf24_46" style="word-spacing:0.0085em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_78" style="word-spacing:0.0059em;">Dosis y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.7185em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0097em;">administracin (2.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_10" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANQ0lEQVR4nO3DMQ2AQBAEwLVBBVqwggyK90HzVv8EUJNLmEkmAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAOtjroc1uAQCAF3cd2uwVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAfp461d89AwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA8LkFgsoGP2TdN3UAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_98" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0418em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.9218em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0177em;">Se produjo erupcin cutnea o dermatitis inmunomediada en el 4.9% (19/388) de los pacientes que estaban &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.9718em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.0085em;">recibiendo IMJUDO en combinacin con durvalumab, incluyendo reacciones adversas Grado 4 (0.3%) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.0318em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.3071em;">Grado 3 (1.5%). Los eventos se resolvieron en 13 de los 19 pacientes y dieron como resultado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.0818em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2721em;">descontinuacin permanente en 2 pacientes. Se requirieron corticosteroides sistmicos en todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.1318em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0317em;">pacientes con erupcin cutnea o dermatitis inmunomediada; de estos, 12 pacientes necesitaron tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.1918em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0001em;">con corticosteroide a dosis alta (como mnimo 40 mg de prednisona o su equivalente por da). Un paciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.2518em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:-0.0088em;">recibi otros inmunosupresores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.1418em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0218em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.009em;">Se produjeron erupciones cutneas o dermatitis inmunomediadas en el 7.2 % (43/596) de los pacientes que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.0718em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2271em;">recibieron IMJUDO en combinacin con durvalumab y quimioterapia basada en platino, incluidas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.1243em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0197em;">reacciones adversas de grado 3 (0.3 %). Los eventos se resolvieron en 32 de los 43 pacientes y dieron lugar &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.1843em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0224em;">a la descontinuacin permanente en 2 pacientes. Todos los pacientes que presentaron erupciones cutneas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.2443em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0022em;">o dermatitis inmunomediadas necesitaron corticosteroides sistmicos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.1343em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0066em;">Pancreatitis inmunomediada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0243em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0018em;">IMJUDO en combinacin con durvalumab puede causar pancreatitis inmunomediada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.9143em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:-0.0006em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.7843em;"><span class="pdf24_17 pdf24_08 pdf24_92" style="word-spacing:-0.0386em;">Ocurri pancreatitis inmunomediada en el 2.3% (9/388) de los pacientes que estaban recibiendo IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.8443em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0444em;">en combinacin con durvalumab, incluyendo reacciones adversas Grado 4 (0.3%) y Grade 3 (1.5%). Los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.8943em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0898em;">eventos se resolvieron en 6 de los 9 pacientes. Se requirieron corticosteroides sistmicos en todos los 9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.9443em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0133em;">pacientes, y de estos, 7 pacientes necesitaron tratamiento con corticosteroide a dosis alta (como mnimo 40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.016em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:-0.0015em;">mg de prednisona o su equivalente por da). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.906em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0006em;">Otras reacciones adversas inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.776em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.1568em;">Las siguientes reacciones adversas clnicamente significativas inmunomediadas se produjeron con una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.836em;"><span class="pdf24_17 pdf24_08 pdf24_92" style="word-spacing:-0.041em;">incidencia inferior al 1%, cada una en pacientes que recibieron IMJUDO en combinacin con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.896em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0024em;">o se notificaron con el uso de otros Inhibidores del punto de control inmunolgico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.786em;"><span class="pdf24_99 pdf24_08 pdf24_18" style="word-spacing:0.0068em;">Cardacas/vasculares: </span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0036em;">Miocarditis, pericarditis, vasculitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.666em;"><span class="pdf24_99 pdf24_08 pdf24_28" style="word-spacing:0.0384em;">Del sistema nervioso: </span><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.036em;">Meningitis, encefalitis, mielitis y desmielinizacin, sndrome miastnico/miastenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.726em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0029em;">grave (incluyendo exacerbacin), sndrome de Guillain-Barr, paresia nerviosa, neuropata autoinmune. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.606em;"><span class="pdf24_99 pdf24_08 pdf24_77" style="word-spacing:0.0378em;">Oculares: </span><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0343em;">Puede ocurrir uvetis, iritis, y otras toxicidades inflamatorias oculares, Algunos casos se puede &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.6585em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.1867em;">asociar a desprendimiento de la retina. Se pueden presentar diversos grados de alteracin visual que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.7185em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.2439em;">incluyen ceguera. Si ocurre uvetis en combinacin con otras reacciones adversas inmunomediadas, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.7685em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.2635em;">considerar la posibilidad de sndrome similar a Vogt-Koyanagi-Harada, ya que este puede requerir &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.8285em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0001em;">tratamiento con esteroides sistmicos para reducir el riesgo de prdida de la visin permanente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.7185em;"><span class="pdf24_99 pdf24_08 pdf24_32" style="word-spacing:0.0064em;">Gastrointestinales: </span><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0035em;">Gastritis, duodenitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5985em;"><span class="pdf24_99 pdf24_08 pdf24_25" style="word-spacing:0.1786em;">Musculoesquelticas y trastornos del tejido conectivo: </span><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.1804em;">Miositis/polimiositis, rabdomilisis y secuelas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.6585em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0008em;">asociadas, incluyendo falla renal, artritis, polimialgia reumtica. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5482em;"><span class="pdf24_99 pdf24_08 pdf24_16" style="word-spacing:0.0055em;">Endocrinas: </span><span class="pdf24_17 pdf24_08 pdf24_20">Hipoparatiroidismo. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_11" class="pdf24_ pdf24_02">
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_99 pdf24_08 pdf24_41" style="word-spacing:0.7946em;">Otras (hematolgicas/inmunolgicas): </span><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.791em;">Anemia hemoltica, anemia aplsica, linfohistiocitosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.386em;">hemofagoctica, sndrome de respuesta inflamatoria sistmica, linfadenitis necrotizante histioctica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1518em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0036em;">(linfadenitis de Kikuchi), sarcoidosis, y trombocitopenia inmunitaria. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.0318em;"><span class="pdf24_12 pdf24_08 pdf24_77" style="word-spacing:0.8161em;">5.2. Reacciones</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0085em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_18" style="word-spacing:0.0029em;">relacionadas con la perfusin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.0818em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0144em;">IMJUDO en combinacin con durvalumab puede causar reacciones relacionadas con la infusin severas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.1418em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0016em;">o que ponen en peligro la vida. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.0218em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0375em;">Supervisar para detectar signos y sntomas de reacciones relacionadas con la perfusin. Interrumpir, reducir &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.0818em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0152em;">la velocidad o descontinuar en forma permanente IMJUDO y durvalumab segn la severidad </span><span class="pdf24_26 pdf24_08 pdf24_13" style="word-spacing:0.0171em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_46">Dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.1318em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0459em;">y administracin (2.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0451em;">. Para reacciones Grado 1 o 2 relacionadas con la perfusin, considerar la posibilidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.1918em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0027em;">de usar pre-medicacin con las dosis posteriores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.0843em;"><span class="pdf24_26 pdf24_08 pdf24_19" style="word-spacing:0.0016em;">IMJUDO con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.9643em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0229em;">Ocurrieron reacciones relacionadas con la perfusin en 10 (2.6%) de los pacientes que estaban recibiendo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0243em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0em;">IMJUDO en combinacin con durvalumab. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9143em;"><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">IMJUDO con durvalumab y quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.7943em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0317em;">Se produjeron reacciones relacionadas con la perfusin en el 2.9 % (17/596) de los pacientes que recibieron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.8443em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.2143em;">IMJUDO en combinacin con durvalumab y quimioterapia basada en platino, incluidas reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9143em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0036em;">adversas de grado 3 (0.3 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.7843em;"><span class="pdf24_12 pdf24_08 pdf24_88" style="word-spacing:0.8157em;">5.3. Toxicidad</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0027em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_100">embriofetal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.8443em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.012em;">Segn los resultados de los estudios en animales y su mecanismo de accin, IMJUDO puede causar dao &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.896em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0326em;">al feto cuando se administra a una mujer embarazada. En estudios en animales, el bloqueo de CTLA-4 se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.956em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0005em;">asocia con una mayor incidencia de prdida de embarazo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.836em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0161em;">Aconseje a las mujeres embarazadas y a las mujeres con potencial reproductivo del riesgo potencial para el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.896em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0355em;">feto. Recomendar a las mujeres con potencial reproductivo que utilicen mtodos anticonceptivos eficaces &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.946em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0287em;">durante el tratamiento con IMJUDO y durante los 3 meses siguientes a la ltima dosis de IMJUDO </span><span class="pdf24_26 pdf24_08 pdf24_46">[ver &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.006em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0015em;">Uso en poblaciones especficas (7.1</span><span class="pdf24_26 pdf24_08 pdf24_14" style="word-spacing:0em;">, </span><span class="pdf24_17 pdf24_08 pdf24_14">7.3</span><span class="pdf24_26 pdf24_08 pdf24_92">)]</span><span class="pdf24_17 pdf24_08 pdf24_92">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.896em;"><span class="pdf24_12 pdf24_08 pdf24_40" style="word-spacing:0.636em;">6. REACCIONES</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0026em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_30">ADVERSAS &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.956em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0006em;">Las siguientes reacciones adversas se comentan en forma ms detallada en otras secciones de la etiqueta. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.7909em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.7534em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:45.896em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0052em;">Reacciones adversas inmunomediadas </span><span class="pdf24_26 pdf24_08 pdf24_46" style="word-spacing:0.0085em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.002em;">Advertencias y precauciones (5.1)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_84">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:47.8585em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0063em;">Reacciones relacionadas con la perfusin </span><span class="pdf24_26 pdf24_08 pdf24_46" style="word-spacing:0.0085em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0007em;">Advertencias y precauciones (5.2)</span><span class="pdf24_26 pdf24_08 pdf24_101">]</span><span class="pdf24_17 pdf24_08 pdf24_101">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.7385em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:0.8169em;">6.1. Experiencia</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.001em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:0.0007em;">en estudios clnicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.8485em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.066em;">Dado que los ensayos clnicos se realizan en condiciones muy variadas, las tasas de reacciones adversas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.8985em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0151em;">observadas en los ensayos clnicos de un frmaco no pueden compararse directamente con las tasas de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.9685em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0003em;">ensayos clnicos de otro frmaco y pueden no reflejar las tasas observadas en la prctica. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.8385em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.2249em;">Los datos descritos en Advertencias y precauciones reflejan la exposicin a IMJUDO 300 mg en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.8982em;"><span class="pdf24_17 pdf24_08 pdf24_19" style="word-spacing:0.3044em;">combinacin con durvalumab 1500 mg en 388 pacientes del estudio HIMALAYA. En el estudio &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_12" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANNklEQVR4nO3DMQ0AIAwAsIUPFeCTA+tMxHigTRoBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMA7Vt5asAcAAFw28tSCLQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADgcwfrZFtU86KvrwAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_102" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0069em;">HIMALAYA los pacientes recibieron IMJUDO 300 mg administrado como perfusin intravenosa nica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0918em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0001em;">en combinacin con durvalumab 1500 mg el mismo da, seguido de durvalumab cada 4 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.9718em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:0.0105em;">Los datos tambin reflejan la exposicin a IMJUDO 75 mg en combinacin con durvalumab 1500 mg y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.0318em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0393em;">regmenes de quimioterapia con platino basados en la histologa en la poblacin de seguridad combinada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.0818em;"><span class="pdf24_17 pdf24_08 pdf24_78" style="word-spacing:0.0051em;">(N=596) de 330 pacientes en POSEIDON [</span><span class="pdf24_26 pdf24_08 pdf24_39" style="word-spacing:0em;">ver Estudios clnicos (11.1)</span><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0002em;">] y 266 pacientes en CASPIAN que &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.1318em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0778em;">recibieron hasta cuatro ciclos de platino-etopsido ms durvalumab 1500 mg con tremelimumab-actl 75 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.1918em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0859em;">mg cada 3 semanas, seguido de durvalumab 1500 mg cada 4 semanas (un rgimen no aprobado para el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.2418em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0225em;">cncer de pulmn de clulas pequeas en estadio extenso). De estos pacientes, el 64 % recibi el mximo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.3118em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0021em;">de 5 dosis de IMJUDO y el 79 % recibi al menos 4 dosis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.1818em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0374em;">En esta poblacin de seguridad combinada, las reacciones adversas ms frecuentes (&gt; 20 %) fueron nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.2418em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0834em;">(37 %), disminucin del apetito (25 %) y fatiga (22 %). En esta poblacin de seguridad combinada, las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.2919em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0548em;">anomalas de laboratorio de grado 3 o 4 (&gt; 10 %) ms frecuentes fueron neutropenia (39 %), leucopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.3544em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:0.2981em;">(21%), linfopenia (20 %), anemia (20 %), hiponatremia (14 %), aumento de la lipasa (12 %) y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.4143em;"><span class="pdf24_17 pdf24_08 pdf24_11" style="word-spacing:-0.0093em;">trombocitopenia (11 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.2943em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0442em;">Los datos descritos en esta seccin reflejan la exposicin a IMJUDO en pacientes con uHCC incluidos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.3543em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0004em;">en el estudio HIMALAYA y en pacientes con NSCLC metastsico enrolados en el estudio POSEIDON. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.2343em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0054em;">Carcinoma hepatocelular &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.3443em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:0.0045em;">Carcinoma hepatocelular no resecable (uHCC) - HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.4443em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.0134em;">La seguridad de IMJUDO administrado en combinacin con durvalumab fue evaluado en un total de 388 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.5043em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0524em;">pacientes con uHCC en HIMALAYA, un estudio multicntrico, aleatorizado, abierto, </span><span class="pdf24_26 pdf24_08 pdf24_41" style="word-spacing:-0.0548em;">[ver Estudios clnicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5643em;"><span class="pdf24_17 pdf24_08 pdf24_66">(11.1)</span><span class="pdf24_26 pdf24_08 pdf24_63">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.446em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.2742em;">Los pacientes que recibieron IMJUDO 300 mg administrado como una perfusin intravenosa en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.496em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.1893em;">combinacin con durvalumab 1500 mg en el mismo da, seguido por durvalumab cada 4 semanas o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.566em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0009em;">sorafenib 400 mg dado oralmente dos veces por da. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.446em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1073em;">Se produjeron reacciones adversas graves en el 41% de los pacientes quienes recibieron IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.496em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.2327em;">combinacin con durvalumab. Las reacciones adversas graves en </span><span class="pdf24_69 pdf24_08 pdf24_25" style="word-spacing:0.2308em;"> 1% de los pacientes incluyeron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.546em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0189em;">hemorragia (6%), diarrea (4%), sepsis (2.1%), neumona (2.1%), erupcin cutnea (1.5%), vmito (1.3 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.606em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0104em;">insuficiencia renal aguda (1.3 %) y anemia (1.3 %). Se produjeron reacciones adversas mortales en el 8 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.656em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1963em;">de los pacientes que recibieron IMJUDO en combinacin con durvalumab, incluida muerte (1 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.716em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:-0.0224em;">hemorragia intracraneal (0.5 %), paro cardaco (0.5 %), neumonitis (0.5 %), insuficiencia heptica (0.5 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.766em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0382em;">y hepatitis inmunomediada (0.5%)</span><span class="pdf24_69 pdf24_08 pdf24_19" style="word-spacing:0.0419em;">. Las reacciones adversas ms frecuentes (que se produjeron en  20% &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.816em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.2187em;">de los pacientes) fueron erupcin cutnea, diarrea, fatiga, prurito, dolor musculoesqueltico, y dolor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.886em;"><span class="pdf24_17 pdf24_08 pdf24_66">abdominal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.7685em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0298em;">La interrupcin permanente del rgimen de tratamiento debido a una reaccin adversa ocurri en el 14 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.8185em;"><span class="pdf24_69 pdf24_08 pdf24_28" style="word-spacing:0.0351em;">de los pacientes; las reacciones adversas ms comunes que llevaron a la interrupcin del tratamiento ( 1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.8785em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0002em;">%) fueron hemorragia (1.8 %), diarrea (1.5 %), aumento de AST (1 %) y hepatitis (1 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.7585em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1654em;">Las interrupciones de la dosis o el retraso del rgimen de tratamiento debido a una reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.8185em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:0.012em;">ocurrieron en el 35% de los pacientes. Las reacciones adversas que requirieron la interrupcin o el retraso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.8685em;"><span class="pdf24_69 pdf24_08 pdf24_72" style="word-spacing:-0.0182em;">de la dosificacin en  1 % de los pacientes incluyeron aumento de ALT (3</span><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0164em;">.6 %), diarrea (3.6 %), erupcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.9185em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:0.1596em;">cutnea (3.6 %), aumento de amilasa (3.4 %), aumento de AST (3.1 %), aumento de lipasa (2.8 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.9782em;"><span class="pdf24_17 pdf24_08 pdf24_67" style="word-spacing:0.3659em;">neumona (1.5 %), hepatitis (1.5 %), pirexia (1.5 %), anemia (1.3 %), trombocitopenia (1 %), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.0382em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0017em;">hipertiroidismo (1 %), neumonitis (1 %) y creatinina en sangre aument (1%). &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_13" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_103" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.231em;">La Tabla 5 resume las reacciones adversas que ocurrieron en pacientes tratados con IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_17 pdf24_08 pdf24_40" style="word-spacing:0.0083em;">combinacin con durvalumab en el estudio HIMALAYA. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:-0.0001em;">Tabla 5. Reacciones adversas (</span><span class="pdf24_104 pdf24_08 pdf24_30" style="word-spacing:-0.0006em;"> 10%</span><span class="pdf24_12 pdf24_08 pdf24_34" style="word-spacing:0.002em;">) en pacientes en el estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.7542em;top:10.2918em;"><span class="pdf24_12 pdf24_08 pdf24_34" style="word-spacing:0.0051em;">IMJUDO y durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.3242em;top:11.3418em;"><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0047em;">N = 388 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.4058em;top:10.2918em;"><span class="pdf24_12 pdf24_08 pdf24_66">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.8058em;top:11.3418em;"><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0033em;">N = 374 &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.022em;top:12.4418em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:0.0021em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.2742em;top:12.4418em;"><span class="pdf24_12 pdf24_08 pdf24_18">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.2442em;top:13.4918em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:0.0023em;">grado (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.3642em;top:12.4418em;"><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0097em;">Grado 3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.7758em;top:12.4418em;"><span class="pdf24_12 pdf24_08 pdf24_18">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.7458em;top:13.4918em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:0.0023em;">grado (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.3958em;top:12.4418em;"><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0093em;">Grado 3-4 (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:15.6418em;"><span class="pdf24_12 pdf24_08 pdf24_18" style="word-spacing:0.0027em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:16.7418em;"><span class="pdf24_17 pdf24_08 pdf24_105">Diarrea</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_106">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:19.8042em;top:16.7418em;"><span class="pdf24_17 pdf24_08 pdf24_14">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.8042em;top:17.8318em;"><span class="pdf24_17 pdf24_08 pdf24_14">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.8042em;top:18.9318em;"><span class="pdf24_17 pdf24_08 pdf24_14">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0158em;top:16.7418em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:26.6658em;top:17.8318em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0158em;top:18.9318em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.3058em;top:16.7418em;"><span class="pdf24_17 pdf24_08 pdf24_14">45 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3058em;top:17.8318em;"><span class="pdf24_17 pdf24_08 pdf24_14">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3058em;top:18.9318em;"><span class="pdf24_17 pdf24_08 pdf24_14">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6983em;top:16.7418em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:17.8318em;"><span class="pdf24_17 pdf24_08 pdf24_14">4</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:18.9318em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:6.472em;top:17.8318em;"><span class="pdf24_17 pdf24_08 pdf24_67" style="word-spacing:-0.0075em;">Dolor abdominal</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_88" style="word-spacing:-0.012em;">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:18.9318em;"><span class="pdf24_17 pdf24_08 pdf24_28">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:20.0243em;"><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.0026em;">Trastornos de la piel y tejido subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:21.1243em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0018em;">Erupcin cutnea</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_18" style="word-spacing:0.0029em;">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:22.2243em;"><span class="pdf24_17 pdf24_08 pdf24_106">Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.8042em;top:21.1243em;"><span class="pdf24_17 pdf24_08 pdf24_14">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.8042em;top:22.2243em;"><span class="pdf24_17 pdf24_08 pdf24_14">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6658em;top:21.1243em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0158em;top:22.2243em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.3058em;top:21.1243em;"><span class="pdf24_17 pdf24_08 pdf24_14">57 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5358em;top:22.2243em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:39.8083em;top:21.1243em;"><span class="pdf24_17 pdf24_08 pdf24_14">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6983em;top:22.2243em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:23.3143em;"><span class="pdf24_12 pdf24_08 pdf24_25" style="word-spacing:0.0014em;">Trastornos del metabolismo y nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:24.4143em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0066em;">Disminucin del apetito</span><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:4.6601em;">&nbsp;</span><span class="pdf24_17 pdf24_08 pdf24_14">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6658em;top:24.4143em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3058em;top:24.4143em;"><span class="pdf24_17 pdf24_08 pdf24_14">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6983em;top:24.4143em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:25.5043em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.0027em;">Trastornos generales y condiciones del sitio de administracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:26.6043em;"><span class="pdf24_17 pdf24_08 pdf24_14">Fatiga</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_14">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:19.8042em;top:26.6043em;"><span class="pdf24_17 pdf24_08 pdf24_14">26 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.8042em;top:27.6943em;"><span class="pdf24_17 pdf24_08 pdf24_14">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6658em;top:26.6043em;"><span class="pdf24_17 pdf24_08 pdf24_14">3.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6658em;top:27.6943em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3058em;top:26.6043em;"><span class="pdf24_17 pdf24_08 pdf24_14">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5358em;top:27.6943em;"><span class="pdf24_17 pdf24_08 pdf24_14">9</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:26.6043em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:39.6983em;top:27.6943em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:27.6943em;"><span class="pdf24_17 pdf24_08 pdf24_107">Pirexia</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_108">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:28.7943em;"><span class="pdf24_12 pdf24_08 pdf24_28" style="word-spacing:0.0031em;">Trastornos psiquitricos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:29.8943em;"><span class="pdf24_17 pdf24_08 pdf24_33">Insomnio &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.8042em;top:29.8943em;"><span class="pdf24_17 pdf24_08 pdf24_14">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.8042em;top:32.0843em;"><span class="pdf24_17 pdf24_08 pdf24_14">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.1242em;top:29.8943em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.1958em;top:29.8943em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.5358em;top:32.0843em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:29.8943em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:32.0843em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:6.472em;top:30.9843em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:0.0023em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:32.0843em;"><span class="pdf24_17 pdf24_08 pdf24_39">Hipotiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_28">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:27.0158em;top:32.0843em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:6.472em;top:33.1743em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.0026em;">Trastornos musculoesquelticos y del tejido conectivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:34.276em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0068em;">Dolor muscoloesqueltico</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_39" style="word-spacing:-0.0107em;">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:19.8042em;top:34.276em;"><span class="pdf24_17 pdf24_08 pdf24_14">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.6658em;top:34.276em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.3058em;top:34.276em;"><span class="pdf24_17 pdf24_08 pdf24_14">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.6983em;top:34.276em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.3762em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">1 </span></sup><span class="pdf24_43 pdf24_08 pdf24_63" style="word-spacing:0.0005em;">Representa un compuesto de varios trminos relacionados. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.386em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0028em;">La Tabla 6 resume las alteraciones de laboratorio que se produjeron en pacientes tratados con IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.436em;"><span class="pdf24_17 pdf24_08 pdf24_100" style="word-spacing:0.0057em;">en combinacin con durvalumab en el estudio HIMALAYA. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.546em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:-0.0015em;">Tabla 6: Alteraciones de laboratorio que empeoraron desde el inicio, producidas en </span><span class="pdf24_104 pdf24_08 pdf24_32" style="word-spacing:0.0002em;"> 20% de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.596em;"><span class="pdf24_12 pdf24_08 pdf24_100" style="word-spacing:0.0043em;">pacientes en el estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:42.696em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:-0.0023em;">Alteracin de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1042em;top:42.696em;"><span class="pdf24_12 pdf24_08 pdf24_34" style="word-spacing:0.0051em;">IMJUDO y durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.9358em;top:42.696em;"><span class="pdf24_12 pdf24_08 pdf24_66">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.2342em;top:43.796em;"><span class="pdf24_12 pdf24_08 pdf24_18">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.9242em;top:44.846em;"><span class="pdf24_12 pdf24_08 pdf24_14">grado</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.3142em;top:45.896em;"><span class="pdf24_12 pdf24_08 pdf24_109">(%)</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_110">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:24.9042em;top:43.796em;"><span class="pdf24_12 pdf24_08 pdf24_58" style="word-spacing:-0.0101em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14" style="word-spacing:0.1465em;">1 </span></sup><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5642em;top:44.846em;"><span class="pdf24_12 pdf24_08 pdf24_111">(%)</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_112">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.0058em;top:43.796em;"><span class="pdf24_12 pdf24_08 pdf24_18">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.7058em;top:44.846em;"><span class="pdf24_12 pdf24_08 pdf24_14">grado</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:32.0858em;top:45.896em;"><span class="pdf24_12 pdf24_08 pdf24_109">(%)</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_110">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:37.0658em;top:43.796em;"><span class="pdf24_12 pdf24_08 pdf24_58" style="word-spacing:-0.0092em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14" style="word-spacing:0.1465em;">1 </span></sup><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.7283em;top:44.846em;"><span class="pdf24_12 pdf24_08 pdf24_109">(%)</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_110">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:46.996em;"><span class="pdf24_12 pdf24_08 pdf24_33">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:48.0885em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0041em;">Aspartato Aminotransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:49.1485em;"><span class="pdf24_17 pdf24_08 pdf24_39">aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:50.2385em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.007em;">Alanina Aminotransferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:51.2985em;"><span class="pdf24_17 pdf24_08 pdf24_39">aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8958em;top:48.0885em;"><span class="pdf24_17 pdf24_08 pdf24_14">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8958em;top:50.2385em;"><span class="pdf24_17 pdf24_08 pdf24_14">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:48.0885em;"><span class="pdf24_17 pdf24_08 pdf24_14">55 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:50.2385em;"><span class="pdf24_17 pdf24_08 pdf24_14">53 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0583em;top:48.0885em;"><span class="pdf24_17 pdf24_08 pdf24_14">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0583em;top:50.2385em;"><span class="pdf24_17 pdf24_08 pdf24_14">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:48.6185em;"><span class="pdf24_17 pdf24_08 pdf24_14">63 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:50.7685em;"><span class="pdf24_17 pdf24_08 pdf24_14">56 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:52.3885em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0033em;">Sodio disminuido &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:52.3885em;"><span class="pdf24_17 pdf24_08 pdf24_14">46 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:53.4885em;"><span class="pdf24_17 pdf24_08 pdf24_14">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:54.5885em;"><span class="pdf24_17 pdf24_08 pdf24_14">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:55.6785em;"><span class="pdf24_17 pdf24_08 pdf24_14">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:56.7785em;"><span class="pdf24_17 pdf24_08 pdf24_14">34 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:57.8682em;"><span class="pdf24_17 pdf24_08 pdf24_14">31 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8958em;top:52.3885em;"><span class="pdf24_17 pdf24_08 pdf24_14">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.1258em;top:53.4885em;"><span class="pdf24_17 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:27.1258em;top:54.5885em;"><span class="pdf24_17 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:26.8958em;top:55.6785em;"><span class="pdf24_17 pdf24_08 pdf24_14">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.1258em;top:56.7785em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:26.7858em;top:57.8682em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:52.3885em;"><span class="pdf24_17 pdf24_08 pdf24_14">40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:53.4885em;"><span class="pdf24_17 pdf24_08 pdf24_14">47 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:54.5885em;"><span class="pdf24_17 pdf24_08 pdf24_14">44 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:55.6785em;"><span class="pdf24_17 pdf24_08 pdf24_14">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:56.7785em;"><span class="pdf24_17 pdf24_08 pdf24_14">43 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:57.8682em;"><span class="pdf24_17 pdf24_08 pdf24_14">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0583em;top:52.3885em;"><span class="pdf24_17 pdf24_08 pdf24_14">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.0583em;top:53.4885em;"><span class="pdf24_17 pdf24_08 pdf24_14">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2883em;top:54.5885em;"><span class="pdf24_17 pdf24_08 pdf24_14">5</span></div>
					<div class="pdf24_01" style="left:39.2883em;top:55.6785em;"><span class="pdf24_17 pdf24_08 pdf24_14">4</span></div>
					<div class="pdf24_01" style="left:38.9483em;top:56.7785em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9483em;top:57.8682em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:53.4885em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0035em;">Bilirrubina aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:54.5885em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0036em;">Fosfatasa alcalina aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:55.6785em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0063em;">Glucosa aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:56.7785em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0021em;">Calcio disminuido &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:57.8682em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0068em;">Albmina disminuida &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_14" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_113" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.472em;top:6.0718em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:-0.0023em;">Alteracin de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.1042em;top:6.0718em;"><span class="pdf24_12 pdf24_08 pdf24_34" style="word-spacing:0.0051em;">IMJUDO y durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.9358em;top:6.0718em;"><span class="pdf24_12 pdf24_08 pdf24_66">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.2342em;top:7.1718em;"><span class="pdf24_12 pdf24_08 pdf24_18">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.9242em;top:8.2218em;"><span class="pdf24_12 pdf24_08 pdf24_14">grado</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.3142em;top:9.2818em;"><span class="pdf24_12 pdf24_08 pdf24_109">(%)</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_110">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:24.9042em;top:7.1718em;"><span class="pdf24_12 pdf24_08 pdf24_58" style="word-spacing:-0.0101em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14" style="word-spacing:0.1465em;">1 </span></sup><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5642em;top:8.2218em;"><span class="pdf24_12 pdf24_08 pdf24_111">(%)</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_112">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.0058em;top:7.1718em;"><span class="pdf24_12 pdf24_08 pdf24_18">Cualquier &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.7058em;top:8.2218em;"><span class="pdf24_12 pdf24_08 pdf24_14">grado</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:32.0858em;top:9.2818em;"><span class="pdf24_12 pdf24_08 pdf24_109">(%)</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_110">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:37.0658em;top:7.1718em;"><span class="pdf24_12 pdf24_08 pdf24_58" style="word-spacing:-0.0092em;">Grado 3</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_14" style="word-spacing:0.1465em;">1 </span></sup><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0em;">o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.7283em;top:8.2218em;"><span class="pdf24_12 pdf24_08 pdf24_109">(%)</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_110">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.472em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0034em;">Potasio aumentado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0041em;">Creatinina aumentada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:12.5618em;"><span class="pdf24_12 pdf24_08 pdf24_32">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_14">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_14">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7858em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_14">3.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7858em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_14">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_14">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9483em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9483em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:13.6619em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0056em;">Hemoglobina disminuida &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:14.7518em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0028em;">Linfocitos disminuidos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:15.8518em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.003em;">Plaquetas disminuidas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:16.9518em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0034em;">Leucocitos disminuidos &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:13.6619em;"><span class="pdf24_17 pdf24_08 pdf24_14">52 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:14.7518em;"><span class="pdf24_17 pdf24_08 pdf24_14">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:15.8518em;"><span class="pdf24_17 pdf24_08 pdf24_14">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7642em;top:16.9518em;"><span class="pdf24_17 pdf24_08 pdf24_14">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7858em;top:13.6619em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.8958em;top:14.7518em;"><span class="pdf24_17 pdf24_08 pdf24_14">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7858em;top:15.8518em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7858em;top:16.9518em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:13.6619em;"><span class="pdf24_17 pdf24_08 pdf24_14">40 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:14.7518em;"><span class="pdf24_17 pdf24_08 pdf24_14">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:15.8518em;"><span class="pdf24_17 pdf24_08 pdf24_14">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.5358em;top:16.9518em;"><span class="pdf24_17 pdf24_08 pdf24_14">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.2883em;top:13.6619em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:39.0583em;top:14.7518em;"><span class="pdf24_17 pdf24_08 pdf24_14">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9483em;top:15.8518em;"><span class="pdf24_17 pdf24_08 pdf24_14">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.9483em;top:16.9518em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.052em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.0093em;">1 </span></sup><span class="pdf24_43 pdf24_08 pdf24_64" style="word-spacing:0.0034em;">Clasificado segn NCI CTCAE versin 4.03. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.012em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1759em;">2 </span></sup><span class="pdf24_43 pdf24_08 pdf24_114" style="word-spacing:0.0206em;">Cada incidencia de la prueba se basa en el nmero de pacientes que tuvieron disponible una medida de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.9745em;"><span class="pdf24_43 pdf24_08 pdf24_63" style="word-spacing:-0.0124em;">inicial y al menos una durante el estudio: IMJUDO con durvalumab (rango: 367-378) y sorafenib (rango: 344-352). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.9843em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0008em;">Cncer de pulmn de clulas no pequeas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.8743em;"><span class="pdf24_26 pdf24_08 pdf24_33" style="word-spacing:0.001em;">NSCLC metastsico </span><span class="pdf24_115 pdf24_08 pdf24_14" style="word-spacing:0em;"> </span><span class="pdf24_26 pdf24_08 pdf24_116">POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.7543em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0628em;">La seguridad de IMJUDO en combinacin con durvalumab y quimioterapia basada en platino en pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.8043em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.2058em;">con NSCLC metastsico se evalu en POSEIDON (NCT03164616), un ensayo aleatorizado, abierto, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.8543em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0546em;">multicntrico y controlado de forma activa. Un total de 330 pacientes recibieron IMJUDO </span><span class="pdf24_69 pdf24_08 pdf24_20" style="word-spacing:0.0547em;">( 30 kg de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.9143em;"><span class="pdf24_69 pdf24_08 pdf24_13" style="word-spacing:0.1807em;">peso corporal recibieron 75 mg y  30 kg de peso corporal recibieron 1mg/kg) en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.9643em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1273em;">durvalumab 1500 mg y regmenes de quimioterapia con platino basados en la histologa </span><span class="pdf24_26 pdf24_08 pdf24_19" style="word-spacing:0.1275em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_80">Estudios &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.0243em;"><span class="pdf24_17 pdf24_08 pdf24_22" style="word-spacing:0.0337em;">clnicos (</span><span class="pdf24_26 pdf24_08 pdf24_14">11</span><span class="pdf24_17 pdf24_08 pdf24_46">.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0421em;">. De estos pacientes, el 66 % recibi hasta el mximo de 5 dosis de IMJUDO y el 79 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.0743em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0315em;">recibi al menos 4 dosis. El tratamiento se continu con durvalumab como agente nico (o con durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.1243em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0443em;">y pemetrexed basado en la histologa para pacientes no escamosos, segn la decisin del investigador) hasta &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.186em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0031em;">la progresin de la enfermedad o toxicidad inaceptable. El ensayo excluy a los pacientes con enfermedad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.236em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.261em;">autoinmune activa o previa o con afecciones mdicas que requirieran corticosteroides sistmicos o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.306em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0082em;">inmunosupresores </span><span class="pdf24_26 pdf24_08 pdf24_24" style="word-spacing:0.0056em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.007em;">Estudios clnicos (11.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_84">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.176em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.2203em;">La mediana de edad de los pacientes que recibieron IMJUDO en combinacin con durvalumab y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.236em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.1342em;">quimioterapia basada en platino fue de 63 aos (rango: 27 a 87); 80 % varones; 61 % blancos, 29 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.296em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0014em;">asiticos, 58 % ex fumadores, 25 % fumadores actuales y 68 % ECOG de rendimiento 1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.176em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.1865em;">Se produjeron reacciones adversas graves en el 44 % de los pacientes que recibieron IMJUDO en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.226em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.1723em;">combinacin con durvalumab y quimioterapia basada en platino. Las reacciones adversas graves ms &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.286em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0241em;">frecuentes notificadas en al menos el 2 % de los pacientes fueron neumona (11%), anemia (5 %), diarrea &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.336em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0675em;">(2.4 %), trombocitopenia (2.4 %), pirexia (2.4 %) y neutropenia febril (2.1%). Se produjeron reacciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.396em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:0.0721em;">adversas mortales en un total del 4.2 % de los pacientes que recibieron IMJUDO en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.446em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0558em;">durvalumab y quimioterapia basada en platino. Estas incluyen hepatitis, nefritis, miocarditis, pancreatitis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.4985em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0585em;">(todas en el mismo paciente), muerte (2 pacientes), sepsis (2 pacientes), neumonitis (2 pacientes), lesin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.5585em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.1307em;">renal aguda (2 pacientes), neutropenia febril (1 paciente), enfermedad pulmonar obstructiva crnica (1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.6185em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0018em;">paciente), disnea (1 paciente), muerte sbita (1 paciente) e ictus isqumico (1 paciente). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4985em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0344em;">La descontinuacin permanente de IMJUDO o durvalumab debido a una reaccin adversa ocurri en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.5485em;"><span class="pdf24_17 pdf24_08 pdf24_19" style="word-spacing:0.166em;">17 % de los pacientes. Las reacciones adversas que dieron lugar a la descontinuacin permanente de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.6185em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0009em;">IMJUDO o durvalumab en &gt; 2 % de los pacientes incluyeron neumona. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.4885em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.1694em;">Se produjeron interrupciones o retrasos de la dosificacin de IMJUDO y durvalumab debido a una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5482em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0247em;">reaccin adversa en el 41 % de los pacientes. Las reacciones adversas que requirieron la interrupcin o el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.5982em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.3289em;">retraso de la dosis de IMJUDO y durvalumab en &gt; 1 % de los pacientes incluyeron anemia, &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_15" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAsvUlEQVR4nO3a4aql93ne4XUeIpagZ5B8UxIwZAbR2qL9INo0aVBAkEQltWRTY4ENAkNiWeARUiqPRigaUos4JfnSnEBOre+gOYD90n3zvPezrwue73+80Nz+7bVuNwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACg3uPjPj7uQ+eK7wcXeINz2+9/Hvf+Bd7hXNP96gbcuzeP++/HveZc8X11gTc4t/3+w3HvXeAdzjXdP9yAe/fvj/uv04+A/0+/mX4APACvH/fu9COgjH2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CAAHDBgYC8gQMnGefIEDAsIGBgDwBA+fZJwgQMGxgICBPwMB59gkCBAwbGAjIEzBwnn2CgDeOe+e415wrvq8u8AZ39/vOy5t+hzt33zvuvQu8w527V1/e9Dse6j27Affu8XEfH/ehc8X31QXe4O5+H7286Xe4c/c3xz25wDvc+fv8Am94qPfivxngnvkJGRv4ir7LW8e9Of0ITvMTsk6v3L79gwEz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMEPDrui+OeO1d8X17gDe7u99nLm36HO3efH/d3F3iHO3dPX970Ox7qfXID7p1vYAAAMnwDAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQIGACADAEDAQIGACBDwECAgAEAyBAwECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBDw+7r3jvutc8f3BBd7gzn1ePrO+e/GZ/f4F3uHO3R/efG6T99kNuHePjvvZcW87V3xfXuAN7u730+N+coF3uHP3/nE/v8A73Ln7y+OeXOAdD/U+uQH3zk/I2MBX9F3eOu7N6Udw2uvHvTv9CE575biPph/xgNknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIeH/fb4/7NueL7lwu8wd39fnvz707j/fNx/3iBd7hz96/H/dMF3vFQ7+kNuHe+gQEAyPANDAQIGACADAEDAQIGACBDwECAgAEAyBAwECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQIGACADAEDAQIGACBDwECAgAEAyBAwEPDGce8c95pzxfc7F3iDu/t95+VNv8Odu1dvPrfGe/XlTb/jod6zG3DvHh/38XEfOld8X13gDe7u99HLm36HO3d/c9yTC7zDnb/PL/CGh3ov/psB7pmfkLGBr+i7vHXcm9OP4LTXj3t3+hGc9srt2z8YMMM+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxDw6LgvjnvuXPF9c4E3uLvfi39znl7gHe785/bsAu9w5z+3ry/wjod6n96Ae+cbGDbwF64uvoHp5BuYTr6BmWWfIEDAsIGB6CJgOgmYTgJmln2CAAHDBgaii4DpJGA6CZhZ9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIEDAsIGB6CJgOgmYTgJmln2CAAHDBgaii4DpJGA6CZhZ9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIEDAsIGB6CJgOgmYTgJmln2CAAHDBgaii4DpJGA6CZhZ9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIEDAsIGB6CJgOgmYTgJmln2CAAHDBgaii4DpJGA6CZhZ9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIODRcU+Pe+5c8X1zgTe4u98Xx/36Au9w5+7FVjy7wDvcuXvxmX19gXc81Pv0Btw738Cwgb9wdfENTCffwHTyDcws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BwKPjvjjuuXPF980F3uDufi/+zXl6gXe485/bswu8w53/3L6+wDse6n16A+6db2DYwF+4uvgGppNvYDr5BmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYKAR8c9Pe65c8X3zQXe4O5+Xxz36wu8w527F1vx7ALvcOfuxWf29QXe8VDv0xtw73wDwwb+wtXFNzCdfAPTyTcws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAGPjvviuOfOFd83F3iDu/u9+Dfn6QXe4c5/bs8u8A53/nP7+gLveKj36Q24d//xuP9x3GvOFd/vXOAN7u73nZc3/Q537l69+dwa79WXN/2Oh3r/fAPunZ+QAQBk+AkZBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQIGACADAEDAQIGACBDwECAgAEAyBAwECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQ8Pi4fzzu35wrvn+5wBvc3e+3L2/6He7c/fPNXjTevx73Txd4x0O9pzfg3vkGhg38havLW8e9Of0ITnv9uHenH8Fprxz30fQjHjD7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkHAo+N+dtzbzhXflxd4g7v7/fS4n1zgHe7c/fC4n1/gHe7c/cVxTy7wjod6L/63B+7Z4+N+cNx3nSu+P7jAG9y5z8tn1ncvPrPfv8A73Ln7w5vPbfI+uwH3zk/IAAAy/IQMAgQMAECGgIEAAQMAkCFgIEDAAABkCBgIEDAAABkCBgIEDABAhoCBAAEDAJAhYCBAwAAAZAgYCBAwAAAZAgYCBAwAQIaAgQABAwCQIWAgQMAAAGQIGAgQMAAAGQIGAgQMAECGgIEAAQMAkCFgIEDAAABkCBgI+KPjvjjuuXPF9+UF3uDufn933GcXeIc7d//r5Wc3/Q537p4e9+sLvOOh3ic34N75BoYN/IWry1vHvTn9CE57/bh3px/Baa8c99H0Ix4w+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BwOPj3jvuu84V37MLvMHd/f76uL+6wDvcufuz4z64wDvcufv+cb+8wDse6n12A+7do+N+dtzbzhXflxd4g7v7/fS4n1zgHe7cvX/czy/wDnfu/vK4Jxd4x0O9T27AvfMTMjbwFX0XPyHr5CdknfyEbJZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyDgj4774rjnzhXfby7wBnf3e3rc5xd4hzt3L7bi2QXe4c5/bn9/gXc81PvkBtw738Cwgb9wdfENTCffwHTyDcws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BwOPj3jvuu84V37MLvMHd/f76uL+6wDvcufuz4z64wDvcufv+cb+8wDse6n12A+7do+N+dtzbzhXff7nAG9zd7499ZpX34tv6/3yBd7hz9998bqP3yQ24d35CBgCQ4SdkECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQIGACADAEDAQIGACBDwECAgAEAyBAwECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAwOPjfnvcvzlXfN9c4A3u7veblzf9Dnfu/um4f7jAO9y5+7/H/e8LvOOh3q9vwL3zDQwb+AtXl7eOe3P6EZz2+nHvTj+C01457qPpRzxg9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIEDAsIGB6CJgOgmYTgJmln2CAAHDBgaii4DpJGA6CZhZ9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIEDAsIGB6CJgOgmYTgJmln2CAAHDBgaii4DpJGA6CZhZ9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIEDAsIGB6CJgOgmYTgJmln2CAAHDBgaii4DpJGA6CZhZ9gkCBAwbGIguAqaTgOkkYGbZJwgQMGxgILoImE4CppOAmWWfIEDAsIGB6CJgOgmYTgJmln2CgMfHvXfcd50rvmcXeIO7+/31cX91gXe4c/dnx31wgXe4c/f94355gXc81PvsBty7R8f97Li3nSu+Ly/wBnf3++lxP7nAO9y5e/+4n1/gHe7c/eVxTy7wjod6n9yAe+cnZGzgK/oufkLWyU/IOvkJ2Sz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkHAo+O+OO65c8X3zQXe4O5+L/7NeXqBd7jzn9uzC7zDnf/cvr7AOx7qfXoD7p1vYNjAX7i6+Aamk29gOvkGZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyDgjePeOe4154rvqwu8wd39/vy4P73AO9y5+95x713gHe7c/e5xv7jAOx7qPbsB9+7xcR8f96FzxfeDC7zB3f1+eNyPLvAOd+5+fNz7F3iHO3cf3L4Nz+l3PNR7cgPunZ+QAQBk+AkZBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQIGACADAEDAQIGACBDwECAgAEAyBAwECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQ8Oi4L4577lzx/eICb3B3v1++vOl3uHP35Oa/tcb7/Li/vcA7Hup9egPunW9g2MBfuLq8ddyb04/gtNePe3f6EZz2ynEfTT/iAbNPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwQIGDYwEF0ETCcB00nAzLJPECBg2MBAdBEwnQRMJwEzyz5BgIBhAwPRRcB0EjCdBMws+wQBAoYNDEQXAdNJwHQSMLPsEwS8cdw7x73mXPF9dYE3uLvfnx/3pxd4hzt33zvuvQu8w5273z3uFxd4x0O9Zzfg3j0+7uPjPnSu+H5wgTe4u98Pj/vRBd7hzt2Pj3v/Au9w5+6D27fhOf2Oh3pPbsC98xMyAIAMPyGDAAEDAJAhYCBAwAAAZAgYCBAwAAAZAgYCBAwAQIaAgQABAwCQIWAgQMAAAGQIGAgQMAAAGQIGAgQMAECGgIEAAQMAkCFgIEDAAABkCBgIEDAAABkCBgIEDABAhoCBAAEDAJAhYCBAwAAAZAgYCBAwAAAZAgYCHh/38XEfOld8P7jAG9zd74fH/egC73Dn7sfHvX+Bd7hz98Fx713gHQ/1ntyAe/fGce8c95pzxffVBd7g7n5vH/cnF3iHO3ffu337f4Sn3+HO3e8d99EF3vFQ79kNuHd+QsYGvqLv8tZxb04/gtNeP+7d6Udw2iu3bwOGGfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyBAwLCBgegiYDoJmE4CZpZ9ggABwwYGoouA6SRgOgmYWfYJAgQMGxiILgKmk4DpJGBm2ScIEDBsYCC6CJhOAqaTgJllnyDgjePeOe4154rvqwu8wd39/vy4P73AO9y5+95x713gHe7c/e5xv7jAOx7qPbsB9+7RcU+Pe+5c8f3iAm9wd79fvrzpd7hz9+Tmv7XG+/y4v73AOx7qfXoD7p2fkAEAZPgJGQQIGACADAEDAQIGACBDwECAgAEAyBAwECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQIGACADAEDAQIGACBDwECAgAEAyBAwEPD4uI+P+9C54vvBBd7g7n4/PO5HF3iHO3c/Pu79C7zDnbsPjnvvAu94qPfkBty7N45757jXnCu+ry7wBnf3e/u4P7nAO9y5+97t2/8jPP0Od+5+77iPLvCOh3rPbsC98xMyNvAVfZe3jntz+hGc9vpx704/gtNeuX0bMMywTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BMECBg2MBBdBEwnAdNJwMyyTxAgYNjAQHQRMJ0ETCcBM8s+QYCAYQMD0UXAdBIwnQTMLPsEAQKGDQxEFwHTScB0EjCz7BME/NFxXxz33Lni+80F3uDufk+P+/wC73Dn7sVWPLvAO9z5z+3vL/COh3qf3IB75xsYNvAXri6+genkG5hOvoGZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8gQMCwgYHoImA6CZhOAmaWfYIAAcMGBqKLgOkkYDoJmFn2CQIEDBsYiC4CppOA6SRgZtknCBAwbGAgugiYTgKmk4CZZZ8g4PFxHx/3oXPF99UF3uDufi/+z9QvLvAOd+7+5rhfXeAd7vz9+gJveKj35AbcuzeOe+e415wrvt+5wBvc3e87L2/6He7cvXrzuTXeqy9v+h0P9Z7dgHvnJ2QAABl+QgYBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQIGACADAEDAQIGACBDwECAgAEAyBAwECBgAAAyBAwECBgAgAwBAwECBgAgQ8BAgIABAMgQMBAgYAAAMgQMBAgYAIAMAQMBAgYAIEPAQICAAQDIEDAQIGAAADIEDAQ8Ou7pcc+dK75vLvAGd/f74rhfX+Ad7ty92IpnF3iHO3cvPrOvL/COh3qf3oB75xsYNvAXri5vHffm9CM47fXj3p1+BKe9ctxH0494wOwTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAEChg0MRBcB00nAdBIws+wTBAgYNjAQXQRMJwHTScDMsk8QIGDYwEB0ETCdBEwnATPLPkGAgGEDA9FFwHQSMJ0EzCz7BAF/fNyvjnvbueL78gJvcHe/nx73kwu8w527Hx738wu8w527vzjuyQXe8VDv/9yAe/fvjvv+cd91rvj+4AJvcOc+L59Z3734zH7/Au9w5+4Pbz63yftPNwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAJv8P6XOwAiH2T+8AAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_117" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.01em;">leucopenia/disminucin del recuento de glbulos blancos, neumona, neumonitis, colitis, diarrea, hepatitis, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0443em;">erupcin cutnea, astenia, aumento de la amilasa, aumento de la alanina aminotransferasa, aumento de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0934em;">aspartato aminotransferasa, aumento de la lipasa, disminucin del recuento de neutropenia/neutrfilos y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.2018em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0024em;">disminucin del recuento de trombocitopenia/plaquetas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.0818em;"><span class="pdf24_69 pdf24_08 pdf24_23" style="word-spacing:0.0996em;">Las reacciones adversas ms frecuentes (ocurrieron en  20 % de los pacientes) fueron nuseas, fatiga, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.1318em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0612em;">dolor musculoesqueltico, disminucin del apetito, erupcin cutnea y diarrea. Las anomalas de laboratorio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.1918em;"><span class="pdf24_69 pdf24_08 pdf24_18" style="word-spacing:0.2171em;">de grado 3 o 4 ( 10 %) fueron neutropenia, anemia, leucopenia, </span><span class="pdf24_17 pdf24_08 pdf24_67" style="word-spacing:0.2065em;">linfopenia, aumento de la lipasa, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.2518em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0018em;">hiponatremia y trombocitopenia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.1418em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0004em;">La Tabla 7 resume las reacciones adversas en POSEIDON. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.0218em;"><span class="pdf24_12 pdf24_08 pdf24_118">T</span><span class="pdf24_104 pdf24_08 pdf24_18" style="word-spacing:0.1056em;">abla 7. Reacciones adversas ( 10 %) en pacientes con NSCLC que recibieron IMJUDO</span><span class="pdf24_12 pdf24_08 pdf24_119" style="word-spacing:0.124em;"> en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.0718em;"><span class="pdf24_12 pdf24_08 pdf24_25" style="word-spacing:0.0029em;">estudio POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.0342em;top:20.1743em;"><span class="pdf24_12 pdf24_08 pdf24_46" style="word-spacing:0.0055em;">IMJUDO con durvalumab y &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.5842em;top:21.2243em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:-0.0022em;">quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.4042em;top:22.2743em;"><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.005em;">N = 330 &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.2258em;top:20.1743em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:-0.0039em;">Quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.7958em;top:21.2243em;"><span class="pdf24_12 pdf24_08 pdf24_14">platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.6558em;top:22.2743em;"><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.005em;">N = 333 &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.112em;top:23.3743em;"><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:0.0024em;">Reaccin adversa &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.6242em;top:23.3743em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:18.2742em;top:24.4243em;"><span class="pdf24_12 pdf24_08 pdf24_76" style="word-spacing:-0.0096em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.0042em;top:23.3743em;"><span class="pdf24_12 pdf24_08 pdf24_54" style="word-spacing:-0.0057em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.5442em;top:24.4243em;"><span class="pdf24_12 pdf24_08 pdf24_86">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:32.3458em;top:23.3743em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.0035em;">Todos los &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.9858em;top:24.4243em;"><span class="pdf24_12 pdf24_08 pdf24_76" style="word-spacing:-0.01em;">grados (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.2983em;top:23.3743em;"><span class="pdf24_12 pdf24_08 pdf24_54" style="word-spacing:-0.0057em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.8483em;top:24.4243em;"><span class="pdf24_12 pdf24_08 pdf24_86">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:25.5243em;"><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:-0.0019em;">Trastornos respiratorios, torcicos y mediastnicos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:26.6243em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0017em;">Tos/tos productiva</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_25" style="word-spacing:0.0027em;">a &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.452em;top:27.7143em;"><span class="pdf24_12 pdf24_08 pdf24_25" style="word-spacing:0.0068em;">Trastornos gastrointestinales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:28.8143em;"><span class="pdf24_17 pdf24_08 pdf24_28">Nuseas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:29.9043em;"><span class="pdf24_17 pdf24_08 pdf24_66">Diarrea &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:31.0043em;"><span class="pdf24_17 pdf24_08 pdf24_72">Constipacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:26.6243em;"><span class="pdf24_17 pdf24_08 pdf24_14">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:26.6243em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.9658em;top:26.6243em;"><span class="pdf24_17 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:26.6243em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:28.8143em;"><span class="pdf24_17 pdf24_08 pdf24_14">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:29.9043em;"><span class="pdf24_17 pdf24_08 pdf24_14">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:31.0043em;"><span class="pdf24_17 pdf24_08 pdf24_14">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:32.0943em;"><span class="pdf24_17 pdf24_08 pdf24_14">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:33.1943em;"><span class="pdf24_17 pdf24_08 pdf24_14">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:28.8143em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:29.9043em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:31.0043em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:32.0943em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:33.1943em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:28.8143em;"><span class="pdf24_17 pdf24_08 pdf24_14">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:29.9043em;"><span class="pdf24_17 pdf24_08 pdf24_14">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:31.0043em;"><span class="pdf24_17 pdf24_08 pdf24_14">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:32.0943em;"><span class="pdf24_17 pdf24_08 pdf24_14">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9658em;top:33.1943em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:28.8143em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:29.9043em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:31.0043em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:32.0943em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:33.1943em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:32.0943em;"><span class="pdf24_17 pdf24_08 pdf24_88">Vmitos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:33.1943em;"><span class="pdf24_17 pdf24_08 pdf24_14">Estomatitis</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_09">b &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.452em;top:34.296em;"><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:0.0024em;">Trastornos endocrinos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:35.386em;"><span class="pdf24_17 pdf24_08 pdf24_39">Hipotiroidismo</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_28">c &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.0142em;top:35.386em;"><span class="pdf24_17 pdf24_08 pdf24_14">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:35.386em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.6158em;top:35.386em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3783em;top:35.386em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:6.452em;top:36.486em;"><span class="pdf24_12 pdf24_08 pdf24_19" style="word-spacing:0.0041em;">Trastornos de la piel y del tejido subcutneo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:37.576em;"><span class="pdf24_17 pdf24_08 pdf24_88">Erupcin</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_77">d &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.452em;top:38.676em;"><span class="pdf24_17 pdf24_08 pdf24_77">Alopecia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:39.766em;"><span class="pdf24_17 pdf24_08 pdf24_106">Prurito &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:37.576em;"><span class="pdf24_17 pdf24_08 pdf24_14">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:38.676em;"><span class="pdf24_17 pdf24_08 pdf24_14">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:39.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:37.576em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:38.676em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:39.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:37.576em;"><span class="pdf24_17 pdf24_08 pdf24_14">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9658em;top:38.676em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:33.6158em;top:39.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:37.576em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3783em;top:38.676em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:40.3783em;top:39.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:6.452em;top:40.866em;"><span class="pdf24_12 pdf24_08 pdf24_24" style="word-spacing:0.0044em;">Trastornos generales y condiciones administrativas del sitio &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:41.966em;"><span class="pdf24_17 pdf24_08 pdf24_72">Fatiga/Atenia</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_39">e &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.452em;top:43.056em;"><span class="pdf24_17 pdf24_08 pdf24_107">Pirexia</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_108">f &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.0142em;top:41.966em;"><span class="pdf24_17 pdf24_08 pdf24_14">36 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:43.056em;"><span class="pdf24_17 pdf24_08 pdf24_14">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:44.156em;"><span class="pdf24_17 pdf24_08 pdf24_14">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:41.966em;"><span class="pdf24_17 pdf24_08 pdf24_14">5</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:43.056em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:44.156em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:41.966em;"><span class="pdf24_17 pdf24_08 pdf24_14">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9658em;top:43.056em;"><span class="pdf24_17 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:44.156em;"><span class="pdf24_17 pdf24_08 pdf24_14">10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:41.966em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.3783em;top:43.056em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:44.156em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:44.156em;"><span class="pdf24_17 pdf24_08 pdf24_87">Edema</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_65">g &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.452em;top:45.246em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.0026em;">Trastornos musculoesquelticos y del tejido conectivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:46.346em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.0068em;">Dolor musculoesqueltico</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_39" style="word-spacing:-0.0107em;">h &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.452em;top:47.446em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:-0.0009em;">Trastornos del metabolismo y la nutricin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:48.5385em;"><span class="pdf24_17 pdf24_08 pdf24_77" style="word-spacing:-0.005em;">Disminucin del apetito &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:49.6385em;"><span class="pdf24_12 pdf24_08 pdf24_24" style="word-spacing:0.0004em;">Infecciones e infestaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:50.7285em;"><span class="pdf24_17 pdf24_08 pdf24_88">Neumona</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_77">i &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.0142em;top:46.346em;"><span class="pdf24_17 pdf24_08 pdf24_14">29 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:46.346em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:48.5385em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:46.346em;"><span class="pdf24_17 pdf24_08 pdf24_14">22 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:48.5385em;"><span class="pdf24_17 pdf24_08 pdf24_14">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:46.346em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:48.5385em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:48.5385em;"><span class="pdf24_17 pdf24_08 pdf24_14">28 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:50.7285em;"><span class="pdf24_17 pdf24_08 pdf24_14">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.0142em;top:51.8285em;"><span class="pdf24_17 pdf24_08 pdf24_14">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:50.7285em;"><span class="pdf24_17 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:26.7358em;top:51.8285em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.7358em;top:50.7285em;"><span class="pdf24_17 pdf24_08 pdf24_14">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9658em;top:51.8285em;"><span class="pdf24_17 pdf24_08 pdf24_14">9</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:50.7285em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:51.8285em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:51.8285em;"><span class="pdf24_17 pdf24_08 pdf24_25">Infecciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.0585em;top:51.8285em;"><span class="pdf24_17 pdf24_08 pdf24_120">del &nbsp;</span></div>
					<div class="pdf24_01" style="left:14.5471em;top:51.8285em;"><span class="pdf24_17 pdf24_08 pdf24_41">tracto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:52.8785em;"><span class="pdf24_17 pdf24_08 pdf24_11" style="word-spacing:-0.0104em;">respiratorio superior</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_66" style="word-spacing:-0.0164em;">j &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.452em;top:53.9785em;"><span class="pdf24_12 pdf24_08 pdf24_34" style="word-spacing:0.0059em;">Trastornos del sistema nervioso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:55.0685em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0035em;">Dolor de cabeza</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_25" style="word-spacing:0.0055em;">k &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:20.0142em;top:55.0685em;"><span class="pdf24_17 pdf24_08 pdf24_14">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.0858em;top:55.0685em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:33.9658em;top:55.0685em;"><span class="pdf24_17 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:40.0383em;top:55.0685em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.6 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.1787em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1395em;">a </span></sup><span class="pdf24_43 pdf24_08 pdf24_121" style="word-spacing:-0.0011em;">Incluye tos y tos productiva. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.1384em;"><sup style="top: -0.2897em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">b </span></sup><span class="pdf24_43 pdf24_08 pdf24_58" style="word-spacing:0.0009em;">Incluye inflamacin de mucosas y estomatitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.0884em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1395em;">c </span></sup><span class="pdf24_43 pdf24_08 pdf24_86" style="word-spacing:-0.0022em;">Incluye aumento de la hormona estimulante del tiroides en sangre e hipotiroidismo. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_16" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_122" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0088em;"><span class="pdf24_62 pdf24_08 pdf24_14">d</span></div>
					<div class="pdf24_01" style="left:6.552em;top:6.042em;"><span class="pdf24_43 pdf24_08 pdf24_85" style="word-spacing:0.0843em;">Incluye eczema, eritema, dermatitis, erupcin medicamentosa, eritema multiforme, penfigoide, erupcin cutnea, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.002em;"><span class="pdf24_43 pdf24_08 pdf24_73" style="word-spacing:0.001em;">erupcin maculopapular, erupcin papular, erupcin pruriginosa y erupcin pustulosa. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.952em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1395em;">e </span></sup><span class="pdf24_43 pdf24_08 pdf24_63" style="word-spacing:-0.0025em;">Incluye astenia y fatiga. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.912em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1392em;">f </span></sup><span class="pdf24_43 pdf24_08 pdf24_121" style="word-spacing:-0.0036em;">Incluye aumento de la temperatura corporal, hiperpirexia, hipertermia y pirexia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.872em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">g </span></sup><span class="pdf24_43 pdf24_08 pdf24_44" style="word-spacing:0.0007em;">Incluye edema facial, edema localizado y edema perifrico. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.832em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.0833em;">h </span></sup><span class="pdf24_43 pdf24_08 pdf24_86" style="word-spacing:-0.0349em;">Incluye artralgia, artritis, dolor de espalda, dolor seo, dolor torcico musculoesqueltico, dolor musculoesqueltico, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.792em;"><span class="pdf24_43 pdf24_08 pdf24_108" style="word-spacing:0.001em;">mialgia, dolor de cuello, dolor torcico no cardaco, dolor espinal. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.7205em;"><span class="pdf24_62 pdf24_08 pdf24_14">i</span></div>
					<div class="pdf24_01" style="left:6.452em;top:12.752em;"><span class="pdf24_43 pdf24_08 pdf24_64" style="word-spacing:0.1087em;">Incluye infeccin del tracto respiratorio inferior, neumona por pneumocystis jirovecii, neumona, neumona por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.702em;"><span class="pdf24_43 pdf24_08 pdf24_86" style="word-spacing:-0.0048em;">aspiracin, neumona bacteriana. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.6305em;"><span class="pdf24_62 pdf24_08 pdf24_14">j</span></div>
					<div class="pdf24_01" style="left:6.482em;top:14.662em;"><span class="pdf24_43 pdf24_08 pdf24_54" style="word-spacing:0.1514em;">Incluye laringitis, nasofaringitis, faringitis, rinitis, sinusitis, amigdalitis, traqueobronquitis e infeccin del tracto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.622em;"><span class="pdf24_43 pdf24_08 pdf24_44" style="word-spacing:0.0034em;">respiratorio superior. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.582em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">k </span></sup><span class="pdf24_43 pdf24_08 pdf24_85" style="word-spacing:-0.0052em;">Incluye dolor de cabeza, migraa. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.5918em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.0002em;">La Tabla 8 resume las anomalas de laboratorio en POSEIDON. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.6443em;"><span class="pdf24_104 pdf24_08 pdf24_23" style="word-spacing:0.1382em;">Tabla 8: Anomalas de laboratorio seleccionadas ( 10 %) que empeoraron respecto al inicio en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.6943em;"><span class="pdf24_12 pdf24_08 pdf24_24" style="word-spacing:0.0012em;">pacientes con NSCLC que recibieron IMJUDO en el estudio POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:22.7943em;"><span class="pdf24_12 pdf24_08 pdf24_66">Anormalidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.2792em;top:22.7943em;"><span class="pdf24_12 pdf24_08 pdf24_123">de &nbsp;</span></div>
					<div class="pdf24_01" style="left:17.9542em;top:22.7943em;"><span class="pdf24_12 pdf24_08 pdf24_20" style="word-spacing:0.005em;">IMJUDO con Durvalumab y &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.1458em;top:22.7943em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:-0.0039em;">Quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:23.8443em;"><span class="pdf24_12 pdf24_08 pdf24_77">laboratorio</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_39">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:17.4442em;top:23.8443em;"><span class="pdf24_12 pdf24_08 pdf24_21" style="word-spacing:-0.0027em;">quimioterapia basada en platino</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_18" style="word-spacing:-0.0042em;">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:36.5658em;top:23.8443em;"><span class="pdf24_12 pdf24_08 pdf24_47">platino</span><sup style="top: -0.33em;"><span class="pdf24_68 pdf24_08 pdf24_76">3 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:17.4742em;top:24.9443em;"><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.0037em;">Todos los grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:19.9942em;top:25.9943em;"><span class="pdf24_12 pdf24_08 pdf24_86">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.7542em;top:24.9443em;"><span class="pdf24_12 pdf24_08 pdf24_54" style="word-spacing:-0.0057em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2958em;top:25.9943em;"><span class="pdf24_12 pdf24_08 pdf24_86">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.5658em;top:24.9443em;"><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.0037em;">Todos los grados &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.0858em;top:25.9943em;"><span class="pdf24_12 pdf24_08 pdf24_86">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:39.4283em;top:24.9443em;"><span class="pdf24_12 pdf24_08 pdf24_54" style="word-spacing:-0.0057em;">Grado 3 o 4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9683em;top:25.9943em;"><span class="pdf24_12 pdf24_08 pdf24_86">(%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:27.0943em;"><span class="pdf24_12 pdf24_08 pdf24_33">Qumica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:28.1843em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0043em;">Aumento de la lipasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:29.2843em;"><span class="pdf24_17 pdf24_08 pdf24_32">Hiponatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:30.3743em;"><span class="pdf24_17 pdf24_08 pdf24_28">Hipernatremia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:31.4743em;"><span class="pdf24_17 pdf24_08 pdf24_11" style="word-spacing:-0.0052em;">Aumento de la amilasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:32.5743em;"><span class="pdf24_17 pdf24_08 pdf24_41">Hipopotasemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:33.666em;"><span class="pdf24_17 pdf24_08 pdf24_39">Hiperglucemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:34.766em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0025em;">Aumento de ALT &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:35.856em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0025em;">Aumento de AST &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:28.1843em;"><span class="pdf24_17 pdf24_08 pdf24_14">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:29.2843em;"><span class="pdf24_17 pdf24_08 pdf24_14">55 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:30.3743em;"><span class="pdf24_17 pdf24_08 pdf24_14">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:31.4743em;"><span class="pdf24_17 pdf24_08 pdf24_14">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:32.5743em;"><span class="pdf24_17 pdf24_08 pdf24_14">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:33.666em;"><span class="pdf24_17 pdf24_08 pdf24_14">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:34.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">64 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:35.856em;"><span class="pdf24_17 pdf24_08 pdf24_14">63 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:36.956em;"><span class="pdf24_17 pdf24_08 pdf24_14">89 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:28.1843em;"><span class="pdf24_17 pdf24_08 pdf24_14">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:29.2843em;"><span class="pdf24_17 pdf24_08 pdf24_14">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.8258em;top:30.3743em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:27.8258em;top:31.4743em;"><span class="pdf24_17 pdf24_08 pdf24_14">9</span></div>
					<div class="pdf24_01" style="left:27.8258em;top:32.5743em;"><span class="pdf24_17 pdf24_08 pdf24_14">7</span></div>
					<div class="pdf24_01" style="left:27.8258em;top:33.666em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:27.8258em;top:34.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:27.8258em;top:35.856em;"><span class="pdf24_17 pdf24_08 pdf24_14">5</span></div>
					<div class="pdf24_01" style="left:27.4858em;top:36.956em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:28.1843em;"><span class="pdf24_17 pdf24_08 pdf24_14">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:29.2843em;"><span class="pdf24_17 pdf24_08 pdf24_14">50 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:30.3743em;"><span class="pdf24_17 pdf24_08 pdf24_14">14 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:31.4743em;"><span class="pdf24_17 pdf24_08 pdf24_14">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:32.5743em;"><span class="pdf24_17 pdf24_08 pdf24_14">17 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:33.666em;"><span class="pdf24_17 pdf24_08 pdf24_14">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:34.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">56 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:35.856em;"><span class="pdf24_17 pdf24_08 pdf24_14">55 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:36.956em;"><span class="pdf24_17 pdf24_08 pdf24_14">83 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.4983em;top:28.1843em;"><span class="pdf24_17 pdf24_08 pdf24_14">5</span></div>
					<div class="pdf24_01" style="left:41.2683em;top:29.2843em;"><span class="pdf24_17 pdf24_08 pdf24_14">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.4983em;top:30.3743em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:41.4983em;top:31.4743em;"><span class="pdf24_17 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:32.5743em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:33.666em;"><span class="pdf24_17 pdf24_08 pdf24_14">3.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:34.766em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:35.856em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:36.956em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:36.956em;"><span class="pdf24_17 pdf24_08 pdf24_100" style="word-spacing:0.1807em;">Aumento de la creatinina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:38.006em;"><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:0.001em;">en sangre &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:39.106em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.3005em;">Aumento de la fosfatasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:40.156em;"><span class="pdf24_17 pdf24_08 pdf24_77">alcalina &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:41.256em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.5041em;">Aumento de la gamma &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:42.306em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0033em;">glutamil transferasa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:43.406em;"><span class="pdf24_17 pdf24_08 pdf24_28">Hiperpotasemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:39.106em;"><span class="pdf24_17 pdf24_08 pdf24_14">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:41.256em;"><span class="pdf24_17 pdf24_08 pdf24_14">38 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4858em;top:39.106em;"><span class="pdf24_17 pdf24_08 pdf24_14">3.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4858em;top:41.256em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:39.106em;"><span class="pdf24_17 pdf24_08 pdf24_14">26 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:41.256em;"><span class="pdf24_17 pdf24_08 pdf24_14">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:39.106em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:41.256em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:43.406em;"><span class="pdf24_17 pdf24_08 pdf24_14">49 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_14">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4858em;top:43.406em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4858em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_14">1.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:43.406em;"><span class="pdf24_17 pdf24_08 pdf24_14">35 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_14">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:43.406em;"><span class="pdf24_17 pdf24_08 pdf24_14">2.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_72">Disminucin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:45.556em;"><span class="pdf24_17 pdf24_08 pdf24_39">albmina &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.9378em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_14">de &nbsp;</span></div>
					<div class="pdf24_01" style="left:15.5266em;top:44.496em;"><span class="pdf24_17 pdf24_08 pdf24_124">la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:46.646em;"><span class="pdf24_17 pdf24_08 pdf24_41">Hipocalcemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:47.7485em;"><span class="pdf24_17 pdf24_08 pdf24_39">Hipomagnesemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:48.8385em;"><span class="pdf24_17 pdf24_08 pdf24_39">Bilirrubinemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:49.9385em;"><span class="pdf24_12 pdf24_08 pdf24_32">Hematologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:51.0385em;"><span class="pdf24_17 pdf24_08 pdf24_41">Neutropenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:52.1285em;"><span class="pdf24_17 pdf24_08 pdf24_33">Anemia &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:46.646em;"><span class="pdf24_17 pdf24_08 pdf24_14">58 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:47.7485em;"><span class="pdf24_17 pdf24_08 pdf24_14">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:48.8385em;"><span class="pdf24_17 pdf24_08 pdf24_14">16 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4858em;top:46.646em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.8258em;top:47.7485em;"><span class="pdf24_17 pdf24_08 pdf24_14">4</span></div>
					<div class="pdf24_01" style="left:27.4858em;top:48.8385em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:46.646em;"><span class="pdf24_17 pdf24_08 pdf24_14">49 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:47.7485em;"><span class="pdf24_17 pdf24_08 pdf24_14">23 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.6258em;top:48.8385em;"><span class="pdf24_17 pdf24_08 pdf24_14">8</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:46.646em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.4983em;top:47.7485em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:41.1583em;top:48.8385em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:51.0385em;"><span class="pdf24_17 pdf24_08 pdf24_14">71 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:52.1285em;"><span class="pdf24_17 pdf24_08 pdf24_14">84 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:53.2285em;"><span class="pdf24_17 pdf24_08 pdf24_14">77 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:54.3185em;"><span class="pdf24_17 pdf24_08 pdf24_14">67 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.3042em;top:55.4185em;"><span class="pdf24_17 pdf24_08 pdf24_14">53 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:51.0385em;"><span class="pdf24_17 pdf24_08 pdf24_14">37 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:52.1285em;"><span class="pdf24_17 pdf24_08 pdf24_14">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:53.2285em;"><span class="pdf24_17 pdf24_08 pdf24_14">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:54.3185em;"><span class="pdf24_17 pdf24_08 pdf24_14">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5958em;top:55.4185em;"><span class="pdf24_17 pdf24_08 pdf24_14">11 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:51.0385em;"><span class="pdf24_17 pdf24_08 pdf24_14">69 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:52.1285em;"><span class="pdf24_17 pdf24_08 pdf24_14">84 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:53.2285em;"><span class="pdf24_17 pdf24_08 pdf24_14">81 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:54.3185em;"><span class="pdf24_17 pdf24_08 pdf24_14">60 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.3958em;top:55.4185em;"><span class="pdf24_17 pdf24_08 pdf24_14">54 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2683em;top:51.0385em;"><span class="pdf24_17 pdf24_08 pdf24_14">32 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2683em;top:52.1285em;"><span class="pdf24_17 pdf24_08 pdf24_14">25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2683em;top:53.2285em;"><span class="pdf24_17 pdf24_08 pdf24_14">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2683em;top:54.3185em;"><span class="pdf24_17 pdf24_08 pdf24_14">19 &nbsp;</span></div>
					<div class="pdf24_01" style="left:41.2683em;top:55.4185em;"><span class="pdf24_17 pdf24_08 pdf24_14">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:53.2285em;"><span class="pdf24_17 pdf24_08 pdf24_88">Leucopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:54.3185em;"><span class="pdf24_17 pdf24_08 pdf24_32">Linfopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.472em;top:55.4185em;"><span class="pdf24_17 pdf24_08 pdf24_28">Trombocitopenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.5187em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">1 </span></sup><span class="pdf24_43 pdf24_08 pdf24_38" style="word-spacing:-0.0012em;">Calificados segn la versin 4.03 de CTCAE del NCI. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.4468em;"><span class="pdf24_62 pdf24_08 pdf24_14">2</span></div>
					<div class="pdf24_01" style="left:6.522em;top:57.4784em;"><span class="pdf24_43 pdf24_08 pdf24_121" style="word-spacing:0.0456em;">El denominador utilizado para calcular la tasa vari de 45 a 326 en funcin del nmero de pacientes con un valor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.4384em;"><span class="pdf24_43 pdf24_08 pdf24_73" style="word-spacing:0.0016em;">basal y al menos un valor postratamiento. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_17" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_125" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0088em;"><span class="pdf24_62 pdf24_08 pdf24_14">3</span></div>
					<div class="pdf24_01" style="left:6.522em;top:6.042em;"><span class="pdf24_43 pdf24_08 pdf24_126" style="word-spacing:0.0435em;">El denominador utilizado para calcular la tasa vari de 43 a 323 en funcin del nmero de pacientes con un valor &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.002em;"><span class="pdf24_43 pdf24_08 pdf24_73" style="word-spacing:0.0016em;">basal y al menos un valor postratamiento. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.0018em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0527em;">Es importante informar las sospechas de reacciones adversas despus del registro del medicamento. Esto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.0518em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.3735em;">permite una vigilancia continua del balance beneficio-riesgo del medicamento. Se solicita a los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.1218em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0023em;">profesionales de la salud que notifiquen cualquier sospecha de reaccin adversa. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.0018em;"><a href="https://contactazmedical.astrazeneca.com/content/astrazeneca-" target="_blank"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.078em;">Para Per: Reportar a travs de la website https://contactazmedical.astrazeneca.com/content/astrazeneca- &nbsp;</span></a></div>
					<div class="pdf24_01" style="left:6.002em;top:14.0518em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0003em;">champion/br/pt/amp-form.html, por correo electrnico patientsafety.peru@astrazeneca.com o por telfono &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.1118em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0015em;">al 6101515 (presione 1 y luego y luego presione 3). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.0018em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.634em;">7. USO</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0019em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_15" style="word-spacing:0.0022em;">EN POBLACIONES ESPECFICAS &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.0618em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:0.8168em;">7.1. Embarazo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.1143em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0061em;">Resumen del riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.1543em;"><span class="pdf24_17 pdf24_08 pdf24_19" style="word-spacing:-0.0309em;">Segn hallazgos de los estudios en animales y su mecanismo de accin, IMJUDO puede causar dao fetal &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.2143em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0282em;">al ser administrado a una mujer embarazada </span><span class="pdf24_26 pdf24_08 pdf24_13" style="word-spacing:-0.0263em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0348em;">Farmacologa clnica (9)</span><span class="pdf24_26 pdf24_08 pdf24_84" style="word-spacing:-0.0369em;">]. </span><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:-0.0276em;">No hay datos disponibles sobre &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.2643em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.0135em;">el uso de IMJUDO en mujeres embarazadas. En estudios con animales, el bloqueo de CTLA-4 se asocia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.3343em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0013em;">con un mayor riesgo de rechazo inmunitario del feto en desarrollo y muerte fetal (</span><span class="pdf24_26 pdf24_08 pdf24_14" style="word-spacing:-0.0001em;">ver Datos</span><span class="pdf24_17 pdf24_08 pdf24_127">). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.3743em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0503em;">Se sabe que la inmunoglobulina humana G2 (IgG2) atraviesa la barrera placentaria; por lo tanto, IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.4243em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0424em;">tiene el potencial de transmitirse de la madre al feto en desarrollo. Informar a las mujeres embarazadas y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.4943em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0006em;">mujeres con potencial reproductivo del riesgo potencial para el feto. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.5343em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0083em;">En la poblacin general de los EE. UU., el riesgo de fondo estimado de defectos congnitos importantes y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.5943em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.3204em;">aborto espontneo en embarazos reconocidos clnicamente es del 2% al 4% y del 15% al 20%, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.656em;"><span class="pdf24_17 pdf24_08 pdf24_25">respectivamente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.706em;"><span class="pdf24_17 pdf24_08 pdf24_106">Datos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.766em;"><span class="pdf24_26 pdf24_08 pdf24_13" style="word-spacing:0.0036em;">Datos en animales &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.806em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1171em;">En un estudio de reproduccin, la administracin de tremelimumab-actl a simias cynomolgus preadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.866em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1492em;">durante el periodo de organognesis no se asoci a toxicidad materna ni a efectos sobre el desarrollo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.916em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0661em;">embriofetal a niveles de exposicin aproximadamente 4 a 31 veces ms altos que los observados con un &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.976em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0639em;">rango de dosis recomendada de 75mg a 300 mg basada en el rea bajo la curva (AUC, por sus siglas en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.026em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.009em;">ingls). La CTLA-4 desempea un papel en el mantenimiento de la tolerancia inmunolgica materna hacia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.076em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0041em;">el feto para preservar las prdidas de embarazo, los pesos fetales o las anomalas esquelticas, viscerales o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.136em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0774em;">externas o los pesos de seleccionados y en la regulacin inmunolgica del recin nacido. En un modelo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1885em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.072em;">murino de embarazo, el bloqueo de CTLA-4 dio como resultado un aumento de las reabsorciones y una &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.2485em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0772em;">reduccin de los fetos vivos. Ratones genticamente modificados acoplados heterocigotos para CTLA-4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.2985em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.164em;">(CTLA-4+/-) dieron a luz a cras CTLA-4+/- y cras deficientes en CTLA-4 (homocigotos negativos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3485em;"><span class="pdf24_17 pdf24_08 pdf24_19" style="word-spacing:0.2186em;">CTLA-4-/-) que parecan saludables al nacer. La descendencia homocigota negativa para CTLA-4-/- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.4085em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0037em;">desarroll signos de un trastorno linfoproliferativo y muri a las 3 o 4 semanas de edad con destruccin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4585em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1997em;">tejido multiorgnico. Segn su mecanismo de accin, la exposicin fetal a tremelimumab-actl puede &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.5285em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0007em;">aumentar el riesgo de desarrollar trastornos inmunomediados o alterar la respuesta inmunolgica normal. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_18" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_128" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0406em;"><span class="pdf24_129 pdf24_08 pdf24_14" style="word-spacing:0.6097em;">7.2. </span><span class="pdf24_12 pdf24_08 pdf24_77">Lactancia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1718em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.006em;">Resumen del riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2218em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0209em;">No existen datos sobre la presencia de tremelimumab-actl en la leche humana, sus efectos en el lactante o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.2718em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0489em;">en la produccin de leche. La IgG materna es conocida por estar presente in la leche humana. Se desconocen &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3218em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0573em;">los efectos de la exposicin gastrointestinal local y la exposicin sistmica limitada en el nio lactante a &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.3818em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.2772em;">IMJUDO. Debido</span><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:0.0115em;">&nbsp;</span><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0135em;">a la posibilidad de reacciones adversas serias en el nio lactante, se recomienda a las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4318em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0273em;">mujeres lactantes no alimentar al seno durante el tratamiento con IMJUDO y por 3 meses despus de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.4918em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0787em;">ltima dosis. Consulte la Informacin de prescripcin de los agentes administrados en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5518em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0003em;">IMJUDO para conocer las recomendaciones de lactancia, segn corresponda. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.4418em;"><span class="pdf24_12 pdf24_08 pdf24_88" style="word-spacing:0.8156em;">7.3. Mujeres</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0002em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_18" style="word-spacing:-0.0033em;">y hombres con potencial reproductivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.4843em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1278em;">IMJUDO puede causar dao fetal al administrarse a una mujer embarazada </span><span class="pdf24_26 pdf24_08 pdf24_46" style="word-spacing:0.1307em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_92" style="word-spacing:0.1253em;">Uso en poblaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.5543em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0059em;">especficas (7.1)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_84">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.4343em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:-0.0021em;">Pruebas de embarazo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.3143em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0388em;">Verifique el estado de embarazo de las mujeres con potencial reproductivo antes de iniciar el tratamiento &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.3743em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0037em;">con IMJUDO. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.2643em;"><span class="pdf24_17 pdf24_08 pdf24_25">Anticoncepcin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.1443em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1891em;">Recomendar a las mujeres con potencial reproductivo que utilicen mtodos anticonceptivos efectivos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.1943em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.2758em;">durante el tratamiento con IMJUDO y durante 3 meses despus de la ltima dosis. Consulte la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.2543em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0042em;">Informacin de prescripcin de los agentes administrados en combinacin con IMJUDO para conocer la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.3143em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0005em;">duracin recomendada de la anticoncepcin, segn corresponda. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.206em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:0.817em;">7.4. Uso</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0011em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_21">peditrico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.246em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.1404em;">No se ha establecido la seguridad y efectividad de IMJUDO en pacientes peditricos. Se evaluaron la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.306em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0599em;">seguridad y eficacia, pero no se establecieron, en un estudio abierto multicntrico (NCT03837899) en el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.356em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0258em;">que 41 pacientes peditricos de 1 a &lt;17 aos de edad con tumores slidos avanzados recibieron IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.416em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0565em;">en combinacin con durvalumab. No se observaron nuevas seales de seguridad en pacientes peditricos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.476em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0021em;">en este estudio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.356em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0304em;">La exposicin sistmica a tremelimumab-</span><span class="pdf24_69 pdf24_08 pdf24_34" style="word-spacing:0.0311em;">actl en pacientes peditricos  35 kg estuvo dentro del rango de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.406em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0402em;">los valores observados previamente en adultos que recibieron la misma dosis basada en el peso, mientras &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.476em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0005em;">que la exposicin sistmica en pacientes peditricos &lt;35 kg fue menor que la de los adultos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.356em;"><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:0.817em;">7.5. Uso</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0011em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_41">geritrico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.4085em;"><span class="pdf24_74 pdf24_08 pdf24_34" style="word-spacing:0.1075em;">De los 393 pacientes con uHCC tratados con IMJUDO en combinacin con durvalumab, 50% de los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.4585em;"><span class="pdf24_74 pdf24_08 pdf24_18" style="word-spacing:0.1604em;">pacientes tenan 65 aos o eran mayores y 13% de los pacientes tenan 75 aos o ms. No han sido &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.5085em;"><span class="pdf24_74 pdf24_08 pdf24_24" style="word-spacing:0.0871em;">observadas diferencias en general en la seguridad o efectividad de IMJUDO entre los pacientes de 65 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.5785em;"><span class="pdf24_74 pdf24_08 pdf24_28" style="word-spacing:0.0021em;">aos o mayores y los adultos ms jvenes. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.4585em;"><span class="pdf24_74 pdf24_08 pdf24_13" style="word-spacing:0.0137em;">De los 330 pacientes con NSCLC metastsico tratados con IMJUDO en combinacin con durvalumab y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.5085em;"><span class="pdf24_74 pdf24_08 pdf24_39" style="word-spacing:0.0272em;">quimioterapia basada en platino, 143 (43 %) pacientes tenan 65 aos o ms y 35 (11 %) pacientes tenan &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.5585em;"><span class="pdf24_74 pdf24_08 pdf24_28" style="word-spacing:0.0067em;">75 aos o ms. No se observaron diferencias generales en cuanto a seguridad o eficacia entre estos sujetos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.6282em;"><span class="pdf24_74 pdf24_08 pdf24_32" style="word-spacing:-0.0007em;">y los ms jvenes. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_19" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANM0lEQVR4nO3QMQ0AMAwEsQdW4p1CLUWQIV1t6QhcAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPy5r9LYWd8FAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAZg38HTauhQa8IgAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_130" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0418em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.634em;">8. DESCRIPCIN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.0818em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1989em;">Tremelimumab-actl, un antgeno 4 asociado a los linfocitos T citotxicos (CTLA-4), que bloquea el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1418em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0234em;">anticuerpo monoclonal humano IgG2, el cual se produce por tecnologa ADN recombinante en un cultivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2018em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0012em;">de suspensin celular NS0 y tiene un peso molecular de 149 kDa. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.0818em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.027em;">IMJUDO (Tremelimumab-actl) inyectable es una solucin estril transparente a ligeramente opalescente, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.1318em;"><span class="pdf24_17 pdf24_08 pdf24_92" style="word-spacing:-0.0087em;">incolora a ligeramente amarilla en un vial de dosis nica para perfusin intravenosa despus de la dilucin. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.1918em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0046em;">IMJUDO contiene tremelimumab-actl a una concentracin de 20 mg/mL en un vial de dosis nica de 25 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.2518em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0008em;">mg/1.25 mL o de 300 mg/15 mL. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.1318em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.2141em;">Cada mL contiene 20 mg de tremelimumab-actl, y edetato disdico (0.09 mg), histidina (0.68 mg), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.1818em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0105em;">clorhidrato de L-histidina monohidrato (3.3 mg), polisorbato 80 (0.2 mg), trehalosa (76 mg*), y agua para &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.2518em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0017em;">inyeccin USP. El pH es aproximadamente 5.5. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.1343em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0035em;">*Equivalente a Trehalosa dihidrato 84 mg. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.0243em;"><span class="pdf24_12 pdf24_08 pdf24_23" style="word-spacing:0.6341em;">9. FARMACOLOGA</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0017em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_27">CLNICA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9043em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0015em;">Grupo Farmacoteraputico: Anticuerpos monoclonales y conjugados de frmacos de anticuerpos; Otros &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.9643em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0033em;">anticuerpos monoclonales y conjugados de frmacos de anticuerpos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.8543em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0062em;">Cdigo ATC: L01FX20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.7443em;"><span class="pdf24_12 pdf24_08 pdf24_72" style="word-spacing:0.8162em;">9.1. Mecanismo</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0007em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_77" style="word-spacing:-0.0096em;">de accin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.7843em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0814em;">CTLA-4 es un regulador negativo de la actividad de las clulas T. Tremelimumab-actl es un anticuerpo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.8443em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0559em;">monoclonal que se une a CTLA-4 y bloquea la interaccin con sus ligandos CD80 y CD86, liberando la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.896em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0296em;">inhibicin de la activacin de clulas T mediada por CTLA-4. En modelos tumorales de ratn sinrgicos, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.946em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0456em;">el bloqueo de la actividad de CTLA-4 dio como resultado una disminucin del crecimiento tumoral y un &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.016em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:-0.0026em;">aumento de la proliferacin de clulas T en los tumores. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.906em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:0.8173em;">9.2. Farmacodinmica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.946em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0197em;">La relacin exposicin-respuesta y el curso temporal de la respuesta farmacodinmica para la seguridad y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.006em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0em;">eficacia de tremelimumab-actl no se han caracterizado por completo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.896em;"><span class="pdf24_12 pdf24_08 pdf24_16" style="word-spacing:0.8164em;">9.3. Farmacocintica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.946em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0895em;">La farmacocintica de tremelimumab-actl se estudi en pacientes con otros tumores slidos luego de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.996em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0632em;">administracin de dosis de 1 mg/kg, 3 mg/kg y 10 mg/kg (1 a 10 veces la dosis recomendada aprobada) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.046em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0031em;">administrada una vez cada 4 semanas. para 4 dosis. Se evalu la farmacocintica de tremelimumab-actl en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1185em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0017em;">dosis nica de 300 mg en pacientes con HCC. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.9985em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0133em;">El AUC de tremelimumab-actl aument proporcionalmente de 1 mg/kg a 10 mg/kg cada 4 semanas (1 a 10 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.0485em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1776em;">veces la dosis recomendada aprobada) y el estado estacionario se alcanz aproximadamente a las 12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.0985em;"><span class="pdf24_17 pdf24_08 pdf24_18">semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.2085em;"><span class="pdf24_17 pdf24_08 pdf24_32">Distribucin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.3185em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.1908em;">La media geomtrica (% coeficiente de variacin [CV%]) de tremelimumab-actl para el volumen de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.3682em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0009em;">distribucin central (V1) y perifrico (V2) fue de 3.45 (24%) y 2.66 (34%) L, respectivamente. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_20" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANPUlEQVR4nO3QsREAEBAAwS9MU9qRqEOkNUYsQWh35hq4CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAALhSZlXb8sNXAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA4Fdt1qWDUgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAwDIAGAWV7+bkVFUAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_131" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_39">Eliminacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0204em;">La semivida terminal media geomtrica (CV%) de tremelimumab-actl fue de 16.9 das (19 %) despus de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0511em;">una dosis nica y de 18.2 das (19 %) durante el estado de equilibrio. El aclaramiento medio geomtrico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.008em;">(CV%) de tremelimumab-actl fue de 0.286 l/da (32 %) despus de una dosis nica y de 0.263 l/da (32 %) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0008em;">durante el estado de equilibrio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0065em;">Poblaciones Especficas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0047em;">No hubo diferencias clnicamente significativas en la farmacocintica de tremelimumab-actl segn el peso &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0447em;">corporal (34 a 149 kg), la edad (18 a 87 aos), el sexo, la raza (blanco, negro, asitico, nativo de Hawi, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1609em;">isleo del Pacfico o indio americano), niveles de albmina srica (0.3 a 396 g/L), niveles de lactato &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.2308em;">deshidrogenasa (12 a 5570 U/L), PD-L1 soluble (67 a 349 pg/mL), tipo de tumor (NSCLC, HCC) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0131em;">disfuncin orgnica incluyendo insuficiencia renal leve a moderada (CLcr 30 a 89 mL/min) e insuficiencia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0007em;">heptica de leve a moderada (bilirrubina &lt; 3 x ULN y cualquier AST). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.0119em;">Se desconoce el efecto de la insuficiencia renal grave (CLcr de 15 a 29 mL/min) o la insuficiencia heptica &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0028em;">grave (bilirrubina &gt; 3 x LSN y cualquier AST) sobre la farmacocintica de tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0743em;"><span class="pdf24_12 pdf24_08 pdf24_72" style="word-spacing:0.8162em;">9.4. Inmunogenicidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1143em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.155em;">La incidencia observada de anticuerpos antifrmaco (ADA, por sus siglas en ingls) depende en gran &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.1743em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:0.0004em;">medida de la sensibilidad y la especificidad del ensayo. Las diferencias en los mtodos de ensayo impiden &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2243em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.154em;">comparaciones significativas de la incidencia de ADA en los estudios descritos a continuacin con la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.2743em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0002em;">incidencia de ADA en otros estudios, incluidos los de tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.3843em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0367em;">En el estudio HIMALAYA, de los 182 pacientes que fueron tratados con una dosis nica de tremelimumab- &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.446em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0243em;">actl en combinacin con durvalumab una vez cada 4 semanas de terapia y evaluables para la presencia de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.496em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:-0.0299em;">ADA frente a tremelimumab-actl en la semana 0 y semana 4 predosis, 11 % (20/182) de pacientes positivos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.546em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0769em;">para anticuerpos anti-tremelimumab-actl. Entre los 20 pacientes que dieron positivo para ADA, el 40 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.606em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0605em;">(8/20) dio positivo para anticuerpos neutralizantes contra tremelimumab-actl. No se identific ningn efecto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.656em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.3253em;">clnicamente significativo de los anticuerpos anti-tremelimumab-actl sobre la farmacocintica o la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.716em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.1926em;">seguridad de tremelimumab-actl; sin embargo, se desconoce el efecto de los ADA y los anticuerpos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.766em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.001em;">neutralizantes sobre la eficacia de tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.876em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0339em;">En el estudio POSEIDON, de los 278 pacientes con ADA evaluables que fueron tratados con IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.926em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0339em;">75 mg durante un mximo de cinco dosis en combinacin con durvalumab 1500 mg y quimioterapia basada &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.986em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0101em;">en platino cada 3 semanas y evaluados para detectar la presencia de ADA frente a tremelimumab-actl en la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:46.036em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0216em;">semana 0, la semana 3 y la semana 12 antes de la dosis, el 14 % (38/278) de los pacientes dieron positivo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.086em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0992em;">para anticuerpos antitremelimumab-actl. Entre los 38 pacientes que dieron positivo para ADA, el 82 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1485em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1314em;">(31/38) dio positivo para anticuerpos neutralizantes contra tremelimumab-actl. No se identific ningn &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.1985em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.1915em;">efecto clnicamente significativo de los anticuerpos antitremelimumab-actl en la farmacocintica o la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.2585em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.1164em;">seguridad de tremelimumab-actl; sin embargo, se desconoce el efecto de los ADA sobre la eficacia de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3085em;"><span class="pdf24_17 pdf24_08 pdf24_41">tremelimumab-actl. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.4285em;"><span class="pdf24_12 pdf24_08 pdf24_40" style="word-spacing:0.0504em;">10. TOXICOLOGA NO CLNICA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.4685em;"><span class="pdf24_12 pdf24_08 pdf24_72" style="word-spacing:0.3162em;">10.1. Carcinognesis,</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0083em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_25" style="word-spacing:0.0008em;">Mutagnesis, alteracin de la fertilidad &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.5782em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0019em;">No se ha evaluado el potencial carcinognico y genotxico de tremelimumab-actl. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_21" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANN0lEQVR4nO3DQQkAIAwAwCWwguawmg+rO0yxwR1cBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADQ1MlX1dJ3AADfzEvV0kcAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA0NUD63nhuRWAqi0AAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_132" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0038em;">No se han realizado estudios de fertilidad con tremelimumab-actl en animales. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1518em;"><span class="pdf24_12 pdf24_08 pdf24_28" style="word-spacing:0.0684em;">11. ESTUDIOS CLNICOS &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.1918em;"><span class="pdf24_12 pdf24_08 pdf24_72" style="word-spacing:0.3163em;">11.1. Carcinoma</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.0007em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:-0.0074em;">hepatocelular metastsico (HCC) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3018em;"><span class="pdf24_26 pdf24_08 pdf24_34" style="word-spacing:0.0045em;">Carcinoma hepatocelular no resecable (uHCC) - HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4119em;"><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.2972em;">La eficacia de IMJUDO en combinacin con durvalumab se evalu en el estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.4618em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.3482em;">(NCT03298451), un estudio aleatorizado (1:1:1), abierto y multicntrico en pacientes con uHCC &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5218em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.316em;">confirmado que no haban recibido tratamiento sistmico previo para HCC. Los pacientes fueron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.5718em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1478em;">aleatorizados a uno de los dos brazos de investigacin (IMJUDO ms durvalumab o durvalumab) o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6218em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:-0.0084em;">sorafenib. El tratamiento del estudio consisti en IMJUDO como una perfusin intravenosa nica de 300 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.6843em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.1443em;">mg en combinacin con durvalumab 1500 mg el mismo da, seguido de durvalumab cada 4 semanas; &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7343em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0405em;">durvalumab 1500 mg cada 4 semanas; o sorafenib 400 mg por va oral dos veces al da, hasta progresin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7943em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0143em;">de la enfermedad o toxicidad inaceptable. La evaluacin de la eficacia de IMJUDO se basa en pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8443em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0913em;">aleatorizados al brazo de IMJUDO ms durvalumab frente al brazo de sorafenib. La aleatorizacin se &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9043em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.088em;">estratific por invasin macrovascular (IMV) (s o no), etiologa de la enfermedad heptica (virus de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9543em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.001em;">hepatitis B frente a virus de la hepatitis C frente a otros) y estado funcional ECOG (0 frente a 1). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0643em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0955em;">El estudio incluy a pacientes con estadio C o B del BCLC (no elegibles para terapia locorregional).El &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1143em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.3814em;">estudio excluy a los pacientes con coinfeccin de hepatitis viral B y hepatitis C, hemorragia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.1743em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.1962em;">gastrointestinal (GI) activa o previamente documentada en los ltimos 12 meses, ascitis que hubiera &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2243em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0291em;">requerido intervencin no farmacolgica en los ltimos 6 meses, encefalopata heptica en los ltimos 12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.2743em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1243em;">meses antes del inicio del tratamiento, y trastornos autoinmunes o inflamatorios activos o previamente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.3343em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0044em;">documentados. La esofagogastroduodenoscopia no era obligatoria antes de la inscripcin, pero se requera &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.3843em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.1074em;">una terapia endoscpica adecuada, de acuerdo con los estndares institucionales, fue requerida para los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.446em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0023em;">pacientes con antecedentes de hemorragia por vrices esofgicas o aquellos evaluados como de alto riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.496em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0046em;">de hemorragia por vrices esofgicas por el mdico tratante. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.606em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.1114em;">Se permiti el tratamiento del estudio ms all de la progresin de la enfermedad si el paciente estaba &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.656em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.0018em;">clnicamente estable y obtena un beneficio clnico segn lo determinado por el investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.766em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:-0.0014em;">La principal medida de resultado de eficacia fue la supervivencia global (SG) entre el brazo de IMJUDO &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.816em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0363em;">ms durvalumab frente al brazo de sorafenib. Los resultados de eficacia adicionales fueron la supervivencia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.876em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0474em;">libre de progresin (PFS) evaluada por el investigador, la tasa de respuesta objetiva (ORR) y la duracin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.926em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0569em;">de la respuesta (DoR) segn RECIST v1.1. Las evaluaciones del tumor se realizaron cada 8 semanas durante &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.986em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0012em;">los primeros 12 meses y luego cada 12 semanas a partir de entonces. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.086em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.1484em;">Los datos demogrficos iniciales de los brazos de IMJUDO ms durvalumab y sorafenib fueron los &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.1485em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0645em;">siguientes: hombres (85 %), edad &lt; 65 aos (50 %), mediana de edad de 65 aos (rango: 18 a 88 aos), &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.1985em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0319em;">blancos (46 %), Asitico (49 %), negro o afroamericano (2 %), nativo de Hawi u otras islas del Pacfico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.2585em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0133em;">(0.1 %), raza desconocida (2 %), hispano o latino (5 %), no hispano o latino (94 %), etnicidad desconocida &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.3085em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0343em;">(1%), ECOG PS 0 (62 %); Child-Pugh Class score A (99 %), invasin macrovascular (26 %), diseminacin &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.3685em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0017em;">extraheptica (53 %), hepatitis B de etiologa viral (31 %), hepatitis C (27 %), no infectada (42 %). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.4685em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0009em;">Los resultados de eficacia se presentan en la Tabla 9 y la Figura 1. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_22" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_133" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_12 pdf24_08 pdf24_46" style="word-spacing:0.0023em;">Tabla 9. Resultados de la eficacia del estudio HIMALAYA &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.102em;top:7.1318em;"><span class="pdf24_12 pdf24_08 pdf24_77" style="word-spacing:0.0013em;">Punto final &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.3842em;top:7.1318em;"><span class="pdf24_12 pdf24_08 pdf24_19" style="word-spacing:0.0063em;">IMJUDO y &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.9342em;top:8.1818em;"><span class="pdf24_12 pdf24_08 pdf24_18">durvalumab(N=393) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9558em;top:7.1318em;"><span class="pdf24_12 pdf24_08 pdf24_66">Sorafenib &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2758em;top:8.1818em;"><span class="pdf24_12 pdf24_08 pdf24_21">(N=389) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.102em;top:9.2818em;"><span class="pdf24_12 pdf24_08 pdf24_134">OS &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.252em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0017em;">Nmero de muertes (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.0242em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.002em;">262 (66.7) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.1342em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_14">16.4 &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.8742em;top:12.5218em;"><span class="pdf24_17 pdf24_08 pdf24_18">(14.2-19.6) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9558em;top:10.3718em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.002em;">293 (75.3) &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.0658em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_14">13.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.8058em;top:12.5218em;"><span class="pdf24_17 pdf24_08 pdf24_18">(12.3-16.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.102em;top:11.4718em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0032em;">Promedio de OS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.102em;top:12.5218em;"><span class="pdf24_17 pdf24_08 pdf24_67" style="word-spacing:-0.0036em;">(IC 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.102em;top:13.6218em;"><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:-0.004em;">HR (IC 95%)</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_14" style="word-spacing:-0.0063em;">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.0958em;top:13.6218em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.003em;">0.78 (0.66, 0.92) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.102em;top:14.7118em;"><span class="pdf24_17 pdf24_08 pdf24_10" style="word-spacing:-0.0053em;">Valor de p</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_29">2,3 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:29.8858em;top:14.7118em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.0035 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.102em;top:15.8118em;"><span class="pdf24_12 pdf24_08 pdf24_34">PFS &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.252em;top:16.9018em;"><span class="pdf24_17 pdf24_08 pdf24_92" style="word-spacing:0.0048em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.252em;top:18.0018em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0012em;">Promedio de PFS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.0242em;top:16.9018em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.002em;">335 (85.2) &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.3642em;top:18.0018em;"><span class="pdf24_17 pdf24_08 pdf24_14">3.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.9558em;top:16.9018em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.002em;">327 (84.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.2858em;top:18.0018em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.102em;top:19.0518em;"><span class="pdf24_17 pdf24_08 pdf24_67" style="word-spacing:-0.0036em;">(IC 95%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.3342em;top:19.0518em;"><span class="pdf24_17 pdf24_08 pdf24_88">(3.7-5.3) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2558em;top:19.0518em;"><span class="pdf24_17 pdf24_08 pdf24_88">(3.7-5.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.252em;top:20.1543em;"><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:-0.004em;">HR (IC 95%)</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_14" style="word-spacing:-0.0063em;">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:28.1658em;top:20.1543em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0021em;">0.90 (0.77-1.05) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.102em;top:21.2543em;"><span class="pdf24_12 pdf24_08 pdf24_66">ORR &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.062em;top:22.3443em;"><span class="pdf24_17 pdf24_08 pdf24_100" style="word-spacing:0.0059em;">ORR % (95% CI)</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_29">4,5 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:8.062em;top:23.4443em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0044em;">Respuesta completa n (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.062em;top:24.5343em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0032em;">Respuesta parcial n (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.9542em;top:22.3443em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0019em;">20.1 (16.3-24.4) &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.4842em;top:23.4443em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0028em;">12 (3.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.2658em;top:22.3443em;"><span class="pdf24_17 pdf24_08 pdf24_58" style="word-spacing:-0.007em;">5.1 (3.2 </span><span class="pdf24_69 pdf24_08 pdf24_14" style="word-spacing:0em;"> </span><span class="pdf24_17 pdf24_08 pdf24_15">7.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.6358em;top:23.4443em;"><span class="pdf24_17 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:23.2542em;top:24.5343em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0023em;">67 (17.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.4158em;top:24.5343em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0028em;">20 (5.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.102em;top:25.6343em;"><span class="pdf24_12 pdf24_08 pdf24_100">DoR &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.062em;top:26.7243em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.004em;">Promedio de DoR (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.062em;top:27.7843em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0038em;">(95% CI) &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.8942em;top:26.7243em;"><span class="pdf24_17 pdf24_08 pdf24_13" style="word-spacing:0.0039em;">22.3 (13.17-NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:33.1158em;top:26.7243em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0019em;">18.4 (6.5-26.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.062em;top:28.8743em;"><span class="pdf24_69 pdf24_08 pdf24_32" style="word-spacing:-0.0002em;">% con duracin  </span><span class="pdf24_17 pdf24_08 pdf24_79" style="word-spacing:0.0058em;">6 meses &nbsp;</span></div>
					<div class="pdf24_01" style="left:8.062em;top:29.9743em;"><span class="pdf24_69 pdf24_08 pdf24_32" style="word-spacing:-0.0002em;">% con duracin  </span><span class="pdf24_17 pdf24_08 pdf24_66" style="word-spacing:-0.0099em;">12 meses &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.1342em;top:28.8743em;"><span class="pdf24_17 pdf24_08 pdf24_14">82.3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:24.1342em;top:29.9743em;"><span class="pdf24_17 pdf24_08 pdf24_14">65.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.0658em;top:28.8743em;"><span class="pdf24_17 pdf24_08 pdf24_14">78.9 &nbsp;</span></div>
					<div class="pdf24_01" style="left:35.0658em;top:29.9743em;"><span class="pdf24_17 pdf24_08 pdf24_14">63.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.043em;"><span class="pdf24_62 pdf24_08 pdf24_14">1</span></div>
					<div class="pdf24_01" style="left:6.542em;top:31.0745em;"><span class="pdf24_43 pdf24_08 pdf24_73" style="word-spacing:0.0675em;">HR (IMJUDO y durvalumab frente a sorafenib) basado en el modelo estratificado de riesgos proporcionales de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.0345em;"><span class="pdf24_43 pdf24_08 pdf24_85">Cox. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.9945em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.0093em;">2 </span></sup><span class="pdf24_43 pdf24_08 pdf24_73" style="word-spacing:0.0006em;">Basado en una prueba de rango logartmico estratificada. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.9562em;"><sup style="top: -0.2917em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1204em;">3 </span></sup><span class="pdf24_43 pdf24_08 pdf24_38" style="word-spacing:-0.0094em;">Basado en una funcin de gasto alfa de Lan-DeMets con lmite de tipo O'Brien Fleming y el nmero real de eventos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:34.9162em;"><span class="pdf24_43 pdf24_08 pdf24_49" style="word-spacing:0.133em;">observados, el lmite para declarar significacin estadstica para IMJUDO y durvalumab frente a sorafenib fue &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.8662em;"><span class="pdf24_43 pdf24_08 pdf24_38" style="word-spacing:0.0025em;">0.0398 (Lan y DeMets 1983). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:36.8262em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">4 </span></sup><span class="pdf24_43 pdf24_08 pdf24_44" style="word-spacing:0.0004em;">Respuesta completa confirmada o respuesta parcial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.7862em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1389em;">5 </span></sup><span class="pdf24_43 pdf24_08 pdf24_84" style="word-spacing:-0.0004em;">Basado en el mtodo de Clopper-Pearson. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.7462em;"><span class="pdf24_43 pdf24_08 pdf24_44" style="word-spacing:0.0012em;">IC=Intervalo de Confianza, HR=Razn de Riesgo, NR=No Alcanzado &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.746em;"><span class="pdf24_12 pdf24_08 pdf24_32" style="word-spacing:0.0002em;">Figura 1. Curva de Kaplan-Meier de la OS &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.1542em;top:56.5813em;"><span class="pdf24_135 pdf24_08 pdf24_15" style="word-spacing:0.0024em;">Tiempo desde la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.632em;top:57.4025em;"><span class="pdf24_136 pdf24_08 pdf24_32" style="word-spacing:0.0085em;">IMJUDO + Durvalumab &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.632em;top:58.0624em;"><span class="pdf24_136 pdf24_08 pdf24_108">Sorafenib &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_23" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAQz0lEQVR4nO3ZMYplVRSF4Rda1TUEA2dhJo5BMBN6RI7B2NzArIMCjVqH0FBV81ge2JmhnMNdr/w+WEM4l/1zbzcAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPif+m7tezMzM7t9ewOg3k9rH83MzOz2ww0AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA/rskLwEA4KSnq28+eDciYAAAThMwsEsEDADAaQIGdomAAQA4TcDALhEwAACnCRjYJQIGAOA0AQO7RMAAAJwmYGCXCBgAgNMEDOwSAQMAcJqAgV0iYAAAThMwsEsEDADAaQIGdomAAQA4TcDALhEwAACnCRjYJQIGAOA0AQO7RMAAAJwmYGCXCBgAgNMEDOyyHtQfa1/ueK9mZmZm5ftw9c0HlFgfhLcAAHR7vPpmAkpEwAAA/QQMMCJgAIB+AgYYETAAQD8BA4wIGACgn4ABRgQMANBPwAAjAgYA6CdggBEBAwD0EzDAiIABAPoJGGBEwAAA/QQMMCJgAIB+AgYYETAAQD8BA4wIGACgn4ABRgQMANBPwAAjAgYA6CdggBEBAwD0EzDAWB+Ez2uvZmZmZsV7uPpmAkrEHxgAoJ8/MMCIgAEA+gkYYETAAAD9BAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2CAEQEDAPQTMMCIgAEA+gkYYETAAAD9BAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2Bgl/Wgflz7eMf7fe3ZzMzMrHgCBnZZD+olAACc9HT1zQfvRgQMAMBpAgZ2iYABADhNwMAuETAAAKcJGNglAgYA4DQBA7tEwAAAnCZgYJcIGACA0wQM7BIBAwBwmoCBXSJgAABOEzCwSwQMAMBpAgZ2iYABADhNwMAuETAAAKcJGNglAgYA4DQBA7tEwAAAnCZgYJcIGACA0wQM7BIBAwBwmoCBXdaD+nntlzvep7VnMzMzs+I9Xn3zASXWB+EtAADdBAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2CAEQEDAPQTMMCIgAEA+gkYYETAAAD9BAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2CAEQEDAPQTMMCIgAEA+gkYYKwPwm9rz2ZmZmbFe7j6ZgJKxB8YAKCfPzDAiIABAPoJGGBEwAAA/QQMMCJgAIB+AgYYETAAQD8BA4wIGACgn4ABRgQMANBPwAAjAgYA6CdggBEBAwD0EzDAiIABAPoJGGBEwAAA/QQMMCJgAIB+AgYYETAAQD8BA4wIGACgn4ABRgQMANBPwAAjAgYA6CdgYJf1oH5d+3TH+7z2t5mZmVnxPlx988G7sR7USwAAOOnp6psP3o0IGACA0wQM7BIBAwBwmoCBXSJgAABOEzCwSwQMAMBpAgZ2iYABADhNwMAuETAAAKcJGNglAgYA4DQBA7tEwAAAnCZgYJcIGACA0wQM7BIBAwBwmoCBXSJgAABOEzCwSwQMAMBpAgZ2iYABADhNwMAuETAAAKcJGNglAgYA4DQBA7usB/X12jd3vL/WXs3MzMyK93D1zQeUWB+EtwAAdHu8+mYCSkTAAAD9BAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2CAEQEDAPQTMMCIgAEA+gkYYETAAAD9BAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2CAEQEDAPQTMMCIgAEA+gkYYETAAAD9BAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2CAEQEDAPQTMMCIgAEA+gkYYETAAAD9BAwwImAAgH4CBhgRMABAPwEDjAgYAKCfgAFGBAwA0E/AACMCBgDoJ2CAEQEDAPQTMMBYH4Q/176YmZmZFe+rq28mAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPiXfwCtYr5J0tWFtwAAAABJRU5ErkJgggAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA" alt="" class="pdf24_137" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.3187em;">11.2. NSCLC</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:-0.0032em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_11">metastsico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:9.1918em;"><span class="pdf24_26 pdf24_08 pdf24_13" style="word-spacing:0.003em;">Cncer de pulmn de clulas no pequeas NSCLC metastsico - POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:-0.0072em;">La eficacia de IMJUDO en combinacin con durvalumab y quimioterapia basada en platino en pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.1172em;">con NSCLC metastsico no tratados previamente sin mutacin sensibilizante del receptor del factor de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0149em;">crecimiento epidrmico (EGFR) ni aberraciones tumorales genmicas de la quinasa del linfoma anaplsico &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:-0.0526em;">(ALK) se investig en POSEIDON, un ensayo aleatorizado, multicntrico, controlado activamente y abierto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.186em;">(NCT03164616). Los pacientes elegibles tenan un estado de rendimiento de 0 o 1 segn el Eastern &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5718em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.1291em;">Cooperative Oncology Group (ECOG) y no deban haber recibido quimioterapia previa ni ningn otro &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0237em;">tratamiento sistmico para el NSCLC metastsico. La eleccin de la quimioterapia basada en platino qued &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1455em;">a discrecin del investigador, teniendo en cuenta el clculo de la depuracin de creatinina. No fueron &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.035em;">elegibles los pacientes con metstasis cerebrales activas y/o no tratadas; antecedentes de inmunodeficiencia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.278em;">primaria activa; trastornos autoinmunes, incluidos trastornos autoinmunes o inflamatorios activos o &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0506em;">previamente documentados; uso de inmunosupresores sistmicos en los 14 das anteriores a la primera dosis &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.002em;">del tratamiento, excepto dosis fisiolgicas de corticosteroides sistmicos. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.0043em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0063em;">La aleatorizacin se estratific por expresin de PD-</span><span class="pdf24_69 pdf24_08 pdf24_19" style="word-spacing:-0.0048em;">L1 en clulas tumorales (TC) (TC  50 % vs. TC </span><span class="pdf24_17 pdf24_08 pdf24_14" style="word-spacing:-0.01em;">&lt; 50 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0643em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.001em;">%), estadio de la enfermedad (estadio IVA vs. estadio IVB) e histologa (no escamosa vs. escamosa). &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1743em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.2245em;">Los pacientes fueron aleatorizados 1:1:1 para recibir IMJUDO en combinacin con durvalumab y &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2243em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0502em;">quimioterapia basada en platino segn los regmenes indicados a continuacin, durvalumab y quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.2743em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0405em;">basada en platino (un rgimen no aprobado para el NSCLC metastsico), o quimioterapia basada en platino. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:31.3443em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0021em;">La evaluacin de la eficacia para el NSCLC metastsico se bas en la comparacin entre: &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:33.2097em;"><span class="pdf24_138 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:9.0017em;top:33.2243em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0405em;">IMJUDO 75 mg (o 1 mg/kg para pacientes &lt; 30 kg) con durvalumab 1500 mg y quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:34.276em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0517em;">basada en platino cada 3 semanas durante 4 ciclos, seguido de durvalumab 1500 mg cada 4 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:35.326em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0228em;">como agente nico. Se administr una quinta dosis de IMJUDO 75 mg (o 1 mg/kg para pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:36.396em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0em;">&lt; 30 kg) en la Semana 16 en combinacin con la dosis 6 de durvalumab. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:38.2514em;"><span class="pdf24_138 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:9.0017em;top:38.266em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0315em;">Quimioterapia basada en platino cada 3 semanas como monoterapia durante 4 ciclos. Los pacientes &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:39.326em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.2026em;">podan recibir 2 ciclos adicionales (un total de 6 ciclos despus de la aleatorizacin), segn &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:40.376em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:-0.006em;">indicacin clnica, a criterio del investigador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.486em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0192em;">Los pacientes recibieron IMJUDO y durvalumab en combinacin con uno de los siguientes regmenes de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:43.546em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0002em;">quimioterapia basados en platino: &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:44.5814em;"><span class="pdf24_139 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:47.7439em;"><span class="pdf24_139 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:50.9039em;"><span class="pdf24_139 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:9.0017em;top:44.596em;"><span class="pdf24_140 pdf24_08 pdf24_24" style="word-spacing:0.0005em;">NSCLC no escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:45.6314em;"><span class="pdf24_139 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:12.0017em;top:45.646em;"><span class="pdf24_140 pdf24_08 pdf24_88" style="word-spacing:0.0108em;">Pemetrexed 500 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_141 pdf24_08 pdf24_14" style="word-spacing:0.181em;">2 </span></sup><span class="pdf24_140 pdf24_08 pdf24_21" style="word-spacing:0.0144em;">con carboplatino AUC 5-6 o cisplatino 75 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_141 pdf24_08 pdf24_14" style="word-spacing:0.1638em;">2 </span></sup><span class="pdf24_140 pdf24_08 pdf24_33" style="word-spacing:0.0134em;">cada 3 semanas &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.0017em;top:46.706em;"><span class="pdf24_140 pdf24_08 pdf24_33" style="word-spacing:-0.0022em;">durante 4 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:47.7585em;"><span class="pdf24_140 pdf24_08 pdf24_33" style="word-spacing:-0.0038em;">NSCLC escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:48.8039em;"><span class="pdf24_139 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:12.0017em;top:48.8185em;"><span class="pdf24_140 pdf24_08 pdf24_32" style="word-spacing:0.0835em;">Gemcitabina 1000 o 1250 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_141 pdf24_08 pdf24_14" style="word-spacing:0.2672em;">2 </span></sup><span class="pdf24_140 pdf24_08 pdf24_77" style="word-spacing:0.0782em;">los das 1 y 8 con cisplatino 75 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_141 pdf24_08 pdf24_14" style="word-spacing:0.2845em;">2 </span></sup><span class="pdf24_140 pdf24_08 pdf24_20" style="word-spacing:0.079em;">o carboplatino &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.0017em;top:49.8685em;"><span class="pdf24_140 pdf24_08 pdf24_24" style="word-spacing:0.0017em;">AUC 5-6 el da 1 cada 3 semanas durante 4 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.0017em;top:50.9185em;"><span class="pdf24_140 pdf24_08 pdf24_34" style="word-spacing:0.0028em;">NSCLC no escamoso y escamoso &nbsp;</span></div>
					<div class="pdf24_01" style="left:10.5017em;top:51.9639em;"><span class="pdf24_139 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:12.0017em;top:51.9785em;"><span class="pdf24_140 pdf24_08 pdf24_72" style="word-spacing:0.0575em;">Nab-paclitaxel 100 mg/m</span><sup style="top: -0.33em;"><span class="pdf24_141 pdf24_08 pdf24_14" style="word-spacing:0.2328em;">2 </span></sup><span class="pdf24_140 pdf24_08 pdf24_21" style="word-spacing:0.0605em;">los Das 1, 8 y 15 con carboplatino AUC 5-6 el Da 1 cada 3 &nbsp;</span></div>
					<div class="pdf24_01" style="left:12.0017em;top:53.0285em;"><span class="pdf24_140 pdf24_08 pdf24_32" style="word-spacing:-0.0006em;">semanas durante 4 ciclos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.1385em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0323em;">IMJUDO se administr hasta un mximo de 5 dosis. Durvalumab y pemetrexed basado en la histologa &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:56.1885em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:0.0447em;">continuaron cada 4 semanas hasta la progresin de la enfermedad o toxicidad inaceptable. Se permiti la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:57.2482em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0717em;">administracin de durvalumab en monoterapia ms all de la progresin de la enfermedad si el paciente &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:58.2982em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0942em;">estaba clnicamente estable y obtena un beneficio clnico segn determinado por el investigador. A los &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_24" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAZy0lEQVR4nO3aMcqd5xGG4bOCbMGqtQZZpMg6YgxZQHagfaQJRk1UOgTZyI6Vwo0xBIQELn6DihQhVdIY0iWfcDH9Gcjzhue6YPq3OTPcnO92AwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD+R/59zXtjTNW8veavB7zDmBPmhwPeYPrmb9f85gbc5cOP6JExpmoeX/PmgHcYc8I8HPAG0zefX/OrG3CXn9IPAP7nfnHN39OPgEO4gyT86Zpfph8B/68sbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBha+ueYTY0zVfHrNlwe8w5gT5vUBbzB989k1T27AXT4EzO+NMVXzu2teHfAOY06YvxzwBtM3f7gJGLibv86hj0/IYLiDJPiEDBYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIGFV9c8M8bUzcsD3mDMCfPVAW8wffP8mic34C4CxpjOETDG/DwCxiRGwMCCv86hj0/IYLiDJPiEDBYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIGFV9c8M8bUzcsD3mDMCfPVAW8wffP8mic34C4CxpjOETDG/DwCxiRGwMCCv86hj0/IYLiDJPiEDBYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFr675rUxpmq+uObbA95hzAnz/QFvMH3z+TUf34C7PFzzyBhTNY+veXPAO4w5YT464A2mb15c8/QG3MVf59DHJ2QAWT4hgwUBA30EDECWgIEFAQN9BAxAloCBBQEDfQQMQJaAgQUBA30EDECWgIEFAQN9BAxAloCBBQEDfQQMQJaAgQUBA30EDECWgIEFAQN9BAxAloCBBQEDfQQMQJaAgQUBA30EDECWgIEFAQN9BAxAloCBBQEDfQQMQJaAgQUBA30EDECWgIEFAQN9BAxAloCBBQEDfQQMQJaAgYWHa94bY6rm7TXvDniHMca0zp+veXoD7uIfGOjjHxiALP/AwIKAgT4CBiBLwMCCgIE+AgYgS8DAgoCBPgIGIEvAwIKAgT4CBiBLwMCCgIE+AgYgS8DAgoCBPgIGIEvAwIKAgT4CBiBLwMCCgIE+AgYgS8DAgoCBPgIGIEvAwIKAgT4CBiBLwMCCgIE+AgYgS8DAgoCBPgIGIEvAwIKAgT4CBiBLwMCCgIE+AgYgS8DAgoCBPgIGIEvAwMLDNY+MMVXz+Jo3B7zDmBPmowPeYPrmxTVPb8BdPgTMe2NM1by95t0B7zDmhPnxgDeYvvn6JmDgbj4hgz4+IYPhDpLgEzJYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFh6ueWSMqZrH17w54B3GnDDuoEnMi2ue3oC7fHfNa2NM1XxxzbcHvMOYE+b7A95g+ubzaz6+AXfx1zn08QkZDHeQBJ+QwYLFDX0EDAx3kAQBAwsWN/QRMDDcQRIEDCxY3NBHwMBwB0kQMLBgcUMfAQPDHSRBwMCCxQ19BAwMd5AEAQMLFjf0ETAw3EESBAwsWNzQR8DAcAdJEDCwYHFDHwEDwx0kQcDAgsUNfQQMDHeQBAEDCxY39BEwMNxBEgQMLFjc0EfAwHAHSRAwsGBxQx8BA8MdJEHAwILFDX0EDAx3kAQBAwsWN/QRMDDcQRIEDCxY3NBHwMBwB0kQMLDwzTWfGGOq5tNrvjzgHcacMK8PeIPpm8+ueXID7vLqmmfGmLp5ecAbjDlhvjrgDaZvnt8EDNzNX+fQxydkMNxBEnxCBgsWN/QRMDDcQRIEDCxY3NBHwMBwB0kQMLBgcUMfAQPDHSRBwMCCxQ19BAwMd5AEAQMLFjf0ETAw3EESBAwsWNzQR8DAcAdJEDCwYHFDHwEDwx0kQcDAgsUNfQQMDHeQBAEDCxY39BEwMNxBEgQMLFjc0EfAwHAHSRAwsGBxQx8BA8MdJEHAwILFDX0EDAx3kAQBAwsWN/QRMDDcQRIEDCxY3NBHwMBwB0kQMLBgcUMfAQPDHSRBwMCCxQ19BAwMd5AEAQMLFjf0ETAw3EESBAwsWNzQR8DAcAdJEDCwYHFDHwEDwx0kQcDAgsUNfQQMDHeQBAEDCxY39BEwMNxBEgQMLFjc0EfAwHAHSRAwsGBxQx8BA8MdJEHAwILFDX0EDAx3kAQBAwsWN/QRMDDcQRIEDCxY3NBHwMBwB0kQMLBgcUMfAQPDHSRBwMCCxQ19BAwMd5AEAQMLFjf0ETAw3EESBAwsWNzQR8DAcAdJEDCwYHFDHwEDwx0kQcDAgsUNfQQMDHeQBAEDC6+ueWaMqZuXB7zBmBPmqwPeYPrm+TVPbsBdvrnmE2NM1Xx6zZcHvMOYE+bXB7zB9M1nNwEDd/PXOfTxCRlAlk/IYEHAQB8BA5AlYGBBwEAfAQOQJWBgQcBAHwEDkCVgYEHAQB8BA5AlYGBBwEAfAQOQJWBgQcBAHwEDkCVgYEHAQB8BA5AlYGBBwEAfAQOQJWBgQcBAHwEDkCVgYEHAQB8BA5AlYGBBwEAfAQOQJWBgQcBAHwEDkCVgYEHAQB8BA5AlYGBBwEAfAQOQJWBgQcBAHwEDkCVgYOG7a14bY6rmi2u+PeAdxhjTOn+85uMbcJeHax4ZY6rm8TVvDniHMca0zotrnt6Au/iEDPr4hAwgyydksCBgoI+AAcgSMLAgYKCPgAHIEjCwIGCgj4AByBIwsCBgoI+AAcgSMLAgYKCPgAHIEjCwIGCgj4AByBIwsCBgoI+AAcgSMLAgYKCPgAHIEjCwIGCgj4AByBIwsCBgoI+AAcgSMLAgYKCPgAHIEjCwIGCgj4AByBIwsCBgoI+AAcgSMLAgYKCPgAHIEjCwIGCgj4AByBIwsPBwzXtjTNW8vebdAe8w5oT54YA3mL75+pqnN+AuHwLmkTGmah5f8+aAdxhzwriDJjEvbgIG7uYTMujjEzIY7iAJPiGDBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWHi45pExpmoeX/PmgHcYc8K4gyYxL655egPu8mFxvzfGVM3ba94d8A5jTpgfD3iD6ZuvbwIG7uavc+jjEzIY7iAJPiGDBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBBYsb+ggYGO4gCQIGFixu6CNgYLiDJAgYWLC4oY+AgeEOkiBgYMHihj4CBoY7SIKAgQWLG/oIGBjuIAkCBhYsbugjYGC4gyQIGFiwuKGPgIHhDpIgYGDB4oY+AgaGO0iCgIEFixv6CBgY7iAJAgYWLG7oI2BguIMkCBhYsLihj4CB4Q6SIGBgweKGPgIGhjtIgoCBhf8YY+rmX9f844B3GHPC/HTAG0zf/POa394AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAFj7LwwVpDjyrRrOAAAAAElFTkSuQmCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==" alt="" class="pdf24_142" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0096em;">pacientes con progresin de la enfermedad durante la monoterapia con durvalumab se les dio la opcin de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.2191em;">ser tratados de nuevo con 4 ciclos adicionales de IMJUDO en combinacin con durvalumab. Las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:-0.0551em;">evaluaciones del tumor se realizaron en la semana 6, en la semana 12 y, a partir de entonces, cada 8 semanas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0977em;">Las principales medidas de resultado de eficacia fueron la supervivencia libre de progresin (PFS) y la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1297em;">supervivencia general (OS) de IMJUDO y durvalumab en combinacin con quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0277em;">platino en comparacin con la quimioterapia basada en platino sola. Las medidas de resultado de eficacia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:13.4119em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0164em;">adicionales fueron la tasa de respuesta general (ORR) y la duracin de la respuesta (DoR). La PFS, la ORR &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4618em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0099em;">y la DoR se evaluaron mediante una revisin central independiente ciega (BICR) de acuerdo con RECIST &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.5218em;"><span class="pdf24_17 pdf24_08 pdf24_14">v1.1. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.6218em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0851em;">Un total de 675 pacientes fueron aleatorizados para recibir IMJUDO con durvalumab y quimioterapia &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6818em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0168em;">basada en platino (n=338) o quimioterapia basada en platino (n=337). La mediana de edad fue de 63 aos &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.7343em;"><span class="pdf24_69 pdf24_08 pdf24_23" style="word-spacing:0.0105em;">(rango: 27 a 87), el 46 % de los pacientes tenan  65 aos, el 77 % eran varones, el 57 % eran blancos, el &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7943em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0068em;">34 % asiticos, el 0.3 % nativos de Hawai u otras islas del Pacfico, el 3 % indios americanos o nativos de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.8443em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0603em;">Alaska, el 2 % negros o afroamericanos, el 4% de otra raza, el 79 % eran ex fumadores o fumadores actuales, &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.9043em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0126em;">el 34 % ECOG PS 0 y el 66 % ECOG PS 1. El treinta y seis por ciento tena histologa escamosa, el 63 % &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:23.9543em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0016em;">histologa no escamosa, el 29 % expresin de PD-</span><span class="pdf24_69 pdf24_08 pdf24_77" style="word-spacing:-0.0038em;">L1 TC  50 %, el 71 % expresin de PD</span><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:-0.0028em;">-L1 TC &lt; 50 %. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.0643em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.001em;">Los resultados de eficacia se resumen en la Tabla 10 y la Figura 2. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:28.1743em;"><span class="pdf24_12 pdf24_08 pdf24_41" style="word-spacing:-0.001em;">Tabla 10. Resultados de eficacia de POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:22.1442em;top:29.2843em;"><span class="pdf24_12 pdf24_08 pdf24_46" style="word-spacing:0.0061em;">IMJUDO con durvalumab y</span><span class="pdf24_12 pdf24_08 pdf24_14" style="word-spacing:0.5992em;">&nbsp;</span><span class="pdf24_12 pdf24_08 pdf24_33" style="word-spacing:0.0022em;">Quimioterapia basada &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.1842em;top:30.3443em;"><span class="pdf24_12 pdf24_08 pdf24_18" style="word-spacing:0.0029em;">quimioterapia basada en &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.0242em;top:31.3943em;"><span class="pdf24_12 pdf24_08 pdf24_39" style="word-spacing:0.002em;">platino (n=338) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.1158em;top:30.3443em;"><span class="pdf24_12 pdf24_08 pdf24_09" style="word-spacing:0.0001em;">en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.5583em;top:31.3943em;"><span class="pdf24_12 pdf24_08 pdf24_66">(n=337) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:32.5143em;"><span class="pdf24_12 pdf24_08 pdf24_86">OS</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_71">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.062em;top:33.626em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0032em;">Nmero de muertes (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:34.746em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0017em;">Mediana de OS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:35.796em;"><span class="pdf24_17 pdf24_08 pdf24_76" style="word-spacing:-0.005em;">(CI del 95 %) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4642em;top:33.626em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0032em;">251 (74) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.2258em;top:34.746em;"><span class="pdf24_17 pdf24_08 pdf24_14">14.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.8842em;top:35.796em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0018em;">(11.7, 16.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.5083em;top:33.626em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0032em;">285 (85) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.2683em;top:34.746em;"><span class="pdf24_17 pdf24_08 pdf24_14">11.7 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.9258em;top:35.796em;"><span class="pdf24_17 pdf24_08 pdf24_21" style="word-spacing:0.0018em;">(10.5, 13.1) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:36.916em;"><span class="pdf24_17 pdf24_08 pdf24_88" style="word-spacing:-0.0033em;">HR (CI del 95 %) &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.9158em;top:36.916em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0032em;">0.77 (0.65, 0.92) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:38.036em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:0.0045em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_32" style="word-spacing:0.0071em;">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:31.4858em;top:38.036em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.00304 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.062em;top:39.146em;"><span class="pdf24_12 pdf24_08 pdf24_20">PFS</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_143">1 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:7.062em;top:40.266em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0039em;">Nmero de eventos (%) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:41.386em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:-0.0063em;">Mediana de PFS (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:42.436em;"><span class="pdf24_17 pdf24_08 pdf24_76" style="word-spacing:-0.005em;">(CI del 95 %) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.4642em;top:40.266em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0032em;">238 (70) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4558em;top:41.386em;"><span class="pdf24_17 pdf24_08 pdf24_14">6.2 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.3442em;top:42.436em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0023em;">(5.0, 6.5) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.5083em;top:40.266em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0032em;">258 (77) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.4983em;top:41.386em;"><span class="pdf24_17 pdf24_08 pdf24_14">4.8 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.3858em;top:42.436em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0023em;">(4.6, 5.8) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:43.556em;"><span class="pdf24_17 pdf24_08 pdf24_88" style="word-spacing:-0.0033em;">HR (CI del 95 %) &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.9158em;top:43.556em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0032em;">0.72 (0.60, 0.86) &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.5158em;top:44.666em;"><span class="pdf24_17 pdf24_08 pdf24_14">0.00031 &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.0042em;top:45.786em;"><span class="pdf24_17 pdf24_08 pdf24_54" style="word-spacing:-0.0074em;">39 (34. 44) &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.4558em;top:46.906em;"><span class="pdf24_17 pdf24_08 pdf24_14">9.5 &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.062em;top:44.666em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:0.0045em;">valor p</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_32" style="word-spacing:0.0071em;">2 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.062em;top:45.786em;"><span class="pdf24_12 pdf24_08 pdf24_20" style="word-spacing:0.002em;">ORR % (CI del 95 %)</span><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_143" style="word-spacing:0.0032em;">3 &nbsp;</span></sup></div>
					<div class="pdf24_01" style="left:6.062em;top:46.906em;"><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.0011em;">Mediana de DoR (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:5.932em;top:47.9585em;"><span class="pdf24_12 pdf24_08 pdf24_116" style="word-spacing:0.0087em;">(CI del 95 %) &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.0458em;top:45.786em;"><span class="pdf24_17 pdf24_08 pdf24_106" style="word-spacing:-0.0065em;">24 (20, 29) &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.4983em;top:46.906em;"><span class="pdf24_17 pdf24_08 pdf24_14">5.1 &nbsp;</span></div>
					<div class="pdf24_01" style="left:37.3858em;top:47.9585em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0023em;">(4.4, 6.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:26.2842em;top:47.9585em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0021em;">(7.2, NR) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.2887em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.1019em;">1 </span></sup><span class="pdf24_43 pdf24_08 pdf24_121" style="word-spacing:-0.0206em;">Los resultados de PFS/OS se basan en anlisis planificados que se realizaron 25/45 meses, respectivamente, despus &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:50.2487em;"><span class="pdf24_43 pdf24_08 pdf24_64" style="word-spacing:0.0034em;">del inicio del estudio. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.2087em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14">2</span></sup><span class="pdf24_43 pdf24_08 pdf24_65" style="word-spacing:0.0644em;">Valores p de 2 lados basados en pruebas de rango logartmico estratificados por PD-L1, histologa y estadio de la &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.1687em;"><span class="pdf24_43 pdf24_08 pdf24_44" style="word-spacing:0.0036em;">enfermedad y comparadas con un valor lmite de 0.00735 para PFS y 0.00797 para OS. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.1187em;"><sup style="top: -0.29em;"><span class="pdf24_42 pdf24_08 pdf24_14" style="word-spacing:0.0093em;">3 </span></sup><span class="pdf24_43 pdf24_08 pdf24_109" style="word-spacing:-0.0062em;">Respuestas confirmadas con intervalos de confianza de Clopper-Pearson del 95 %. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:54.0787em;"><span class="pdf24_43 pdf24_08 pdf24_86" style="word-spacing:0.0028em;">NR=No Alcanzado, CI=Intervalo de Confianza &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_25" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_144" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_12 pdf24_08 pdf24_24" style="word-spacing:0.0003em;">Figura 2. Curva de Kaplan-Meier de la OS en POSEIDON &nbsp;</span></div>
					<div class="pdf24_01" style="left:21.2942em;top:25.4071em;"><span class="pdf24_135 pdf24_08 pdf24_15" style="word-spacing:0.0024em;">Tiempo desde la aleatorizacin (meses) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:26.7545em;"><span class="pdf24_43 pdf24_08 pdf24_86" style="word-spacing:0.0003em;">Nmero de pacientes en riesgo &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_109">Mes &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:28.7545em;"><span class="pdf24_43 pdf24_08 pdf24_64" style="word-spacing:0.0001em;">IMJUDO + durvalumab + quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5917em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:11.8317em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_14">3</span></div>
					<div class="pdf24_01" style="left:14.0717em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:16.3242em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_14">9</span></div>
					<div class="pdf24_01" style="left:18.5542em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">12 &nbsp;</span></div>
					<div class="pdf24_01" style="left:20.7942em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">15 &nbsp;</span></div>
					<div class="pdf24_01" style="left:23.0342em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">18 &nbsp;</span></div>
					<div class="pdf24_01" style="left:25.2742em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:27.5058em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">24 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.7458em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">27 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.9858em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">30 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2258em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">33 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.4558em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">36 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.6983em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">39 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9383em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">42 &nbsp;</span></div>
					<div class="pdf24_01" style="left:43.1783em;top:27.7545em;"><span class="pdf24_43 pdf24_08 pdf24_145">45 &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5917em;top:30.1445em;"><span class="pdf24_43 pdf24_08 pdf24_145" style="word-spacing:0.9239em;">338 298 256 217 183 159 137 120 109 95 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.452em;top:31.1045em;"><span class="pdf24_43 pdf24_08 pdf24_54" style="word-spacing:0.0029em;">Quimioterapia basada en platino &nbsp;</span></div>
					<div class="pdf24_01" style="left:9.5917em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_145" style="word-spacing:0.9251em;">337 284 236 204 160 132 111 91 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.9858em;top:30.1445em;"><span class="pdf24_43 pdf24_08 pdf24_145">88 &nbsp;</span></div>
					<div class="pdf24_01" style="left:31.9858em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_145">52 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2258em;top:30.1445em;"><span class="pdf24_43 pdf24_08 pdf24_145">64 &nbsp;</span></div>
					<div class="pdf24_01" style="left:34.2258em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_145">38 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.4558em;top:30.1445em;"><span class="pdf24_43 pdf24_08 pdf24_145">41 &nbsp;</span></div>
					<div class="pdf24_01" style="left:36.4558em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_145">21 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.6983em;top:30.1445em;"><span class="pdf24_43 pdf24_08 pdf24_145">20 &nbsp;</span></div>
					<div class="pdf24_01" style="left:38.6983em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_145">13 &nbsp;</span></div>
					<div class="pdf24_01" style="left:40.9383em;top:30.1445em;"><span class="pdf24_43 pdf24_08 pdf24_14">9</span></div>
					<div class="pdf24_01" style="left:40.9383em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_14">6</span></div>
					<div class="pdf24_01" style="left:43.1783em;top:30.1445em;"><span class="pdf24_43 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:43.1783em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_14">0</span></div>
					<div class="pdf24_01" style="left:27.5058em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_145">72 &nbsp;</span></div>
					<div class="pdf24_01" style="left:29.7458em;top:32.0645em;"><span class="pdf24_43 pdf24_08 pdf24_145">62 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.136em;"><span class="pdf24_12 pdf24_08 pdf24_34" style="word-spacing:0.0304em;">12. FORMA DE SUMINISTRO/ALMACENAMIENTO Y MANIPULACIN &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.176em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:-0.0544em;">IMJUDO (tremelimumab-actl) inyeccin es una solucin transparente a ligeramente opalescente, incolora &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:38.226em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.1507em;">a ligeramente amarilla, suministrada en una caja de cartn que contiene un vial de dosis nica en las &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:39.296em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0035em;">siguientes presentaciones: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:41.1409em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.2609em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:41.246em;"><span class="pdf24_17 pdf24_08 pdf24_11" style="word-spacing:-0.0081em;">25 mg/1.25 mL (20 mg/mL) &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:42.366em;"><span class="pdf24_17 pdf24_08 pdf24_88" style="word-spacing:-0.0075em;">300 mg/15 mL (20 mg/mL) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:44.246em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:-0.0098em;">Almacenar en refrigeracin a una temperatura de 2C a 8C en la caja de cartn original para protegerlo de &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:45.306em;"><span class="pdf24_17 pdf24_08 pdf24_106" style="word-spacing:-0.0009em;">la luz. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.196em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0028em;">No congelar. No agitar. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:49.0785em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0038em;">Mantener fuera del alcance de los nios. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:51.1972em;"><span class="pdf24_129 pdf24_08 pdf24_14" style="word-spacing:0.1097em;">12.1. </span><span class="pdf24_12 pdf24_08 pdf24_25" style="word-spacing:0.003em;">Vida til &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.3685em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0025em;">No sobrepasar la fecha de caducidad indicada en el envase. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:55.4872em;"><span class="pdf24_129 pdf24_08 pdf24_14" style="word-spacing:0.1097em;">12.2. </span><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.002em;">Naturaleza y contenido del envase &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_26" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAzAAAAQgCAYAAAA5ebkOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAANT0lEQVR4nO3DoQ2AMBAAwJcY5sE1nQHdpBviUazGaxyqyecuuQgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACqG3mqS54BAMAvLXd1ySMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAIBiRp5qqXsAABTVcldL3QIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAo7c6Pfl4BAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAArPUCNjCJMHcVT4UAAAAASUVORK5CYIIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=" alt="" class="pdf24_146" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:6.0318em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0202em;">Vial de vidrio tipo I de concentrado para solucin para perfusin, con un tapn de elastmero y un precinto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:7.0818em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0503em;">de aluminio violeta de apertura fcil (flip-off), que contiene 25 mg de tremelimumab. Contenido del envase: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:8.1418em;"><span class="pdf24_17 pdf24_08 pdf24_09" style="word-spacing:0.0003em;">1 vial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.2518em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0485em;">Vial de vidrio Tipo 1 de concentrado para solucin para perfusin, con un tapn de elastmero y un precinto &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3018em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0118em;">de aluminio azul oscuro de apertura fcil (flip-off), que contiene 300 mg de Tremelimumab. Contenido del &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:12.3518em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:-0.0015em;">envase: 1 vial. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:14.4718em;"><span class="pdf24_12 pdf24_08 pdf24_46" style="word-spacing:0.0272em;">13. INFORMACIN DE ASESORA AL PACIENTE &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:16.5218em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.0023em;">Recomendar al paciente que lea el inserto para el paciente. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:18.6218em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0017em;">Reacciones adversas inmunomediadas &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.7343em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.1657em;">Informar a los pacientes sobre el riesgo de reacciones adversas inmunomediadas que pueden requerir &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.7943em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.1956em;">tratamiento con corticosteroides e interrupcin o descontinuacin de IMJUDO en combinacin con &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:22.8443em;"><span class="pdf24_17 pdf24_08 pdf24_16" style="word-spacing:-0.0035em;">durvalumab, incluyendo </span><span class="pdf24_26 pdf24_08 pdf24_147" style="word-spacing:0.0186em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:-0.0029em;">Advertencias y precauciones (5.1)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_84">: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.9192em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.0892em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:29.2692em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:25.0243em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.1197em;">Neumonitis: Recomendar a los pacientes que se comuniquen con su proveedor de atencin mdica &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:26.0743em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.001em;">inmediatamente si presentan tos nueva o empeoramiento, dolor en el pecho, o dificultad para respirar. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:27.1943em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.2707em;">Colitis: Recomendar a los pacientes que se comuniquen con su proveedor de atencin mdica &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:28.2443em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0028em;">inmediatamente si presentan diarrea, sangre o moco en las heces, o dolor abdominal severo. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:29.3743em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.1964em;">Hepatitis: Recomendar a los pacientes que se comuniquen con su proveedor de atencin mdica &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:30.4243em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0652em;">inmediatamente si presentan ictericia, nuseas severas o vmito, dolor al lado derecho del abdomen, &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:31.4743em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.0019em;">letargia, o aparicin fcil de hematomas o sangrado. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.4992em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:32.6043em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0236em;">Endocrinopatas: Recomendar a los pacientes que se comuniquen con su proveedor de atencin mdica &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:33.656em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2834em;">inmediatamente si presentan signos o sntomas de hipotiroidismo, hipertiroidismo, insuficiencia &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:34.706em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0001em;">adrenal, diabetes mellitus tipo 1, o hipofisitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:35.7209em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:37.9009em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:40.0709em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:6.002em;top:42.2409em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:35.826em;"><span class="pdf24_17 pdf24_08 pdf24_28" style="word-spacing:0.2389em;">Nefritis: Recomendar a los pacientes que se comuniquen con su proveedor de atencin mdica &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:36.876em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0011em;">inmediatamente si presentan signos o sntomas de nefritis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:38.006em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.1724em;">Reacciones dermatolgicas: Recomendar a los pacientes que se comuniquen con su proveedor de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:39.056em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.0056em;">atencin mdica inmediatamente si presentan signos o sntomas de reacciones dermatolgicas severas. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:40.176em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.1191em;">Pancreatitis: Aconseje a los pacientes que se comuniquen con su proveedor de atencin mdica de &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:41.226em;"><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.0032em;">inmediato en caso de signos o sntomas de pancreatitis. &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:42.346em;"><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0891em;">Otras reacciones adversas inmunomediadas: Recomendar a los pacientes que se comuniquen con su &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:43.396em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0434em;">proveedor de atencin mdica inmediatamente si presentan signos o sntomas de meningitis asptica, &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:44.456em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:0.0808em;">trombocitopenia inmunitaria, miocarditis, anemia hemoltica, miositis, uvetis, queratitis y miastenia &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:45.506em;"><span class="pdf24_17 pdf24_08 pdf24_72">grave. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:47.6185em;"><span class="pdf24_17 pdf24_08 pdf24_24" style="word-spacing:0.0062em;">Reacciones relacionadas con la perfusin: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:48.6434em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:48.7485em;"><span class="pdf24_17 pdf24_08 pdf24_41" style="word-spacing:0.0021em;">Recomendar a los pacientes que se comuniquen con su proveedor de atencin mdica inmediatamente &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:49.7985em;"><span class="pdf24_17 pdf24_08 pdf24_18" style="word-spacing:0.2307em;">si presentan signos o sntomas de reacciones relacionadas con la perfusin </span><span class="pdf24_26 pdf24_08 pdf24_46" style="word-spacing:0.2394em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.2335em;">Advertencias y &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:50.8485em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:0.0018em;">precauciones (5.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:52.9585em;"><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:-0.0076em;">Toxicidad embriofetal: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:53.9734em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:54.0785em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0155em;">Advertir a las mujeres en edad reproductiva que IMJUDO puede causar dao al feto e informar a su &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:55.1285em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.1576em;">proveedor de cuidado de la salud sobre un embarazo conocido o sospechado </span><span class="pdf24_26 pdf24_08 pdf24_83" style="word-spacing:0.1483em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:0.1465em;">Advertencias y &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:56.1885em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0066em;">precauciones (5.3) </span><span class="pdf24_26 pdf24_08 pdf24_57" style="word-spacing:0.0138em;">and </span><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0012em;">Uso en poblaciones especficas (7.1, 7.3)</span><span class="pdf24_26 pdf24_08 pdf24_84">]. &nbsp;</span></div>
				</div>
			</div>
		</div>
		<div id="page_27" class="pdf24_ pdf24_02">
			<div class="pdf24_03">
				<img src="data:image/png;base64,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" alt="" class="pdf24_148" />
			</div>
			<div class="pdf24_view">
				<div class="pdf24_05 pdf24_06">
					<div class="pdf24_01" style="left:6.002em;top:5.9967em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:6.1018em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0737em;">Recomendar a las mujeres con potencial reproductivo que utilicen mtodos anticonceptivos eficaces &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:7.1518em;"><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.0167em;">durante el tratamiento y por 3 meses despus de la ltima dosis de IMJUDO </span><span class="pdf24_26 pdf24_08 pdf24_20" style="word-spacing:-0.0122em;">[ver </span><span class="pdf24_17 pdf24_08 pdf24_23" style="word-spacing:-0.016em;">Uso en poblaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:8.2018em;"><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:0.0048em;">especficas (7.3)</span><span class="pdf24_26 pdf24_08 pdf24_84">]. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:10.3118em;"><span class="pdf24_17 pdf24_08 pdf24_77">Lactancia: &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:11.4418em;"><span class="pdf24_74 pdf24_08 pdf24_13" style="word-spacing:-0.0175em;">Recomendar a las pacientes de sexo femenino no amamantar mientras estn tomando IMJUDO y por &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:11.3367em;"><span class="pdf24_35 pdf24_36 pdf24_14"></span></div>
					<div class="pdf24_01" style="left:7.502em;top:12.5006em;"><span class="pdf24_74 pdf24_08 pdf24_13" style="word-spacing:0.0337em;">3 meses despus de la ltima dosis </span><span class="pdf24_26 pdf24_08 pdf24_46" style="word-spacing:0.0302em;">[ver </span><span class="pdf24_129 pdf24_08 pdf24_88" style="word-spacing:0.0261em;">Advertencias y precauciones (5.3) </span><span class="pdf24_26 pdf24_08 pdf24_14" style="word-spacing:0.0344em;">y </span><span class="pdf24_129 pdf24_08 pdf24_72" style="word-spacing:0.0299em;">Uso en poblaciones &nbsp;</span></div>
					<div class="pdf24_01" style="left:7.502em;top:13.6506em;"><span class="pdf24_129 pdf24_08 pdf24_16" style="word-spacing:0.0015em;">especficas (7.2)</span><span class="pdf24_26 pdf24_08 pdf24_84">]</span><span class="pdf24_17 pdf24_08 pdf24_84">. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:15.8506em;"><span class="pdf24_07 pdf24_08 pdf24_14">14. </span><span class="pdf24_12 pdf24_08 pdf24_13" style="word-spacing:0.0037em;">Informacin adicional &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:17.9818em;"><span class="pdf24_12 pdf24_08 pdf24_24" style="word-spacing:0.0033em;">Para Ecuador: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:19.5318em;"><span class="pdf24_12 pdf24_08 pdf24_28" style="word-spacing:0.0043em;">Fabricado por: </span><span class="pdf24_17 pdf24_08 pdf24_46" style="word-spacing:0.0052em;">Vetter Pharma, Ravensburg, Alemania. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:20.5843em;"><span class="pdf24_12 pdf24_08 pdf24_18" style="word-spacing:0.0049em;">Acondicionado por: </span><span class="pdf24_17 pdf24_08 pdf24_34" style="word-spacing:0.005em;">AstraZeneca AB, Sdertlje, Suecia. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:21.6343em;"><span class="pdf24_12 pdf24_08 pdf24_24" style="word-spacing:0.0033em;">Importado y distribuido por: </span><span class="pdf24_17 pdf24_08 pdf24_25" style="word-spacing:-0.002em;">Dyvenpro distribucin y venta de productos S.A., Guayaquil, Ecuador. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:24.8043em;"><span class="pdf24_26 pdf24_08 pdf24_13" style="word-spacing:0.0049em;">IPP Clave: 1-2025 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:25.8543em;"><span class="pdf24_26 pdf24_08 pdf24_25" style="word-spacing:0.0002em;">Fecha de preparacin de esta versin: 6 de junio de 2025 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:26.9043em;"><span class="pdf24_17 pdf24_08 pdf24_33" style="word-spacing:-0.0011em;">Versin en espaol: VV-RIM-07186826 v.2.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:27.9643em;"><span class="pdf24_17 pdf24_08 pdf24_39" style="word-spacing:-0.0012em;">Versin en ingls: VV-RIM-07186693 v.2.0 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:30.0743em;"><span class="pdf24_17 pdf24_08 pdf24_32" style="word-spacing:-0.0014em;">Documento de referencia: USPI 7/2024 (VV-RIM-04938407 v. 8.0) &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:32.1743em;"><span class="pdf24_17 pdf24_08 pdf24_79">IMJUDO</span><span class="pdf24_74 pdf24_08 pdf24_14" style="word-spacing:0.0011em;"> </span><span class="pdf24_17 pdf24_08 pdf24_20" style="word-spacing:0.0038em;">es una marca registrada del grupo de compaas AstraZeneca. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.002em;top:33.2343em;"><sup style="top: -0.33em;"><span class="pdf24_37 pdf24_08 pdf24_33"></span></sup><span class="pdf24_17 pdf24_08 pdf24_72" style="word-spacing:0.0016em;">AstraZeneca 2025 &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:39.9635em;"><span class="pdf24_149 pdf24_08 pdf24_14" style="word-spacing:-0.0001em;">AstraZeneca Per SA, Calle Las Orqudeas 675, Interior 802, San Isidro, Lima-Per, tel.: &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:41.0675em;"><span class="pdf24_149 pdf24_08 pdf24_14" style="word-spacing:0em;">6101515 RUC 20513645547. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:43.2755em;"><span class="pdf24_149 pdf24_08 pdf24_14" style="word-spacing:0em;">IMFINZI 50mg/mL. Registro Sanitario: BE-01202. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:45.4835em;"><span class="pdf24_149 pdf24_08 pdf24_22" style="word-spacing:0em;">Material exclusivo para el profesional de la salud. Informacin aplicable a Per. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:46.5875em;"><span class="pdf24_149 pdf24_08 pdf24_22" style="word-spacing:-0.0001em;">Mayor informacin Departamento Mdico AstraZeneca Per. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:47.6915em;"><a href="https://aereporting.astrazeneca.com" target="_blank"><span class="pdf24_149 pdf24_08 pdf24_22" style="word-spacing:-0.0001em;">En caso de evento adverso ingrese a https://aereporting.astrazeneca.com y seleccione en pas Per, o escriba al correo &nbsp;</span></a></div>
					<div class="pdf24_01" style="left:6.1091em;top:48.7955em;"><span class="pdf24_149 pdf24_08 pdf24_22" style="word-spacing:-0.0001em;">electrnico PatientSafety.Peru@astrazeneca.com. Link de Data Privacy para reporte de eventos adversos: https:// &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:49.8995em;"><span class="pdf24_149 pdf24_08 pdf24_14">bit.ly/35p2CRf. &nbsp;</span></div>
					<div class="pdf24_01" style="left:6.1091em;top:51.0035em;"><span class="pdf24_149 pdf24_08 pdf24_14" style="word-spacing:0.0002em;">MATPROM: PE-2383 Prep: 07-2025 &nbsp;</span></div>
				</div>
			</div>
		</div>
	</body>
</html>

`;